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Despite the availability of effective treatment strategies, tuberculosis remains a leading 
cause of death world-wide. A major problem in the attempt to eradicate the disease has 
been the reliance on long-term multi-drug antibiotic treatment. The development of novel 
anti-tuberculosis treatment and possibly of a vaccine is essential for successful eradication 
of the disease. An understanding of the host cellular immune response to Mycobacterium 
tuberculosis infection is pivotal in the development of any new treatment programme. The 
cellular immune response following infection with M. tuberculosis is multi-factorial and 
complex. The granulomatous lesion within the lung is the outcome of the co-ordinated 
interaction of macro phages and T lymphocytes. The interplay between these two cell types 
is generally successful in limiting the infection to the lung. How these cells effect an 
eradication of infecting mycobacteria remains unclear. The present study has examined T 
lymphocyte activity in tuberculous pleuritis. The tuberculous pleural effusion affords a unique 
opportunity to study the mononuclear cell population of a M. tuberculosis disease-associated 
site. The mononuclear cells derived from the effusion displayed unique day 5 peak 
proliferation to PPD, a pattern intermediate between previously described accelerated day 4 
and normal day 7 responses. Induction of in vitro cytotoxiC activity was also intermediate to 
normal day 6 and accelerated day 3 kinetic patterns. The responder cell frequency in the 
effusion population was elevated as compared to peripheral blood-derived mononuclear 
cells, however LDA data suggested an element of suppressor activity as we". Although the 
CD4+ T lymphocyte population was expanded in the effusion, CD8+ cells were also 
detected. T lymphocyte clones of both CD4+ and CD8+ cell populations were generated. 
Mycobacterial antigen-specific CD4+ T lymphocyte clones were all of a type-1 phenotype, 
producing high levels of interferon-y (> 10500 pg/ml), but undetectable levels « 16 pg/ml) of 
interleukin-4. The clones all proliferated in response to mycobacterial antigen stimulation. 
The majority of the clones were cytolytic and the lysis of infected macrophages by CD4+ 
cytolytic clones resulted in a reduction in intracellular mycobacterial viability. Mean reduction 
in CFU counts of between 31 % and 42% were detected. Mycobactericidal activity was 
associated with macrophage apoptosis, however apoptosis itself could not account for 
mycobacterial killing. A major defining feature in CD4+ mycobactericidal activity was the 
existence of a predominant granule exocytosis mechanism of killing. Clone cytolytic activity 
was strongly calcium-dependent, and inhibition of granule exocytosis by EGTA, cyclosporin 
A, concanamycin A and strontium resulted in a significant reduction of cytolytic activity. In 
addition to the effusion-derived clones, an effusion-derived T lymphocyte line, which also 
possessed a predominant granule-mediated killing pathway, could similarly induce 
mycobacterial death. A peripheral blood-derived CD4+-enriched T lymphocyte line derived 
from the same patient and which possessed a predominant Fas killing pathway, was unable 
to effect any change in mycobacterial viability. The occurrence of a granule-mediated 











important component of protective cell immunity and may explain organism clearance at 
disease sites. An antigen-specific CD8+ clone was unique in that it produced both interferon­
y and interleukin-4. In addition, the clone displayed no antigen-specific cytolytic activity. 
Proliferative responses were also poor. The clone lacked CD28 and was able to suppress 
mycobacterial-specific proliferation of autologous PBMNC and CD4+ clones. Mean levels of 
suppression of PBMNC of between 78% and 92% were observed. The suppression was 
p8rtially mediated by IL-4 and IL-10 and was dependent on contact between suppressor cell, 
antigen presenting cell and responder cell. The activity of the suppressor CD8+ clone 
appeared to be HLA-DR-restricted. Suppressor activity mediated by CD8+ T cells may 
account for certain immunosuppressive features observed in TB patients. In conclusion, the 
major novel findings of this study were the characterisation. of both effusion-derived 
mycobactericidal CD4+ type-1 CTL clones, and a suppressor CD8+ type-2/type-O T cell 
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Introduction and review of the literature 
1.1. Tuberculosis 
1.1.1. Overview of the problem 
Tuberculosis (TB) is the leading cause of death due to a single infectious human pathogen 
(Bloom and Murray, 1992). The disease remains a global problem of enormous magnitude 
despite the fact that effective treatment strategies are available. It has been estimated that 
one third of the human population is infected with Mycobacterium tuberculosis (Raviglione et 
al., 1995). Chemotherapy, involving long-term combination antibiotic treatment regimens with 
rifampicin, isoniazid, streptomycin and other drugs, has greatly reduced the mortality rate of 
TB. As a result, pre-chemotherapy mortality rates of 50-60% have been drastically reduced in 
countries where the population has access to adequate treatment. Despite the much 
improved situation since the implementation of drug therapy, approximately 3 million people 
die from TB annually (Brennan, 1997). 
Globally TB causes over 25% of avoidable adult deaths, and 7% of all deaths (Enarson and 
Murray, 1996). The great majority of the world's population and therefore also of infected 
individuals occurs in developing countries. Since the disease is often associated with 
poverty, over-crowding, malnutrition and poor hygiene it has always been a major burden in 
areas where these conditions flourish (Murray et al., 1990). South Africa is no exception to 
these trends, indeed the incidence of TB infection in South Africa is one of the highest in the 
world (Strebel and Seager, 1991). The lack of effective diagnostic procedures, particularly in 
rural areas, is a major contributory factor in the severity of the problem since early diagnosis 
is essential for successful treatment. In addition, limited access to anti-tuberculous drugs, 
and more importantly, problems with the monitoring of drug administration compound an 
already serious health problem in these regions. Although the impact of TB on the population 
is highest in the third world, the incidence of the disease in industrialised nations has been 
increasing (Brennan, 1997). The false notion that the disease was under control in Europe 
and North America following the implementation of drug therapy and bacillus Calmette­
Guerin (BCG) vaccination programmes has been shattered with the occurrence of human 
immunodeficiency virus (HIV)-related TB and the emergence of multi-drug resistant (MDR) 
strains of the organism. Between 1985 and 1992, the number of TB cases in the US 










and Murray, 1992}. TB accounts for approximately 40% of deaths related to HIV worldwide 
(Ellner, 1997). 
The development of acquired immune deficiency syndrome (AIDS}-refated TB and the 
occurrence of MDR-tubercufosis has exacerbated the already serious and complex nature of 
M. tuberculosis infection. The problem of HIV and TB co-infection in sub-Saharan Africa is 
enormous, due to the high level of HIV sera-positivity in the population, as well as exposure 
to TB at an early age (Benatar, 1991a). AIDS poses a major risk for the re-activation of 
dormant TB, a problem readily observed in this region (Narain et al., 1992). Drug resistance, 
on the other hand, is a problem resulting from mutations in the causative M. tuberculosis 
organism. Already treatment strategies involve a multi-drug treatment regimen to try and 
alleviate the problem of resistance to single drugs (Snider et al., 1994). The development of 
MDR-TB is a very serious problem in that it is difficult to treat effectively. Treatment time is 
prolonged and the infected individual poses a threat due to an extended period of infectivity 
(Benatar, 1991 b; Brennan, 1997). 
The serious burden of tuberculosis on the human population may suggest that the problem is 
a new one. On the contrary, TB is an ancient disease which is intrinsically linked to 
processes of urbanisation, industrialisation and colonisation. The earliest conclusive 
evidence of TB comes from Egypt. The well-preserved mummy of a child showing evidence 
of both pulmonary and vertebral TB has been dated back to 3400BC (Metcalf, 1991). The 
scourge of tuberculosis has thus been pathogenically linked to humankind since the dawn of 
civilisation. The earliest evidence of TB in Europe comes from a skeleton found in Denmark 
and dating back to between 2500 and 1500 BC. Historical data on tuberculosis are erratic 
due to the fact the different forms of the disease were for a long time not recognised as a 
single condition (Metcalf, 1991). Only with the isolation of the causative organism M. 
tuberculosis in 1882 by Robert Koch (1843-1910) did diagnosis and treatment of tuberculosis 
become more coherent. Despite this early breakthrough in the isolation and cultivation of M. 
tuberculosis, the rate of advancement in understanding of both bacteriological and clinical 
aspects of this disease has been slow. The misinformed conclusion that the introduction of 
chemotherapeutic treatment in the 1940's and 1950's basically eradicated the problem of TB 
led to the cessation of much research into the disease (Benatar, 1991 b). With the recent re­
emergence of the disease in Europe and North America, a new focused and intensive 
research programme has now been developed. 
Without a concerted and aggressive intervention strategy the already serious world-wide 
situation will deteriorate rapidly. Any strategy which hopes to address the eradication of this 
disease must therefore take into consideration the restrictions under which developing 
countries operate. Due to the high cost of current treatment regimens and the compounding 












successful preventative approach (Young and Duncan, 1995). Previous preventative 
approaches, such as the use of BeG vaccination, have been controversial in that their 
efficacy has not been clearly shown. A well co-ordinated and multi-factorial anti-TB vaccine 
programme could lead to successful eradication of this disease. However, due to the 
complex nature of disease pathogenesis and a remarkable survival strategy employed by the 
causative organism, such a programme is proving difficult (Kaufmann and Andersen, 1998). 
A clearer understanding of the pathogenesis of tuberculosis remains a priority for the 
\,levelopment of effective therapies and/or vaccines to eradicate the disease. Of particular 
importance is a more precise knowledge of the immunopathogenesis of this disease, since 
preventative and curative measures directed at the host immune response could circumvent 
the problem of mycobacterial antibiotic resistance (Kaufmann and Andersen, 1998). 
1.1.2. Characteristics of Mycobacterium tuberculosis 
Mycobacterium is the only genus of the family Mycobacteriaceae (Wayne and Kubica, 1986). 
The majority of mycobacteria are non-pathogenic and occur in varied environmental 
conditions from soil and water species to those occurring as natural human symbionts 
(Wolinsky, 1979). The pathogenic species of the genus Mycobacterium can be divided into 4 
main groups: the tuberculous mycobacteria (M tuberculosis, M. bovis and M africanum); the 
lepromatous mycobacterium M leprae; the non-tuberculous mycobacteria (M avium 
complex, M kansasii, M marinum, M. scrofulaceum, M ufcerans, M xenopi, M szulgai and 
M. simae); and the rapid growing potential pathogens (M fortuitum and M chelone/) 
(Hopewell, 1990). 
A defining feature of all mycobacteria is the complex cell wall that is composed of cross­
linked peptidoglycan molecules with attached polysaccharide (arabinogalactan) side chains. 
These arabinogalactan side chains are esterfied at their distal ends by high molecular weight 
fatty acids (mycolic acids) (Brennan and Draper, 1994). Mycolic acids are large (70 to 90 
carbon atoms in length) and complex fatty aci.ds which may contribute to the ability of 
mycobacteria to survive within macrophage phagocytic vacuoles. Other important wall 
associated components are the disaccharide trehalose (cord factor), lipoarabinomannan 
(LAM) and phosphatidylinositol mannosides (PIMs), all which have been implicated in the 
virulence and/or survival strategies of the mycobacteria (Fenton and Vermeulen, 1996). The 
definitive wall structure, which is high in lipid content, accounts for the acid fastness of the 
mycobacteria, a feature demonstrated by the Ziehl-Neelsen staining procedure. 
M tuberculosis is an acid-fast rod that that is typically beaded or stains unevenly, is 
somewhat curved, and approximately 0.3 to 0.6J.1m in width and 1 to 4 J.1m in length (Runyon 
et al., 1974). In Gram-stained preparations the organism may appear Gram-positive, 












shared by all mycobacteria - therefore it is impossible to distinguish between M. tuberculosis, 
the non-tuberculous mycobacteria or M. leprae by staining characteristics alone (Hopewell, 
1990). 
CuUivation of the organism and examination of colonial appearance and determination of 
biochemical characteristics allows separation of M. tuberculosis from non-tuberculous 
mycobacteria. Mycobacteria are strictly aerobic, hydrophobic and generally slow growing. 
The strong aerophilic natU!e of M. tuberculosis accounts for the lung being the primary site of 
infection, an area with a constant supply of oxygen. Under optimum conditions, laboratory 
strains of M. tuberculosis undergo one replication in approximately 18 hours (Wayne, 1994). 
Colonies become visible on agar-based media (e.g. Middlebrook 7H10) by 2 weeks, and on 
egg-based media (e.g. Lowenstein-Jensen) by 3 weeks. Colonies of M. tuberculosis are buff 
coloured and rough surfaced. The lack of pigmentation and slow growth rate enables M. 
tuberculosis to be distinguished from most non-tuberculous mycobacteria. The niacin test 
allows for distinguishing M. tuberculosis and other slow-growing mycobacteria, particularly M. 
avium complex, only M. tuberculosis showing a positive result. Confirmation of the niacin test 
can be made by nitrate reduction assays which also give a strongly positive result with M. 
tuberculosis (Roberts et al., 1991). 
1.1.3. Pathogenesis of tuberculosis 
The vehicle for transmission of the tubercle bacillus is the droplet nucleus (Toossi and Ellner, 
1992). During the process of exhalation water droplets are expelled. Once outside of the 
mouth, the water content of the drop soon evaporates leaving a solid nucleus. In the case of 
persons harbouring a M. tuberculosis infection, tubercle bacilli may be a part of the nucleus. 
Coughing is the most effective means of generating droplet nuclei (Hopewell, 1990). For this 
reason, the more symptomatic a person with pulmonary TB, the greater the infectious 
potential. Apart from coughing, the processes of speech, sneezing and even normal 
breathing can generate droplet nuclei. The infectious potential of an individual is also related 
to the number of organisms that have access to the airway, and thus are liable for inclusion 
in the droplet nuclei. The concentration of organisms in the air is not only determined by the 
number being expelled but is also related to the volume of air into which the organism is 
being released. Small, poorly ventilated areas are thus more conducive to the spread of 
disease than large, well-aerated areas. The droplet nucleus remains in suspension for a 
short while only, but if inhaled by another individual within a few minutes it can initiate a new 
tuberculous infection (Hopewell, 1994). 
The fate of the inhaled droplet nucleus and its associated tubercle bacilli depends on a 
number of .factors, an important criterion being the size. Large particles (>8-10fJm) are 











between 5 and 10/lm enter the conducting airways, land on the mucociliary blanket which 
extends to the level of the terminal bronchiole - and are swept into the oropharynx. A 
substantial number of particles smaller than 5/lm penetrate beyond the ciliated epithelium 
and are thus retained in the lung (Riley et a/., 1995; Hopewell, 1994). 
Once the tubercle bacillus is within the alveolus it encounters a second line of defence - the 
alveolar macrophage. Tubercle bacilli are chemotactic and attract alveolar macrophages to 
the site of implantation. An inflammatory response 1" generated at the site of initial infection, 
the extent of the response being related to the number and virulence of the invading 
organisms (Dannenberg and Rook, 1994). Simultaneously there is a process of systemic 
haematogenous dissemination of organisms. This bacillemia does not cause symptoms but 
results in the seeding of other portions of the lung and other organs with the bacilli. Sufficient 
proliferation of organisms, either within the lung or at extra-pulmonary sites may cause 
clinically evident disease at this stage. Generally, however, the multiplication of organisms is 
held in check until the development of cellular immunity within 30 to 50 days of initial 
implantation (Toossi and Ellner, 1992). The development of an effective cellular immune 
response is marked by a cutaneous reactivity to tuberculin. Sensitised T -cells produce 
cytokines following exposure to infected antigen presenting macrophages. The cytokines 
activate resident macrophages and recruit further macrophages to the site of inflammation. 
The activated macrophages are more competent in theJr ability to control the proliferation of 
the bacilli, but generally complete clearance does not occur (Dannenberg and Rook, 1994). 
Once acquired, the infection may reactivate later in life, a process known as endogenous 
reactivation. The reason for the dormant foci reactivating are unknown but seems to be 
linked to factors which depress delayed type hypersensitivity responses (Doenhoff, 1998). 
The pattern of tuberculosis infection has been divided into 5 stages based on extensive 
studies of the disease in rabbits (Dannenberg and Rook, 1994; Dannenberg, 1991). The first 
stage is onset, which begi s with inhalation of the bacillus into an alveolus, the uptake of the 
bacillus by the alveolar macrophage and the subsequent destruction of the organism. 
Generally successful destruction is not accomplished at this early stage and the second 
stage, symbiosis, begins. Here the infected macrophage is lysed and bacilli are taken up by 
other macrophages recruited to the infection site by chemotaxis. A state of symbiosis ensues 
and bacilli multiply readily within the macrophages without any associated pathology. Some 
macrophages move to the draining lymph nodes and T lymphocytes are expanded following 
antigen recognition. The T lymphocytes relocate to the initial focus of infection. The dynamic 
interaction of T lymphocytes and macrophages results in the formation of the tubercle. The 
third stage is termed caseous necrosis. This stage begins with the cessation of bacillary 
multiplication. Tuberculin negative patients become tuberculin positive and the lesions 
undergo a characteristic necrosis with extensive cellular destruction at the core of the 












equilibrium of tissue-damaging and macrophage activating immune responses. The cellular 
immune response is predominant at this point, With the associated activity of helper- and 
cytolytic-T lymphocytes. The fifth and final stage is liquefaction and cavity formation. 
Extensive destruction of granuloma tissue occurs due to enzymatic activity. The bacilli are 
released from the disease focus into the alveolus or into the blood stream. From the alveolus 
the bacilli are expelled to the exterior and spread to new hosts. If bacilli gain entry to the 
bloodstream, dissemination and multi-organ involvement may ensue. In this model of 
tuberculosis pathogenesis, the sequential progression of disease may be haF.,~d at any stage, 
since entry into a subsequent stage is dependent on the failure of the previous one. Since 
the majority of infected individuals do not proceed to clinical disease, the later stages of 
infection are not observed. 
1.1.4. Clinical manifestations of tuberculosis 
Clinical manifestations of tuberculosis span a broad range from a subtle, indolent process to 
an explosive, life-threatening or fatal illness. The clinical expression of infection with M. 
tuberculosis is quite varied and depends on a number of factors including the age and 
immune status of the host, the virulence of the organism, and the sites of disease 
involvement (Hopewell, 1994). Primary tuberculosis is seldom associated with Significant 
clinical symptoms. Post-primary TB, which is generally responsible for the majority of 
symptoms leading towards positive diagnosiS, may be due to either reactivation or 
exogenous re-infection. Most cases of adult tuberculosis represent reactivation of previous 
dormant foci. 
Among healthy individuals infection with M. tuberculosis is generally likely to be 
asymptomatic. It has been estimated that the lifetime risk of developing clinically evident TB 
after being infected is 10% - with a 90% likelihood of the disease remaining latent 
(Comstock, 1982). In specific sub-populations - e.g. in immunocompromised individuals - the 
proportion which develop evident TB is much higher. BCG immunisation is believed to 
minimise the risk of early disseminated TB in these groups and especially in children. 
The most important factor influencing the clinical features of TB is the site of involvement. In 
non-HIV related TB, approximately 85% of cases are limited to the lungs, the remainder 
involving non-pUlmonary sites or both (Farer et al., 1979). The situation in HIV co-infection is 
skewed towards extra-pulmonary or dual pulmonary and non-pUlmonary involvement (Small 
et al., 1991). This involvement of multiple sites in HIV related TB is an indication of the 
serious effects of limited immune function on the containment of infection. 
. . 
Systemic manifestations of the disease include fever, malaise and weight loss - symptoms 












most easily quantified and has been found to occur in between 37-80% of patients (Kiblawi et 
al., 1981). In addition to generalised effects there are remote manifestations which are not a 
result of anatomic site of involvement. Amongst these the most commonly encountered are 
haematological abnormalities (especially leukocytosis and anaemia), hyponatremia and 
psychological disorders (Hopewell, 1994). 
1.1.4.1. Pulmonary TB 
The clinical manifestations of reactivation of pulmonary tuberculosis are very variable and 
include both generalised systemic symptoms (e.g. malaise, lethargy, fever, weight loss and 
night sweats) and localised symptoms (Toossi and Ellner, 1992). Cough is by far the most 
common localised symptom of pulmonary TB. Early in infection the cough may be non­
productive, but subsequently as inflammation and tissue necrosis ensue, sputum is generally 
produced. Inflammation of lung parenchyma adjacent to the pleural surface may cause 
pleuritic pain. Spontaneous pneumothorax may occur causing chest pain and dyspnea. In 
addition severe respiratory failure sometimes also occurs. Haemoptysis may also be a 
presenting symptom but is not necessarily indicative of active TB (Hopewell, 1990). 
Pulmonary TB nearly always causes abnormalities on chest radiographs (Benatar, 1991 b). In 
primary TB occurring as a result of recent infection, the rocess is generally seen as a 
middle or lower lung zone infiltrate. Tuberculosis that develops as a result of endogenous 
reactivation of latent infection usually causes abnormalities in the upper lobes of one or both 
lungs. Cavitation (destruction of lung tissue) is common in this form of TB. Healing of the 
tuberculous lesions usually results in development of a scar with loss of lung pa~enchymal 
volume and calcification. Erosion of a parenchymal focus of tuberculosis into a blood or 
lymph vessel may result in dissemination of the organism. 
Definitive diagnosis of tuberculosis can be established only by isolation of tubercle bacilli in 
culture or via identificatio  of M. tuberculosis DNA using polymerase chain reaction (PCR) 
techniques. In pulmonary TB sputum is the diagnostiC specimen of choice. Detection of acid 
fast bacilli (AFB) in sputum smears is indicative of active TB. Sputum negativity (i.e. no 
detection of AFB) must be followed up with bacteriologic culture which generally confirms 
clinical diagnosis (Roberts et al., 1991). 
1.1.4.2. Extra-pulmonary TB 
Extra-pulmonary TB presents more of a diagnostic and therapeutic problem in that it is a less 
common manifestation of TB and therefore less familiar to the clinician (Weir and Thornton, 
1985). Extra-pulmonary TB involves relatively inaccessible sites and due to the nature of the 
sites fewer bacilli are able to cause greater damage. Low numbers of bacilli and difficulty in 
isolation from infection sites make positive diagnosis more problematic than in pulmonary 












manifestations are lymphatic (27% of all extra-pulmonary TB), pleural (22%), genitourinary 
(16%), miliary/disseminated (10%), skeletal (9%), meningeal (4%) and peritoneal (4%) 
(Hopewell, 1990). Although miliary or disseminated TB usually involves the lungs - there is 
generally multi-organ involvement, hence the inclusion in the extra-pulmonary category. 
Other less common sites of infection include abdominal and pericardial TB. A detailed 
discussion of all of these manifestations is beyond the scope of this thesis, however pleural 
tuberculOSis will be discussed due to its relevance in this study. 
Pleural tuberculosis was traditionally considered to almost always be a manifestation of 
primary tuberculosis. Today it is recognised as a manifestation in older patients with 
concomitant pulmonary TB. The epidemiology of pleural TB parallels that of the overall 
pattern of TB (Benatar, 1991 b). The disease is more common in males and anincrease in 
incidence occurs with increasing age between 5 and 45. There are two mechanisms by 
which the pleural space becomes involved in tuberculosis and the difference in pathogenesis 
results in different clinical presentations, diagnostic approaches and treatment. These two 
forms are tuberculous pleuritis and tuberculous empyema. The latter form is much rarer, 
involves large numbers of organisms and appears to be caused by rupture of adjacent 
tuberculous cavities in the lung. Further discussion is focused on classical tuberculous 
pleuritis. 
In the course of a tuberculous infection a few organisms may gain access to the pleural 
space and in the presence of cell-mediated immunity (CMI), cause a hypersensitivity 
response (Ellner, 1978). Normally this occurrence goes unnoticed and the process 
spontaneously resolves. In some patients, however, tuberculous involvement of the pleura is 
manifested as an acute illness with fever and pleuritic pain. Effusions are generally small and 
usually unilateral, but sometimes large effusions are produced causing dyspnea. 
Diagnosis of pleural tuberculosis is generally established by analysis of pleural fluid or by 
pleural biopsy. Pleural fluid is nearly always straw coloured with cell counts of between 100 ­
5000/1l1 (Jay, 1985). Mononuclear cells predominate in most cases. The fluid is exudative 
with a high protein concentration. Pleural fluids rarely give positive smear results due to low 
numbers of organisms. Culture positivity is also low, with only 20-40% of patients with proved 
tuberculous pleuritis being culture positive. Confirmation of diagnosis is often via needle 












1.1.5. Pathogenesis and Immune response in tuberculosis 
1.1.5.1. Overview 
Host defences against M. tubercul.osis depend on cell-mediated rather than humoral 
immunity. Persons with defective cell-mediated immunity, such as those with HIV infection 
and chronic renal failure, are markedly at risk for TB, whereas those with defective humoral 
immunity, such as those with sickle cell disease or multiple myeloma, show no increased 
disposition to the disease (Barnes and Modlin, 1996). Experimental evidence indicates that 
anti-mycobacterial defence mechanisms are mediated primarily by T lymphocytes and 
, 
macrophages. Macrophages act as effectors and T lymphocytes act as inducers of 
protection (Kaufmann, 1998b). Adoptive transfer of resistance against tubercul.osis in animal 
models is dependent .on T cells, a fact which implicates these cells as the mediators of 
disease resolution (Orme and Collins, 1984). 
Macrophages, in addition to being mediators of cell-mediated immunity (CMI), also act as the 
preferred host cells of M. tubercul.osis. Their role in tuberculosis is thus contradictory ­
promoting not only protection against the disease but also survival of the pathogen. T cells 
similarly have a dual role, being pivotal for protective immunity, but also contributing to 
pathogenesis. A co-ordinated interacti.on .of T cells and macrophages is essential for 
optimum pr.otection (Barnes et a/., 1994). This interacti.on is best achieved in the 
granul.omatous leSion, which provides the tissue site for defence against tubercul.osis. 
Despite the localised, co-ordinated T cell-macrophage interaction, full eradicati.on of 
.organisms is seld.om achieved and individuals usually remain infected without developing 
disease. Later imbalances in immune function may prom.ote mycobacterial re-emergence 
and the development of clinical disease. 
A major factor in successful protective immunity is the producti.on of cytokines by both 
infected macrophages and T cells. The initial pattern of cyt.okine production by the 
macrophages appears t.o be pivotal in the establishment .of a protective Th1 type T cell 
response. The T cells in turn produce cyt.okines which activate .other T cells (interleukin-2) as 
well as macrophages (interferon (IFN)-y and TNF-a), and which may also impart anti­
mycobacterial activity. 
1.1.5.2. Macrophages and macrophage-derived cytokines 
Murine macrophages have for a long time been known to have anti-mycobacterial activity 
(Rook and Bloom, 1994). Later work identified interferon (IFN)-y as the key endogenous 
activating cytokine that triggers the anti-mycobacterial activity of macrophages (Rook et a/., 
1986a, 1986b; Flesch and Kaufmann, 1987). In addition to IFN-y, TNF-a, although ineffective 
alone, is able to synergise with IFN-y to induce in vitro anti-mycobacterial effects in murine 
macrophages (Flesch and Kaufmann, 1990). Other cytokines have been implicated in 












Interleukin (IL)-4 and IL-6 both have anti-mycobacterial effects if added to infected 
macrophage cultures (Flesch and Kaufmann, 1990). Various cytokines involved in 
granuloma formation including IL-8, IL-1, IL-2, IL-4 and IFN-y also contribute indirectly in anti­
mycobacterial activity. IL-12 is a key pro-inflammatory cytokine and appears to playa major 
role in activating macrophages as well (Zhang et al., 1994). In contrast, the cytokines IL-10 
and transforming growth factor (TGF)-~ have been shown to reduce macrophage anti­
mycobacterial activity (Bermudez and Champsi, 1993; Bermudez 1993). 
Protective immunity in murine models occurs via a strong T helper cell type 1 (Th1) process. 
The CD4+ cells, and to a lesser extent the CD8+ cells, produce high levels of interferon-y, 
which in turn correlates with protective immunity (Kawamura et al., 1992, Huygen et al., 
1992). In humans the pattern of cytokine production of T cell clones derived from TB patients 
has been shown to include interferon-y, TNF-a, and IL-10. This is indicative of a ThO pattern, 
but it appears that the pro-inflammatory cytokines predominate (Barnes et a/., 1993). 
Infection of macrophages with M. tuberculosis results in the production of a characteristic 
pattern of cytokines that have the potential to exert potent immunoregulatory effects and to 
mediate many of the clinical manifestations of TB (Barnes et a/., 1992). The most important 
of these include IL-1, TNF-a, IL-6, IL-10, T cell growth factor (TGF)-~, and IL-12. 
IL-1 is produced upon stimulation of human monocytes with M. tuberculosis, and with the 
mycobacterial cell wall component lipoarabinomannan (Barnes et a/., 1992; Zhang et a/., 
1993). IL-1 is an endogenous pyrogen and may contribute to the fever that is characteristic of 
TB. IL-1 may also enhance the inflammatory response by inducing macrophages to produce 
other cytokines e.g. TNF-a, and by stimulating T cell proliferation. Interestingly, IL-1 has also 
been linked to immunosuppression, since patients with depressed proliferative responses to 
M. tuberculosis produce high levels of IL-1 (Ellner, 1978). 
Human mononuclear cells including alveolar macrophages produce high levels of TNF-a in 
response to M. tuberculosis, LAM and mycobacterial proteins of molecular masses of 20,44, 
58 and 65kD (Barnes et al., 1990, 1992). The expression of the CD14 molecule is also 
necessary for TNF-a production (Zhang et at, 1993). Clinical and experimental data suggest 
that TNF contributes both to protection against tuberculosis and to immunopathology. TNF 
enhances antimycobacterial activity of macrophages in vitro (Flesch and Kaufmann, 1990). 
In addition, TNF appears to be involved in successful granuloma formation, since the 
administration of anti-TNF antibodies interferes with granuloma formation and mycobacterial 
clearance in mice (Kindler et a/., 1989). TNF levels are elevated at the site of disease in 
tuberculous pleuritis patients (Barnes et a/., 1990/, and patients with chronic refractory 
pulmonary TB have lower levels of TNF than newly diagnosed patients, which indicates the 












immunopathology has been demonstrated by the administration of TNF to animals - a 
procedure that results in fever and wasting (Beutler and Cerami, 1987). In TB patients with 
cachexia and high fever, levels of TNF are higher than in patients with less severe symptoms 
(Cadranel et al., 1990). Thalidomide abrogates the functional activity of TNF, and in the 
process alleviates symptoms such as anorexia and fever (Tramontana et al., 1995). TNF 
thus has a dual role in TB, as an important anti-mycobacterial mediator within the localised 
granuloma, but also as a mediator of tissue necrosis, fever and cachexia. 
fL-6 reduces the binding of TNF to macrophages and reduces the anti-mycobacterial activity 
of TNF in mycobacteria-infected macro phages (Bermudez et al., 1992). Addition of IL-6 
enhances intracellular and extracellular mycobacterial growth, and may therefore be 
important in down regulating the inflammatory response (Shiratsuchi et aI, 1991). 
IL-10 and TGF-p are both anti-inflammatory cytokines produced by macrophages following 
exposure to M. tuberculosis (Barnes et ai, 1992). IL-10 inhibits cytokine production by 
monocytes, inhibits the microbicidal activity of murine macrophages and suppresses antigen­
specific T-cell proliferation by down-regulation of macrophage MHC class " expression 
(Oswald et ai, 1992; De Waal Malefyt et aI, 1991). Neutralisation of IL-10 with anti-IL-10 
significantly reduces bacterial load in mice (Bermudez and Champsi, 1993). IL-10 also 
reverses the anti-mycobacterial activity of TNF. In TB patients the neutralisation of IL-10 
enhances IFN-y production by PBMC, by enhancing IL-12 production by monocytes (Gong et 
al., 1996). IL-10 may thus playa role in anergic responses to M. tuberculosis, but may also 
be important in moderating what could become an uncontrolled pro-inflammatory response 
leading to sever tissue damage. 
TGF-p inhibits cytokine production by macrophages and inhibits MHC class II expression 
(Ruscetti et ai, 1993). This cytokine also inhibits IL-2 dependent T-cell proliferation and IL-2 
receptor expression (Ortaldo, 1991). TGF-p also appears to de-activate macrophages, and is 
produced at the highest levels in macrophages infected with the most virulent mycobacterial 
strains. In the presence of anti-TGF-p, the anti-mycobacterial effects of IFN-y are reduced 
(Toossi et ai, 1995) 
IL-12 is a macrophage derived cytokine which plays a pivotal role in the induction of a Th1 
type response and is discussed below. 
1.1.5.3. Binding and uptake of M. tuberculosis 
M. tuberculosis is a facultative intracellular pathogen and has developed numerous 
mechanisms for entering human macrophages. The receptors involved in er,try processes 












surfactant protein receptors, (iv) CD14, (v) scavenger receptors, and (vi) Fc receptors (Ernst, 
1998). 
M. tuberculosis bacilli are thought to enter the macrophage by specific binding to several 
distinct cell surface molecules, and the precise route of entry is likely to determine the fate of 
the bacilli within the macrophage. Direct binding of M. tuberculosis to the macrophage is 
possible via complement receptors (CRs) and the macrophage man nose receptor (MMR). 
The MMR is involved in non-opsonic binding and phagocytosis through recognition of 
terminal mannose residues on the invading bacilli. MMRs seem to be important in 
phagocytosis of virulent strains of M. tuberculosis in the absence of serum (Schlesinger, 
1993). Mannose-dependent binding accounts for only a small proportion of total M. 
tuberculosis phagocytosis. CD14 has also been implicated in non-opsonic binding and 
uptake (Peterson et a/., 1995). Opsonic binding involves heat-labile serum components and 
the complement receptors CR1 (CD35), CR3 (CD11 b/CD18) and CR4 (CD11 c/CD18). The 
role of these components is well established, with adherence and ingestion of M. 
tuberculosis being strongly inhibited (up to 84%) by antibodies t  the various CRs 
(Schlesinger and Horwitz, 1991). Complement component 3 (C3) is important in the 
facilitation of M. tuberculosis binding and uptake (Schlesinger et a/., 1990). Fc receptors, 
however, are unlikely to play a major role due to their initiation of reactive oxygen 
intermediates (ROI) following engagement. 
Surfactant proteins are abundant in the alveoli of the lung and therefore a role for surfactant 
protein (Sp) receptors in the pathogenesis of M.tuberculosis has been proposed. It appears 
that Sp-A enhances binding and uptake of M. tuberculosis, but the exact mechanisms remain 
unclear. The binding and entry of M. tuberculosis via CD14, scavenger receptors and Fc 
receptors is less well characterised than CR-mediated entry (Ernst, 1998). 
M. tuberculosis seems to have exploited multiple receptors to ensure successful entry into 
the macrophage. Why do mycobacteria target macrophages? Several hypotheses have been 
proposed, The most commonly cited reasons include the idea that the macrophage provides 
a safe haven for replication since the organism has succesfully developed strategies that 
protect it from both the normal macrophage anti-bacterial properties and from the cellular 
immune response (Schaible et a/., 1999). Macrophages may also enable the organism to 
spread accross pulmonary epithelial barriers. Also, M. tuberculosis may gain from being 
within in the macrophage in the sense that pathogenicity may be enhanced in this location 












1.1.5.4. Intracellular survival of M. tuberculosis 
Following attachment and subsequent phagocytosis, sustained intracellular bacterial growth 
depends on the ability to avoid destruction by lysosomal enzymes, ROI and reactive nitrogen 
intermediates (RNI). These macrophage defence mechanisms can be avoided if the 
mycobacterium-containing phagosomes are prevented from fusing with the Iysosomes. 
Virulent M. tuberculosis appears to be able to prevent phagosome-lysosome fusion by 
disrupting normal functioning of phagosomes and preventing them from developing acidic 
'J1yarolase-rich compartments. Mycobacterium-containing vesicles fail to fuse with endosomal 
vesicles containing other ingested material e.g. electron-dense colloids (Rastogi et al., 1992). 
The restricted ability of the mycobacterium-containing phagosomes to fuse suggests an 
alteration in their biochemical composition - either preventing delivery of mycobacteria into 
the lysosomal compartment or blocking phagosome association with anti-bacterial 
molecules. The latter possibility has been confirmed in studies that revealed that vacuolar 
membranes surrounding the bacilli lacked a proton ATP-ase, which may be responsible for 
phagosomal acidification (Sturgill-Koszycki et al., 1994). Continued containment of 
mycobacteria within these specialised vesicles may also reduce the ability of mycobacterial 
antigens to be processed, associated with MHC class II, and transported to the surface of 
the cell (Pancholi et al., 1993). 
1.1.5.5. Microbicidal activity of macro phages 
The assumption that activated human macrophages can kill M. tuberculosis has not been 
demonstrated unequivocally in vitro, especially in the case of human monocytes and 
macrophages. Douvas et al. (1986) reported that 3-day-old macrophages showed 
suppression of growth of virulent M. tuberculosis. Furthermore, human monocytes activated 
by IFN-y and TNF-a. have been repo ted to possess strong mycobactericidal activity (Dennis, 
1991). Later studies have disputed these findings as artefactual, since treatment of 
macro phages with these cytokines may render them more sensitive to the toxic effects of the 
mycobacteria (Warwick-Davies et a/., 1994). 
Were mycobacterial killing to take place it would occur within macrophage phagolysosomes. 
Toxic constituents within this acidic vesicle include lysosomal hydrolases, ROI e.g. H20 2 and 
O2', RNI e.g. NO and N02". RNI production is an important effector mechanism against a 
variety of pathogens in murine macrophages. NO and other RNI are derived from L-arginine 
via an enzymatic pathway which is controlled by an inducible nitric oxide synthase (iNOS) 
(Nathan and Xie. 1994). Cytokines are powerful mediators of RNI synthesis. The pro­
inflammatory cytokines TNF-a. and IFN-y are potent activators of iNOS, while IL-4, IL-10 and 
TGF-J3 suppress it. Growth inhibition of mycobacteria by cytokine-stimulated murine 












Although well characterised in mice, the role of RNI in humans is less well understood. 
Production of iNOS mRNA and protein have been reported, however the absence of 
detectable RNI activity seems to indicate that resting macrophages require other induction 
signals for RNI production. Another explanation may be that infected human macrophages 
produce higher levels of the cytokines IL-4, IL-10 and TGF-~ than their murine counterparts _ 
thus suppressing successful RNI production (Fenton and Vermeulen, 1996). 
Initial infection by M. tubef"Clllosis leads to the rapid activation of alveolar macrophages, the 
induction of cytokines which serve to limit the growth of ingested organisms, and the 
recruitment of additional leukocytes from the peripheral circulation. Enhancement of 
mycobactericidal function can be exerted by T cells, especially a~+ CD4+ T cells which 
secrete IFN-y and IL-2 (Orme, 1993). Although IFN-y alone seems unable to activate 
macrophages sufficiently to kill M tuberculosis, combined cytokine exposure (with e.g. TNF­
a) may lead to successful macrophage anti-mycobacterial activity. TNF is essential for both 
granuloma formation and mycobactericidal activities of macrophages in the murine model 
(Kindler et al., 1989). Other macrophage-derived cytokines that may activate human 
macro phages to kill mycobacteria are granulocyte-macrophage colony-stimulating factor 
(GM-CSF) and IL-12. 
1.1.5.6. Interactions between macrophages and T cells 
The collaboration of T cells and macrophages at the disease site is essential for clearance of 
M. tuberculosis infection. This occurs via antigen specific DTH responses. Initial presentation 
of antigens to T cells in the lymph nodes is primarily carried out by dendritic cells, which 
migrate from infection sites to draining lymph nodes. Antigen presentation by either dendritic 
cells (in the lymphoid tissue) or macrophages (in the granulomatous lesion at the disease 
site) occurs in association with MHC class I or class II proteins or with non-polymorphic 
MHC-like proteins e.g. CD1. Macrophage-derived cytokines play critical roles in the 
stimulation of antigen-specific T cells. Subsequently to activation, cytokines produced by T 
cells further modulate macrophage function, although the final outcome may be either to 
augment or inhibit intracellular M. tuberculosis growth. 
The Th1-type cytokines (e.g. IL-2 and IFN-y) may enhance antigen presentation and 
stimulate antimicrobial responses within the macrophage itself. The presence of both 
antigen-specific T cells and activated macrophages together with their associated cytokines 
within the granuloma provides for long term containment of infected macrophages. In murine 
models of TB, this initial Th1-type response is followed by a Th2-type response Which limits 
inflammation and minimises tissue damage, but also suppresses the DTH reaction (Orme et 
al., 1993). Il-12 may be a pivotal cytokine in the initiation of the Th1-type pro-inflammatory 
DTH response. IL-12 enhances production of IFN-y which facilitates the production of Th1 













Elevated levels of IL~12 have been observed in pleural fluids of tuberculous pleuritis patients 
(Zhang et al., 1994). In contrast, the Th2~type responses may contribute to the 
immunosuppression often observed in advanced disease. This type of response is 
particularly apparent in HIV and TB co~infection, where Th1~type responses are diminished. 
Macrophages are likely to contribute to these responses via the production of 
immunosuppressive cytokines e.g. IL~10 and TGF~~ (Zhang et al., 1994). The cytokine 
..... network therefore controls a complex set of responses that may be growth modulatory to M. 
tuberculosis, pro~inflammatory, or immunosuppres.~;1ve. 
Due to the protected environment within host macrophages that pathogenic strains of M. 
tuberculosis create, tuberculosis can be considered as a prototype of an infection controlled 
through the cellular immune response. Without the activity of functional cellular immunity M. 
tuberculosis would be able to replicate and spread rapidly, initiating systemic infection and 
death. The cellular immune response is responsible for the containment of the disease 
observed in the majority of infected individuals. 
1.1.5.7. T lymphocyte-mediated protection in M. tuberculosis infection 
The T cell receptor (TCR) and the non-covalently linked CD3 molecule on the surface of 
peripheral T cells are responsible for the transduction of the antigenic signal received from 
the antigen-presenting cell. The TCR is a disulphide heterodimer which is composed either 
of an a and ~ chain, or a y and a 0 chain. In human peripheral blood approximately 90% of T 
cells express the a~ TCR, with generally <10% expressing the yo TCR. 
Macrophages are professional antigen-presenting cells (APC) and in tuberculosis it is the T 
cell-macrophage interaction which is pivotal for successful control of the disease (Orme et 
al., 1993). Antigen is processed and then presented by antigen presenting cells in one of two 
ways. Endogenous antigens are processed via the MHC class I pathway and are classically 
presented to CD8+ T cells. Exogenous antigens are processed via the MHC class II pathway 
and are presented to CD4+ T cells. Exceptions to this standard pattern have been observed, 
and it now also recognised that non-peptide antigens may also be presented to T cells, but 
not via MHC-linked pathways, but rather through the CD1 complex of cell surface molecules 
(Porcelli et al., 1992). 
The a~ T cells which express the CD4 marker are able to 'recognise portions of 
phagocytosed protein presented by the APC in combination with the MHC class II molecule. 
The CD8-expressing a~ T cells recognise peptides derived from proteins of cytosolic origin 
which are presented in combination with MHC class I molecules. Functionally, CD4+ T cells 
are involved in the amplification of the immune response (helper function). whilst some CD4+ 











Based on their cytokine production profile, C04+ T cells in the mouse have been subdivided 
into two groups. Th1 cells produce IL-2 and IFN-y, which support their role as regulatory and 
effector cells in the cellular immune response. Th2 cells produce IL-4, IL-5, IL-6 and IL-10. 
and provide help to B-cells for the production of immunoglobulin. Th2 cells seem to 
predominate later in tuberculosis infections in the mouse, and are linked with the down­
regulation of the pro-inflammatory response. Both subsets have been found to secrete the 
cytokines IL-3, TNF-a and GM-CSF (Del Prete et al., 1994). 
Adoptive transfer studies in mice have shown that protective immunity is reliant upon 
functional CD4+ or CD8+ T cells, as well as monocytes/macrophages (Orme and Collins, 
1984). The continued exposure of T cells to mycobacterial antigens induces a significant 
state of memory immunity, which in most cases leads to a delayed type hypersensitivity 
(DTH). In the murine system the T cell-mediated response can amplify the power of the 
macrophages to kill and digest the bacilli. The degree of T cell activation and the local 
concentration of antigens influences the outcome of the disease. A strong T cell response 
and a small antigen load generates a highly organised granuloma consisting of lymphocytes, 
macrophages, giant cells and fibroblasts in dynamic equilibrium. Once the infected 
macrophages are lysed, either directly or via the action of CTL, escaping bacteria are 
subsequently ingested and destroyed by surrounding macrophages activated by T cells. A 
necrotic caseous centre is formed in the tubercle. Such a tubercle is termed a proliferative 
focus and is a very successful tissue reaction, since it can arrest the infection and in some 
cases even leads to sterilisation of the caseous tissue (Toossi and Ellner, 1992). An over­
reactive T cell response with high antigen load brings about a less well-organised tubercle. In 
this case there is liquefaction of the caseous tissue due to lytic enzymes released from 
degenerating and dying macrophages. Mycobacterial growth is not contained in such a 
scenario, and destruction of pulmonary tissue can occur leading to the formation of a cavity 
adjacent to the bronchi, permitting the mycobacteria to spread to other tissues or to the 
environment. Clinical tuberculosis therefore seems to be directly associated with 
mycobacterial T cell reactivity, which controls the local concentrations of tubercle bacilli and 
their antigens (Munk and Emoto, 1995). 
1.1.5.8. T cell subsets involved in M. tuberculosis infection 

Of the different subsets of T cells for which a role has been defined in M. tuberculosis i.e. 

CD4+, CD8+, yo, and double negative, CD4+ T cells have been most thoroughly investigated. 

Their role is two-fold since they are involved both in the production of cytokines (helper 

function) and in cytotoxic activity. 

1.1.5.8.1. CD4+ T cells 

The bulk of experimental and clinical data suggest a central role for CD4+ cells in immune 














M. tuberculosis are unable to control mycobacterial growth (Pedrazzini et al., 1987; Muller et 
al., 1987). MHC class II-deficient mice which lack conventional CD4+ effector cells suffer 
severely from both M. bovis BCG and M. tuberculosis, disease ultimately leading to death 
(Ladel et ai, 1995). Adoptive transfer of CD4+ cells from sensitised animals confers 
protection against tuberculosis (Orme, 1987; 1988). In the human, CD4+ cells are expanded 
at the site of disease in patients with tuberculous pleuritis. HIV infection, which depletes 
CD4+ T cells, markedly increases susceptibility to both primary and reactivation tuberculosis 
(Barnes et al., 1991). In addition, HIV infected tuberculosis patients demonstrate a 
progressive increase in clinical indicators of severe disease (e.g. extra-pulmonary 
involvement, mycobacteremia and acid fast smears) concomitant with a decline in CD4+ cell 
count (Jones et al., 1993). The severity of this change is illustrated by the fact that 
mycobacteremia was observed in 4% of patients with a CD4+ cell count of >200IJlI, but 
increased to 49% in those with 100 or less CD4+ T cells/Jll. 
1.1.5.8.2. Th1 and Th2 subsets in human mycobacterial infection 
Human T cells can exhibit dichotomous patterns of cytokine production similar to those of 
murine Th1 and Th2 cells. The startling difference between the murine and human groups is 
the production of IL-10. This cytokine is only produced by Th2 mouse T cells, but by both Th1 
and Th2 groups in the human (Del Prete et al., 1993). In leprosy, the two divergent forms of 
disease are due to the predominance of either a Th1 population (tuberculoid leprosy), or a 
Th2 population (lepromatous leprosy). Patients displaying the latter form of the disease have 
IL-4 and IL-10 predominating within the lesions, there is an ineffective immune response and 
bacillary burdens are enormous (Yamamura et al., 1991). 
The relative amounts of either Th1 or Th2 cytokines occurring at the site of pathology in M. 
tuberculosis infections, or being secreted by PBMNC or T cell clones, have been reported by 
several groups. Contradictory patterns have been reported. Certain reports have noted that 
CD4+ M. tuberculosis-reactive T cell clones are Th1-like, in that they produce high levels of 
IFN-y, but no IL-4 or IL-5 (Del Prete et al., 1991). Other groups have indicated that M. 
tuberculosis-reactive T cells secrete a broad range of cytokines including IFN-y, IL-2, IL-4, IL­
5 and IL-10 (Boom et al., 1991; Barnes et al., 1993). Evaluation of PBMNC from both 
tuberculosis patients and healthy tuberculin responders, stimulated with M. tuberculosis in 
vitro, showed that levels of IL-4 production and mRNA expression were similar for both 
groups. However, the PBMNC from the tuberculosis patients had reduced IL-2 and IFN-y 
production and mRNA expression compared to healthy tuberculin reactors (Zhang et al., 
1995). This would suggest susceptibility to TB being associated with a depressed Th1 
response, but not an enhanced Th2 response. Other investigators have reported the 
frequency of IL-4 producing cells being higher in M. tuberculOSIs-stimulated PBMC from 
patients, than those from healthy tuberculin reactors - whereas the frequency of IFN-y­












result from different experimental procedures and may reflect actual events in vivo. These 
findings emphasise the importance of assessment of actual response at the site of disease. 
In patients with tuberculous pleuritis, expression of mRNA for the Th1 cytokines IFN-y and IL­
2 is greater in the pleural fluid than in the blood, with concentrations of IFN-y being 15-fold 
higher than in serum (Barnes et al., 1993). Levels of mRNA expression of IL-4, a Th2 
cytokine, are lower in the pleural fluid than in the blood. Lymphocytes isolated from the 
pleural fluid and stimulated with M. tuberculosis, produce more IFN-y and IL-2 than do 
peripheral blood lymphocytes. These findings suggest that there is a selective concentration 
of Th1 like cells at the site of disease with patients showing a resistant immune response. 
Th1 cells are thus important in anti-mycobacterial defences. 
The capacity of IFN-y to augment mycobacterial killing in human macrophages remains 
controversial (Douvas et al., 1985; Shiratsuchi et al., 1990). However, this cytokine has been 
shown to stimulate human macrophages to produce TNF and 1,25-dihydroxy-vitamin D, both 
of which facilitate mycobacterial clearance (Rook et al., 1986a, 1986b; Bermudez and Young, 
1988). IFN-y administration to patients with disseminated M. avium complex disease, 
resulted in marked improvement (Holland et al., 1994). IL-2, another classic pro-inflammatory 
Th1-type cytokine, is also beneficial in that it expands populations of antigen-reactive T cells. 
simultaneously increasing the level of macrophage-activating factors secreted by the same T 
cells. IL-2 has been reported to reduce the bacillary burden in lepromatous leprosy (Kaplan. 
1991). In contrast to Th1 cytokines. IL-4 deactivates macrophages (Lehn et al., 1989; Ho et 
al., 1992). IL-4 also blocks T cell proliferation by down-regulating IL-2 receptor expression 
(Martinez et al., 1990). In contrast to the effects of IFN-y and IL-2, IL-4 has the capacity to 
suppress the immune response of tuberculosis patients. 
IL-12 plays a central role in defining the development of a protective Th1 type response in 
tuberculosis. IL-12 is a macrophage derived heterodimeric cytokine which strongly augments 
pro-inflammatory Th1 type responses (Barnes et al.. 1994). IL-12 is concentrated at the site 
of disease in patients with tuberculosis pleuritis, and the cytokine is produced by pleural fluid 
leukocytes on stimulation with M. tuberculosis (Zhang et al., 1994). IL-12 production is 
enhanced in leprosy patients who develop a Th1 predominant response (Sieling et aI., 1994). 
IL-12 also enhances cytotoxicity and augments proliferation of antigen-specific cytolytic T 
cells and NK cells (Gately et al., 1992; Bertagnolli et al., 1992). An intriguing property of IL-12 
is the fact that its capacity to induce proliferation of cytolytic T cells is dependent on co­
stimulation of the TCR with· antigen or anti-CD3. This contrasts strongly with other 
proliferation inducing cytokines e.g. IL-2 and IL-7 (Bertagnolli .et al., 1992; Bertagnolli and 
Hermann. 1990). IL-12 may thus be an important candidate in controlling cytolYSiS and 
cytolytic cells in the initial immune response to microbial pathogens by inducing expansion of 
such cells only in the presence of antigen. IL-12 enhances cytotoxicity of CD4+ T cells 











roles for IL-12 may include enhancement of mycobacterial antigen recognition, or promotion 
of T cell expansion, based on the ability of IL-12 to synergise with IL-2, and thus to enhance 
lymphocyte proliferation and result in the generation of a Th1 response (Zhang et al., 1994) . .,.. 
1.1.5.8.3. Cytolytic activity of CD4+ cells 
In addition to their role as helper T cells, CD4+ T cells also contribute to immune defence 
through direct cytolysis of macrophages and non-phagocytic cells infected with M. 
tuberculosis. Human j\lf. tuberculosis-specific cytolytic T cells cultured in vitro are 
predominantly CD4+ (Otten hoff and Mutis, 1990). In addition the cytolytic activity of CD4+ 
cells is enhanced at the site of pathology, as compared with peripheral blood (Lorgat et al., 
1992a). Many macrophages infected with M. tuberculosis are thought to have low anti­
mycobacterial potential, allowing the bacilli to evade host defences (Kaufmann, 1988b). 
Cytolytic T cells that specifically recognise mycobacterial antigens can lyse these 
macrophages, releasing bacilli to be engulfed and killed by macrophages with greater anti­
mycobacterial activity. It has been suggested that cytolytic T cells could directly reduce the 
bacillary load by causing mycobacterial death simultaneous to host macrophage death. 
Mycobacterial antigen-specific cytolytic CD4+ T cells generated in vitro have not been able to 
reduce bacillary load (Fazal et al., 1994). Recently however, CD8+ mycobacterial antigen­
specific cytolytic T cells have been able to reduce mycobacterial numbers (Stenger et a/., 
1997). In the current study we show that cytolytic CD4+ T cells do indeed reduce 
mycobacterial numbers. These findings implicate CD4+ CTL directly in the reduction of 
bacillary load and in a favourable outcome for the disease process. It should, however, be 
noted that a diametrically opposed hypothesis has been suggested, in which cytolytic T cells 
serve to cause immunopathology by releasing toxic products following the destruction of host 
macrophages. These toxic products would serve to induce immunopathological conditions 
leading to caseous necrosis (Dannenberg, 1991) 
1.1.5.8.4. CD8+ T cells and human mycobacterial disease 
CD8+ T cells are the major cytolytic population in defenses against many intracellular 
pathogens. In animal models of tuberculosis, CD8+ T cells appear to play an i!TIportant role. 
Adoptive transfer and cell depletion studies have implicated these cells in the control of M. 
tuberculosis infection (Orme and Collins, 1984; Orme 1987; Muller et a/., 1987). Murine 
CD8+ T cell lines and clones lyse M. tuberculosis-infected macrophages in an antigen­
specific manner, and restrict the growth of the bacilli within the macrophages (De Libero et 
al., 1988). The most striking evidence for a role for CD8+ T cells comes from studies with 132­
microglobulin deficient mice. These mice are unable to express functional MHC Class I 
molecules and thus cannot develop a CD8+ T cell response. On infection with M. 
tuberculosis, 70% of the p2~microglobulin deficient mice died, whereas normal mice did not 
(Flynn et a/., 1992). Although granuloma formation was still intact, the granulomata contained 











CD4+ T cells and NK cells are not sufficient for protection. The most likely explanation for 
these phenomena are that mycobacterial antigens can and are presented to CD8+ T cells via 
the MHC class I route. The 65kD mycobacterial heat shock protein has been shown to be 
presented in this way (SHva and Lowrie. 1994). Despite the importance of CD8+ T cells in the 
murine system. their role in human tuberculosis has remained uncertain. Human M. 
tuberculosis-specific cytolytic T cells are not CD8+. There is no expansion of this population 
of cells at the site of diseases (Barnes et al.• 1989) and the severity of tuberculosis in HIV­
infected patients is unaffected by the CD8+ cOLlr.(Jones et al., 1993). Despite these facts, 
CD8+ T cell clones have been generated which respond to M. tuberculosis antigens and 
which are MHC class I restricted (Rees et a/., 1988). Cytolytic MHC class I-restricted CD8+ 
clones have also recently been described (Lalvani et a/., 1998). 
1.2. Cytotoxicity 
1.2.1. Introduction 
Cytotoxic T cells are an important component of the cellular immune response. All cytotoxic 
activity was originally attributed to either natural killer (NK) cells or CD8+ lymphocytes (Kagi, 
et al. 1996). Intensive research in the area of cytotoxicity has subsequently demonstrated 
that CD4+ lymphocytes (Tite and Janeway, 1984; Erb et a/., 1990), as well as yS cells (Munk 
et a/., 1990) and double negative (CD4-CD8-) cells (Stenger et a/ .. 1997) possess cytotoxic 
capabilities. T cell-mediated cytotoxicity has long been recognised as pivotal for the 
elimination of both virus-infected cells and transformed (oncogenic) cells. This elimination is 
mediated by CD8+ T cells which respond to MHC class I-associated antigen (Smyth and 
Trapani, 1998). Since MHC class I molecules are expressed on almost all somatic cells. the 
surveillance by CD8+ T cells for fo eign antigen is extensive. Until recently, the model of 
CD8+ cytolytic activity included the processes of: (i) recognition of foreign antigen. (ii) 
activation of effector cells, (iii) release of cytolytic granules (including granzymes and 
perforin), and, (iv) target cell lysis (Berke. 1994). Target cell lysis was regarded as a form of 
necrosis. This model has subsequently been modified to incorporate not only phenotypically 
different effector cells involved in cytotoxicity, but also divergent mechanisms of induction of 
target cell death (granule- vs. receptor-mediated), and different forms of target cell death 
itself (apoptosis vs. necrosis/oncosis). 
1.2.2. Mechanisms of cell death: Necrosis (Oncosis) and Apoptosis 
There are two mechanisms of cell death. Necrosis is a cell death process which irwolves 
extensive intracellular organelle breakdown. loss of membrane integrity. cell swelling and 
finally disintegration (Majno and Joris, 1995). Necrosis is rapid and results in localised 
inflammation - the dying cell releases cellular components which may trigger activation of 
nearby immune cells. Necrotic death has also been termed accidental cell death - and this 












alteration in normal physiological functioning. Necrosis was for a long time the only 
recognised form of cell death, however in the last decade or so another major mechanism of 
cell death, apoptosis, has been exhaustively studied. Apoptosis is a regulated death process, 
which has been termed physiological cell death, programmed cell death or cellular suicide. 
Apoptosis is fundamentally different from necrosis in that it involves a highly regulated 
sequence of events unlike the random destruction observed in necrotic death (Abastado, 
1996; Depretaere and Golstein, 1998). Apoptosis usually involves nuclear shrinkage and 
densification, which is then followed by nuclear fragmentation. In addition ~he cytoplasmic 
component (cytosol) shrinks and the cell breaks down into distinct apoptotic bodies. During 
this process the cell membrane remains intact and it is only at the later stages of apoptosis 
that membrane integrity is lost (Green, 1998). This stage of apoptosis is termed secondary 
necrosis. The process of secondary necrosis is generally averted in vivo. since apoptotic 
bodies are rapidly and efficiently removed by phagocytes (neutrophils and macrophages). 
which recognise phosphatidyl serine (PS) moieties exposed on the surface of apoptotic cells 
(Zwaal and Schroit. 1997). Due to the confusion that the term secondary necrosis raises, it 
has been proposed that oncosis be used as an alternative to classical necrosis (Majno and 
Joris, 1995). 
Apoptosis is triggered by a variety of signals. These include irradiation, low level oxidative 
stress, toxins, glucocorticoids, ATP, drugs, cytolytiC granules (perforin, granzymes, 
granulysin etc.) and specific receptor-ligand interactions i.e. Fas receptor (C095/Apo-1) and 
FasL, TNF receptor (TNF-R) and TNF-a interactions (Abastado, 1996; Vaux and Strasser, 
1996). Of particular interest in T cell mediated cytotoxity are the cytolytic granules and the 
Fas-mediated pathway, which account for the majority of T cell-mediated cytotoxicity (K3gi et 
al., 1994: Trapani, 1998). 
1.2.3. CD4+ and CD8+ cytotoxic T cells 
T lymphocytes of the C08 type possess cytolytiC granules (Shresta et al., 1998). They are 
able to kill target cells via release of these components. Depending on the level of onslaught, 
the target cell may die via necrosis or apoptosis (Berke, 1995). High level attack leads to loss 
of membrane integrity and rapid death. CytolytiC granules are however also able to induce 
apoptosis. This occurs via cytolytiC granule component (granzyme)-mediated activation of the 
apoptotic signal cascade which involves the interleukin 1 converting enzyme (ICE)-related 
family of cysteine proteinases termed caspases (Shresta et al., 1998). Although granule­
mediated killing is predominant in C08 cells, killing of target cells via FasL ligation with Fas 
has also been reported (Esser et al., 1997; Ju et al., 1994). 
The recognition that C04 cells can also be cytotOXiC led to an intensive inves4.igation into the 
mechanism of action of these cells (K3gi et al., 1996). C04 cells were for a long time 












cytolytic activity of these cells was reported to operate via receptor-ligand (Fas-FasL) 
interaction, resulting in target cell apoptosis (Erb et al., 1990; Rahelu et al., 1993; Stalder et 
al., 1994; Ashany et al., 1995). It has since been reported that certain CD4 lymphocytes do 
possess cytolytic granules and they can induce target cell death via the secretory pathway 
(Lewinsohn et al., 1998; Sevilir-Williams and Engelhard, 1996). The development of cytolytic 
granule-mediated killing by CD4 cells appears to be an adaptation for the containment of 
infections which involve intracellular bacteria or other parasites (Sevilir-Williams and 
Engelhart, 1997). The occurrence of multiple mechanisms of cytolysis induction in both CD4 
and CD8 cells pOints toward functional diversification. Granule mediated killing is generally 
associated with the removal of infected or transformed cells (Page et al., 1998). Fas-FasL­
mediated apoptosis does not have this association, and appears to be more generally linked 
with immunomodulation and clearance of host cells from areas of immune activity 
(Takayama et al., 1995; Depretaere and Golstein, 1997). Fas-mediated target cell apoptosis 
is dependent on the expression of the Fas molecule on the target cell (Lewinsohn et aI., 
1998; Liles et al., 1996). Since a large number of cell types do not express Fas, or do so only 
at low levels, optimal killing via this pathway is prevented. The presence of an alternative 
mechanism of lysing infected cells would ensure their elimination, even in the absence of Fas 
expression. 
1.2.4. General features of CTL activity 
Irrespective of the predominant mechanism of CTL killing, the sequential stages in the 
process appear similar. In all cases of T cell-mediated killing, the initial events involve T cell 
receptor (TCR)-MHC-peptide interactions (Berke, 1994). This stage is also termed 
conjugation. The formation of the CTL-target conjugate also involves adhesion molecules 
and co-receptors. Following TCR engagement, the CTL is activated via a TCR signal 
transduction cascade. The activation of CTL by definition involves the preparation of the T 
cell for cytotoxic activity. The principal mode of activity may be via granule release (secretory 
or exocytotic kill), or via receptor-ligand interaction, principally Fas-FasL (non-secretory or 
receptor-mediated kill). The activation of CTL which kill via exocytosis, involves the functional 
maturation of cytolytic granules and their localised release (Page et al., 1998; Griffiths, 1997). 
In CTL which operate via Fas-FasL interaction, the up-regulation of FasL on the CTL 
membrane is the pivotal activation event (Takayama et al., 1995). Following the binding 
(conjugation) and activation of the CTL, the CTL delivers the lethal hit. This is the effector 
phase of the process and involves the release of cytolytic granules, or the engagement of 
FasL with its receptor molecule. The lethal hit initiates the target cell death (Berke, 1994). 
Once the lethal hit has been delivered, the CTL detaches and is free to recycle and initiate a 
new cytolytic event. The fate of the target cell is generally death via apoptosis, however if the 
onslaught is extreme (high numbers of CTL or concentrated release of granule contents, 












1.2.4.1. Conjugate formation and CTL activation 
The simplified model of lymphocyte-target cell adhesion mediated solely by intercellular 
binding of the TCR/CD3 complexes with MHC class I or II molecules has been expanded 
following the recognition of the important role that auxiliary adhesion molecules play (Berke, 
1994). CTL-target cell conjugation is dependent on temperature, metabolic energy and Mg2 +, 
features not observed in events solely dependent on TCR-MHC interactions. 
In the case of secretory cytolysis, the formation of a stable CTL-target conjugate appears to 
be dependent on contact between large surfaces of the cells involved, TCR-MHC-peptide 
interaction and a "zipping-up" process. The "zipping-up" involves auxiliary CTL determinants 
e.g. CD2, CD4, CD8, CD28, CD43 and LFA-1 molecules, and target cell determinants e.g. 
B7 components, CD22, ICAM-1, ICAM-2 and LFA-3 molecules (Berke, 1994). Minimal cross­
linking of the TCR leads to activation, however granule release only occurs once firm 
adherence between CTL and target has occurred. Conjugate formation in Fas-mediated 
cytolysis is similar, with up-regulation of FasL expression being initiated at this stage (Yagita 
et 'aI. , 1995). 
Conjugation is a rapid event. Activation of the CTL and delivery of the lethal hit is dependent 
on the status of the effector cell. If already primed, the CTL can deliver the lethal hit within 
minutes, since the cytolytic granules have been recruited and/or FasL has been expressed 
on the cell membrane. Following initial priming of the CTL via TCR engagement, the CTL is 
able to to recycle i.e. disengage from the initial target cell and move on to a new one. For 
granule exocytosis this involves a new sequence of conjugate formation, but in FasL­
mediated killing, the CTL is able to initiate apoptosis in any target cell expressing Fas on its 
surface. This fundamental difference between the two major mechanisms of cytolysis has 
important implications (Trapani, 1998). FasL-expressing CTL have the ability to lyse any cell 
which expresses Fas, including other T cells (Nagata and Golstein, 1995). This is not a 
feature of exocytosis-mediated kill, since each lethal hit requires TCR-MHC engagement 
which ensures that only infected/transformed target cells are eliminated. This is a protective 
mechanism of the host, since elimination of all cells presenting foreign antigen would hinder 
normal immune function which is dependent on antigen-presenting cells for initiation (Kagi et 
al., 1996). 
1.2.4.2. Lethal hit delivery 
1.2.4.2.1. Secretory mechanism of lethal hit 
The fact that both NK cells and certain CTL contain cytoplasmic lytic granules and their 
target cells display complement-like lesions on their membranes led to the proposal that both 
these cell types employed a mechanism of cytotoxicity involving secretion of lytic 
components. This process was believed to result in pore formation on the target cell 












followed by localised Ca
2
+-dependent degranulation. The origin of the pore forming material 
is the cytoplasmic granules which contain perforin and granzymes (i.e. granule enzymes) 
(Tschopp and Nabholz, 1990; Page etal., 1998). 
The requirement for extracellular Ca2+ is absolute and multi-levelled. Ca2+ is required for (i) 
the regulated secretion of lytic granule constituents, such as perforin and proteases, (ii) 
binding of perforin to the target cell membrane, and (iii) polymerisation of perforin to 
polyperforin which is btdieved to be important in pore formation (Mac Lennan et al., 1980; 
Berke, 1994). The discovery that certain CTL can lyse target cells in the absence of 
extracellular Ca2+ led to the elucidation of the non-secretory mechanism of cytolysis which 
was confirmed by the lack of perforin or BLT-esterase activity in certain CTL (Kagi et al., 
1996). 
Cytoplasmic granules are present in most CTL (Page et al., 1998). They are present at early 
activation and proliferation stages of immune responses to viruses or allografts in vivo, and 
in cells cultured with IL-2 or stimulated with antigens or mitogens in vitro. The cytolytic 
granules contain perforin (cytolysin) a 65kD lytic protein. In addition the granules contain 
hydrolytic lysosomal enzymes, serine proteases and proteoglycans. Both perforin and serine 
esterases have been located within the same granule (Henkart et al., 1987). The cytoplasmic 
granule consists of a dense core and a multi-vesicular cortex. The dense core contains 
secretory proteins such as perforin and chondroitin sulphate proteoglycans. The core is also 
rich in mannose-6-phosphate (Man-6-P) receptor, a marker present in early endocytic 
compartments. Granzymes A and B possess Man-6-P residues, which enable specific 
recognition and targeting by the Man-6-P receptor for concentration in the lytic granules 
(Trapani, 1998; Griffiths, 1997). The multi-vesicular cortex of the granules contains 
lysosomal proteins such as acid phosphatase, a-glycosidase, and cathepsin D. The pH of 
the cortex is acidic like cortices of endosomes and Iysosomes. Acidification of granules is an 
essential process for functional granule activity (Kataoka et al., 1996). The granules are 
complex and unique and much remains unknown about their formation, maturation and 
release. 
Although perforin is structurally similar to the complement components C6-C9, and 
complement-like pores have been observed in target cells, complement and perforin differ in 
that perforin does not have a membrane bound receptor but rather binds to 
phosphorylcholine residues of target cell membranes (Krahenbuhl and Tschopp, 1991). Both 
perforin and complement do induce pores or channels in the target cell membrane. In the 
case of perforin, polyperforin-induced channels appear to be similar to other ion channels. 
There is increased conductance across such channels, however whether they are crucial in 











water resulting in swelling and osmotic lysis occurs, since exposure of cells to perforin 
resulted in net contracture of the cell prior to lysis (Liu et al., 1995). 
Perforin is a 70kD protein which is stored in the cytoplasmic granules of killer lymphocytes 
(Liu et al., 1995). Perforin is water-soluble and shares many features with a broad family of 
pore forming proteins/peptides produced widely in nature. Binding and polymerisation of 
perforin appear to be separate events, however both are dependent on Ca2+ ions. The 
perforin pore is in the range of 5-20nm in dLmeter and has a conductance of 0.4-6 
nanoSiemens (nS) (Trapani, 1998). 
The perforin pore has a maximal permissive conductance size of approximately 8kD. This 
would preclude massive efflux of cellular constituents, but would allow movement of small 
intracellular molecules such as ATP and K+ ions which could perturb intracellular 
homeostasis. Perforin could contribute to target cell death by two mechanisms: (i) by creating 
an osmotic stress sufficient to induce colloid osmotic lysis, (ii) by triggering an influx of 
potentially lethal extracellular molecules (Liu et al., 1995). Very few (3-4) perforin monomers 
are required to form a functional ion channel, while 10-20 are necessary to produce the 
larger pores observable on EM. These larger pores may only occur at high perforin 
concentrations. It seems unlikely that the smaller pores would allow entry of other cytolytic 
granule components such as granzyme B. Indeed, it has now been demonstrated that 
granzyme B can enter cells independently of perforin, however perforin is essential for 
activation of granzyme B and for translocation to the nucleus (Froehlich, et al., 1996). 
Why are CTL resistant to their own cytolytic products? CTL have been shown to be resistant 
to the activity of other killer cells which would nonetheless recognise them as targets either in 
an antigen-specific manner or via lectin or monoclonal antibody conjugation. These cells are 
also resistant to isolated cytolytic granules or purified perforin. It thus seems that an innate 
mechanism of protection exists. Protectins have been postulated as CTL-specific proteins 
which mediated resistance to perforin killing (Young and Cohn, 1988). The activity of these 
molecules is envisaged to occur via blocking or inactivation of docked perforin monomers ­
thus stopping polymerisation.Other possible protection mechanisms may involve extensive 
repair mechanisms - involving shedding or endocytosis of bound perforin monomers. Recent 
work has suggested that perforin alone is unable to lead to cell death, therefore the insertion 
of perforin into the membranes of CTL would not be problematic unless concomitant uptake 
of other cytolytic components such as granzyme B occurred. It has been proposed that 
binding and uptake of granzyme B is via a specific receptor. If CTL lack the receptor for 
granyme B they would be protected from granule induced apoptosis (Froehlich et al., 1998) 
Perforin is important in CTL function, a fact that has been demonstrated in perforin knockout 











role of perforin the lysis of the target cell or does it operate as an entry mediator/carrier or 
activator of granzymes? Recent work has led to a novel hypothesis that the role of perforin in 
target cell death is predominantly one of co-operation with granzymes, ensuring delivery of a 
directional lethal hit but preventing self-annihilation (Froehlich et al., 1998). In this model, 
perforin as well as granzymes (particularly granzyme B) bind to the target cell. Specific 
granzyme receptors have been proposed, but as yet remain unidentified. It has been 
demonstrated that CTL clones are more resistant to lysis by other CTL, lytic granules or 
perforin, than to complement-mediated lysis. This may be indicative of a r..~ceptor-mediated 
process. Following the binding of these molecules to the target cell a process of endocytosis 
occurs which results in internalisation of both perforin and granzymes within endosomal 
compartments or vesicles (Froehlich et al., 1996). Whether this internalisation is triggered by 
receptor engagement (GzB-GzBR) or merely represents a repair mechanism by the host cell 
which is trying to counteract the perforin perturbation of membrane homeostasis remains 
unknown. Once internalised the perforin then polymerises and the polyperforin channels 
allow the release of granzymes into the target cell cytoplasm. This model accounts for the 
intriguing finding that granzyme B can enter a target cell independently of perforin. Proof of 
this model of endosomal release via perforin has not been provided, however it has become 
apparent that the internalised granzymes are dependent on perforin for translocation to the 
nucleus and for succesful induction of apoptosis (Jans et al., 1996; Froehlich et al., 1998). 
The previously held belief that perforin pores allowed the entry of granzymes now seems less 
likely based on the fact that perforin pores are often very small ion-exchange channels which 
would not readily permit entry of large proteins. Even though granzyme B can independently 
enter a target cell, it is unable to induce target cell death without the presence of perforin (or 
similar membranolytic components). This suggests that internalised granzyme B is 
"entrapped" within the target cell without perforin present to facilitate release. Another 
proposed granzyme-activation mechanism is the perforin-induced modification of 
cytoplasmic pH, however this model has not been confirmed either (Shestra et al., 1998). 
Once released, the granzyme B molecule is able to access the caspase cascade via direct 
activation of caspase 3/CPP-32. In addition, granzyme B is able to translocate to the nucleus, 
possibly via exploitation of host cytoskeletal components. Once within the nucleus, granzyme 
B may be able to directly cleave certain structural and/or regulatory molecules leading to the 
characteristic features of apoptosis (Henkart et af., 1995; Andrade et af., 1998; Medema et 
al., 1998). 
The granzymes are the most important constituents of cytolytic granules. being directly 
involved in induction of target cell apoptosis (Pham and Ley, 1997). Granzymes comprise 
approximately 90% of the protein content within cytolytic granules (Henkart et al., 1987). 
Granzymes are related to the chymotrypsin family of serine proteases and demonstrate 












1996). A total of 8 mouse granzymes have been described and characterised (Gz A-G, and 
M), whereas in humans only 5 have been characterised (Gz A, B, H. M, and protease-3). 
Granzymes display many features in common with other chymotrypsin-like enzymes, but do 
possess certain defining features such as highly conserved residues at certain positions (1-4. 
9-16). conserved propeptide sequences (generally G-O, or a-a), 3 conserved disulphide 
bridges, and unusual substrate preferences (Smyth et a/., 1996). Numerous other cytolytic 
granule components exist, however their exact role in cytolysis remains unknown. 
1.2.4.2.2. Receptor- (Fas-) mediated mechanism of lethal hit 
The occurrence of an alternative mechanism of target cell lysis involving receptor-ligand 
interactions has been acknowledged for some time. The fact that exocytotic granule 
mediated killing could not account for all target cell death mediated by CTL necessitated an 
alternative cytolytic pathway. Work on apoptosis in many areas of research led to the 
discovery of an apoptosis-inducing molecule, subsequently termed Fas (CD95/Apo-1). Fas is 
a receptor expressed on the surface of numerous cell types. It is a member of the TNF 
receptor (TNFR) family. Several other receptors have been implicated in transducing death 
Signals, including TNFR1 and death receptors (DR) 3, 4, and 5 (Ashkenazi and Dixit. 1998). 
Engagement of Fas with its ligand, Fas ligand (FasL), leads to induction of apoptosis in the 
Fas-expressing cell. FasL may be membrane bound or secreted. The induction of apoptosis 
via this mechanism is dependent on the expression of Fas on the target cell surface. Fas is 
not universally expressed by all cell types, and requires up-regulation under certain 
conditions (Vaux and Strasser, 1996). 
The fact that CTL were found to induce apoptosis in the absence of perforin and proteases 
led to the conclusion that these components were not involved in induction of apoptosis. 
Subsequently, with the discovery of the Fas-mediated pathway of target cell apoptosis it has 
become clear that this was the mechanism responsible for granule-independent death. Since 
both Fas- and granzyme-mediated target cell death occurs predominantly via apoptosis, 
mechanistic similarities between the two processes were investigated. It has now been 
demonstrated that both Fas ligation and granzyme B activation lead to switching on of the 
central apoptotic caspase cascade, via activation of either caspase 8 (FLlCE), or caspase 3 
(CPP 32) (Henkart, 1996). 
The Fas-mediated mechanism of target cell killing is also dependent on an initial conjugation 
stage. Following conjugation and TCR-MHC-peptide interaction, the effector CTL is activated 
and FasL is up-regulated on the lymphocyte cell surface. The delivery of the lethal hit then 
involves the ligation of FasL with the Fas molecule on the target cell. Although this process 
can occur in the absence of Ca2 +, processes involved in upregulation of FasL do require Ca2 + 
(Yagita et a/., 1995). Naturally this can only occur if Fas is expressed on the target cell. 












initial target and then bind to any Fas-expressing cell and trigger its apoptosis. The 
occurrence of such MHC-unrestricted and activated CTL could be a danger to the host in 
that not only infected or transformed targets are eliminated (Yagita et al., 1995). Due to this 
possibility, it appears that the Fas-mediated mechanism of CTL activity is more important in 
immunoregulation. Activated T cells have to be eliminated at sites of activity to prevent 
massive cellular expansion. The activated T cell expressing FasL. is able to act in a 
regulatory manner by eliminating other T cells which have been shown to express Fas as 
well. This ensures a regulated elimination of activated T cells capable of causing damage by 
both the release of pro-inflammatory cytokines and unchecked CTL activity (Nagata and 
Golstein, 1995; Takayama et al., 1995). The exocytotic mechanism of kill is, on the other 
hand, preferentially employed by the host in the elimination of infected and transformed cells. 
This mechanism is safer for the host, in that it is dependent on repeated TCR-MHC-peptide 
interactions, and only targets cells expressing presenting foreign antigen will be eliminated. 
In addition the cytolytic granule components may be bactericidal and/or viricidal and thus aid 
in killing infectious organisms simultaneous to the induction of target cell apoptosis (Stenger 
et al., 1998; Trapani, 1998). 
1.2.4.3. Apoptosis: co-ordinated cell death 
Most, if not all, animal cells have the ability to self-destruct by activation of an intrinsic cell 
suicide programme (Allen et al., 1998). This usually occurs in situations where the cell is no 
longer needed (homeostasis) or has been seriously damaged (injury). Apoptosis plays an 
important role in development and homeostasis, and is also beneficial to the host in that it 
allows for containment and elimination of damaged or diseased cells. Errors in apoptosis 
may account for certain neoplastic disorders and links between apoptosis. AIDS and certain 
neurodegenerative diseases have been established (Lincz, 1998). The discovery that CTL 
activity operates via the induction of apoptosis highlighted the importance of this 
phenomenon in the area of cellular cytotoxicity. 
1.2.4.3.1. Molecular and cellular features of apoptosis 
Apoptosis is characterised by a regulated sequence of cellular changes. The nucleus and 
cytoplasm condense (pyknosis), without any damage to the cell membrane. Organelle 
structure is maintained until the later stages which involve the fragmentation of the nucleus 
(karyorhexis) and the "budding" of the cell into apoptotic bodies (Majno and Joris, 1995). 
Following apoptotic body formation, necrotic changes such as membrane leakage, swelling 
and lysis may occur. The regulated formation of apoptotic bodies without any leakage or lysis 
appears to be an adaptation by the host to avoid a localised inflammatory response 
(Depretaere and Golstein, 1998). Apoptotic bodies are readily phagocytosed by granulocytes 












In addition to the gross morphological changes induced during apoptosis, certain regulated 
molecular events also occur. Indeed, an area of intensive research at present is the 
endeavour to link the morphological changes with the molecular sequence of events which 
has recently been elucidated. The most characteristic event at the molecular level is the 
activation of nucleases which degrade chromosomal DNA, first into large (50-300kb), and 
subsequently very small oligonucleosomal fragments (Barinaga, 1998). It is now apparent 
that this DNA fragmentation is the result of a complex cascade of protease activation 
involving a family of cy ...teine proteases related to the interleukin-1 converting enzyme (ICE), 
termed caspases (Nicholson and Thornberry, 1997). 
The process of apoptosis has four distinct stages: (i) decision by the cell to die or to attempt 
repair or replication, (ii) death, (iii) engulfment of apoptotic fragments by phagocytes, and (iv) 
degradation of engulfed corpses (Chao and Korsmeyer, 1998). 
Certain major aspects of apoptosis do not require the transcription of new genes. Thus, cells 
possessing all the machinery required for successful apoptosis, will undergo the death 
process without concomitant protein synthesis (Uncz, 1998). Enucleated cells (cytoplasts) 
have been shown to undergo cytoplasmic apoptotic changes in the absence of nuclear 
material. This seems to indicate that morphological changes are not directed by nuclear 
events. It has now become clear that the apoptotic process is controlled by the bcl-2 family of 
proteins in close association with the mitochondria, and that execution of apoptosis and 
structural changes are mediated by the caspases. The mitochondrion is now regarded as the 
central co-ordinator of apoptosis, mediating the both cellular and nuclear events of apoptosis 
(Mignotte and Vayssiere, 1998). 
The point of intersection of the mitochondria and apoptosis appears to operate in the 
mediation of the activity of the Bcl-2 family of anti-apoptotic proteins (Adams and Cory, 
1998). The Bcl-2 proteins may remove caspases from the cytoplasm by dragging them 
across the mitochondrial membrane, thus preventing apoptotic events. Alternatively, the 
mitochondria-derived caspase activitors cytochrome c and the apoptosis-inducing factor 
(AIF) could be prevented from exiting the mitochondria by Bcl-2 proteins. Pro-apoptotic 
signals such as Fas ligation may lead to inactivation of Bcl-2 proteins, followed by activation 
of caspases and finally cell death (Green and Reid, 1998). 
1.2.4.3.2. The caspases • regulators of apoptosis 
Extensive research in the last couple of years has led to major clarification of certain aspects 
of the molecular processes involved in apoptosis, but in so doing have raised yet further 
questions. At present the: accepted model for induction of apoptosis assigns a cardinal role to 
the caspases, a family of cysteine proteases related to ICE, and which cleave their 












Blockage of peptide caspases by specific inhibitors blocks apoptosis itself, a finding which 
implicates these proteases as the core co-ordinators of the death programme. The caspases 
themselves serve as substrates for other caspases and are thus activated by cleavage at 
specific aspartic acids resulting in a cascade phenomenon with a certain amount of 
redundancy (Kidd, 1998). Activation of the caspase cascade is dependent on a shift to the 
cytosol of certain regulatory components, i.e. cytochrome c and apoptosis-inducing factor 
(AIF). These components are normally sequestered within the mitochondria. (Kluck et al., 
1997; Krippner et al. 1996). It is now acknowlec.:.)ed that the mitochondria are pivotal in the 
control of apoptosis, so much so that they have been termed the "central executioners" of 
apoptosis. The activities initiated and controlled by the mitochondria are carried out by the 
caspases which cleave certain intracellular proteins, including proteins of the nucleus, 
cytoskeleton, endoplasmic reticulum and cytosol (Henkart and Grinstein, 1996; Barinaga, 
1998). This action is believed to lead to the processes of blebbing, condensation and 
fragmentation, which characterise apoptosis. Exactly which proteins are involved and how 
their cleavage results in the morphological changes observed remains an area of intensive 
research (Depretare and Golstein, 1998). 
The term caspase (cysteinyl aspartate-specific proteinase) embodies two distinguishing 
features of this group of enzymes: they are cysteine proteases and they are specific for 
cleavage after aspartate (Asp) residues. Accumulating evidence now suggests that the group 
may be subdivided into at least two subfamilies. These have been categorised as the ICE 
and CED-3 (C. elegans death gene encoded protein 3) subfamilies. The ICE subfamily 
appears to be predominantly involved in inflammation whereas the CED-3 subfamily is 
largely, if not exclusively, involved in apoptosis. 
The ICE subfamily consists of caspase-1 (ICE), caspase-4 (ICErel-II, TX, ICH-2), and 
caspase-S (ICErel-lIl, TY). The CED-3 family consists of the remaining 7 caspases including 
caspase-7 (Mch3, ICE-LAP3, CMH-1), caspase-3 (CPP32, apopain, Yama), caspase-6 
(Mch2), caspase-8 (MACH, FLlCE, MchS), caspase-10 (Mch4), caspase-2 (ICH-1), and 
caspase-9 (ICH-LAP6, Mch6). This scheme of classification has been modified on the basis 
of tetrapeptide specificity of the caspases. This has resulted in the CED-3 family being 
subdivided into 2 groups. Group II contains Caspases-3, -7, and -2. Group III contains 
caspases-6, -8, and -9. Interestingly, granzyme B, which is a serine proteinase, displays 
similarities to the Group "I caspases. 
Numerous substrates for caspase activity have been reported. The most important of these 
are PARP (poly(ADP-ribose) polymerase), DI'JA-PK (DNA-dependent protein kinase), lamins, 
fodrin, actin, gelsolin, and protein kinase C (o-isofmm) (Depretaere and Golstein, 1998). The 
net effect of the proteolytic events mediated by caspases is to (i) halt cell cycle progression, 












its surrounding tissue structures, (iv) disassemble structural components, and (v) mark the 
dying cell for engulfment by other cells such as macrophages. It seems unlikely that one 
specific cleavage event is responsible or necessary for cell death. Rather the collective effect 
of multiple cleavage events, but of limited key proteins, culminates in the highly ordered and 
systematic process of apoptotic cell death. 
Regulation of caspase activity predominantly occurs at the level of proenzyme processing 
and maturation. Dormant caspase proeniymes are converted to cata!,'tically competent 
heterodimeric proteases by cleavage at Asp-x bonds (Cohen, 1997). The active caspases 
then activate other dormant proenzymes into their active protease (caspase), thus leading to 
a cascade effect. For example, it has been demonstrated that binding of FasL to Fas (CD95) 
leads to the transmembrane activation of the adapter molecule FADD (Fas-associated death 
domain). FADD is able to trigger activation of caspase 8 proenzyme leadlng to caspase 8 
being able to activate other proenzymes e.g. caspases-3 and -7. Following a sequence of 
successive cascade activations, the caspases (particularly caspase-3) then mediate the 
proteolysis of certain target proteins which may be structural, reparative or homeostatic. This 
then culminates in apoptosis (Wallach at al., 1998). 
1.2.4.4. Granule-mediated target cell apoptosis 
Following the delivery of the lethal hit and the entry of the cytolytic components into the target 
cell, either via a co-ordinated receptor-ligand and endocytotic pathway, or direct entry via 
polyperforin pores, the target cell is induced to undergo apoptosis. How the granule-mediated 
mechanism of kill bypasses the apoptotic inhibitory bcl-2 family is unknown. However certain 
of the cytolytic granules, particularly granzyme 8, have been well studied, and have been 
found to be structurally and functionally similar to the caspases. Therefore, once within the 
cytoplasm, either following direct entry. or release from an endosome via internalised 
polyperforin pores, the granzyme 8 molecules are free to initiate the caspase cascade. The 
outcome is the same as observed in receptor mediated target cell death (Froehlich at al., 
1998; Trapani, 1998). 
Cytotoxic activity mediated by granule components such as granzymes A and 8 has 
conclusively been shown to intersect with the receptor-mediated apoptotic pathway at the 
level of caspase activity. Granzyme 8 is able to mediate the conversion of caspase-3 (CPP 
32) proenzyme to its active form. In this sense granzyme 8 is similar to caspase-8 or FLiCE 
(Lincz, 1998). In addition, granzyme 8 is able to cleave certain other caspase proenzymes 
including caspases 10, 9, 7 and 6 (Hen kart, at a/. , 1997; Thornberry, at al., 1997). An 
intriguing finding has been that granzyme 8 is able to cleave certain substrates downstream 
of the caspase cascade independent of caspase activity (Sarin et al., 1997; Talanian et al., 
1997). These substrates include the DNA-dependent protein kinase catalytiC subunit (DNA­











cleavage of certain other substrates downstream of the caspase cascade, including 
poly(ADP-ribose) polymerase (PARP), U1-70kD and lamin B, is mediated by the caspases 
and not by granzyme B directly, there appears to be a dual pathway of granzyme B-mediated 
target cell apoptosis, a caspase-dependent and -independent pathway (Sarin et a/., 1998; 
Trapani, 1998). 
What is the relevance of this redundancy? Various models and theories have been put 
forward, and one in particular seems very important in the light of CTL control of infected 
host cells. The Fas-mediated death pathway is strictly caspase-dependent and is under the 
stringent control of the various apoptotic inhibitory proteins. Ligation of Fas by FasL will not 
always result in target cell death as the signal may be blocked at several levels (Wallach et 
a/., 1998). Granzyme-mediated target cell apoptosis that is caspase-dependent is also 
subject to certain host control mechanisms - most importantly the availablity of caspase 
substrates, which we have seen is controlled by host cell mitochondria. If an intracellular 
organism (virus, bacteria or parasite) were able to enhance the activity of inhibitory proteins, 
it would theoretically be able to engineer a protected milieu for itself within the host cell 
(Trapani, 1998). A caspase-independent pathway would bypass any such protective 
pathway. This is particularly interesting in the case of M. tuberculosis infection of 
macro phages. 
The macrophage is the chosen host cell of M. tuberculosis and offers the organism a 
protected environment within which to replicate and possibly attain heightened virulence. 
Induction of host cell apoptosis due to mycobacterial infection has been reported (Schluger 
and Rom, 1998). This may be due to the fact that H37Rv is able to down regulate Bcl-2 
which results in increased apoptosis. This model makes sense jf apoptosis is beneficial to 
the invading organism. If apoptosis does not in any way harm mycobacterial viability, 
apoptosis would lead to spread of the organism to additional macrophages enhancing the 
chances of dissemination. This simple model does not appear to be universally applicable. 
Induction of macrophage apoptosis by both H20 2 and ATP treatment, can lead to a reduction 
in organism viability (Molloy et a/., 1994; Lammas et a/., 1997; Laochumroonvorapong et a/., 
1996; 1997). In addition granule-mediated apoptosis following exposure to cytolytiC CD8+ 
I 
lines led to a reduction in mycobacterial numbers (Stenger et a/., 1997). Similarly soluble 
FasL-induced apoptosis led to a reduction in organisms (Oddo et a/., 1998). Apoptosis does 
not seem to be a desired outcome for the infecting mycobacteria. A scenario whereby the 
mycobacteria enhance anti-apoptotic mechanisms would seem more likely. Perhaps whether 
the organism chooses pro- or anti-apoptotic signals is dependent on level of infection and 
virulence of organism. Host cell lysis via necrOSis is not advantageous in that a localised 
inflammatory response would result. Perhaps, in heavily infected cells induction of apoptosis 
would then avoid necrosis and enable spread. On the other hand, mycobacteria within 












to occur. How organisms induce apoptosis themselves is unknown, and similarly whether 
they are able to block certain apoptotic events remains conjectural (Placido et al., 1997; 
Schluger and Rom, 1998). The granzyme-mediated model of cytolysis allows for a bypassing 
of host cell control mechanisms leading to death despite blocking of certain apoptotic events 
by the host cell. In this way the host is able to control the outcome of CTL activity. Although a 
recent paper has reported FasL as being able to induce apoptosis and reduce organism 
viability, earlier work showed that anti-Fas was not able to achieve the same result (Oddo et 
. al., 1998). In addition M tuberculosis appears to be able to down-regulate Fas expression on 
macrophages, and dendritic cells are resistant to Fas-mediated killing (Ashany et al., 1999). 
Without any granule-mediated CTL activity, blocking of Fas-mediated lysis would enable the 
organism to multiply readily within the protected environment of the macrophage 
phagosome. Development of a granule-based cytolytic mechanism, which is only dependent 
on MHC-antigen presentation, would represent insurance for the host 
1.2.4.5. Fas-mediated target cell apoptosis 
The Fas-mediated mechanism of target cell death is the best characterised of all apoptotic 
pathways. The mechanism of Fas-induced apoptosis is similar to TNF-mediated cell death, 
both Fas and TNF-.R being members of the TNF receptor family (which includes several 
other receptors e.g. CD27, CD30, and CD40). The ligation of these receptors results in a 
consistent sequence of events culminating in cell death. 
Binding of FasL to Fas initiates a process whereby the adapter molecule FADD is linked to 
Fas at the cell membrane but on the cytosolic side. Complexing of Fas and FADD leads to 
the ability of the caspase-8/FLlCE (Fas-linked ICE) proenzyme to be activated (Peter and 
Krammer, 1998). The activated form of caspase-8 is then able to activate other caspase 
precursors and initiate the cascade as discussed above. The bcl-2 family is intimately 
involved in this process, and it appears that initial Fas ligation and association with FADD 
may trigger a signal to the mitochondria and the associated bcl-2 components allowing for 
the release of caspases or their activation by Apaf-1 or cytochrome c (Green, 1998). Exact 
mechanisms are still unclear, but blocking by bcl-2 and bcl-XL occurs at the level of 
FLiCE/caspase-8 induction of the cascade (Ashkenazi and Dixit, 1998). In other systems the 
blockage may occur even further upstream. The exact links between signal reception and 
caspase activation in apoptosis induced by growth factor deprivation and exposure to 
glucocorticoids, for example, are still being assessed. 
All Fas-mediated apoptotic activity is dependent on caspases, and the initiation of apoptosis 
is strictly monitored by the bcl-2 family of proteins. A similar situation occurs in TNF-induced 













1.2.5. Role of cytotoxic T cells in the clearance of tuberculosis infection 
Fas-mediated target cell apoptosis is under strict control of the host cell. Apoptosis induced 
by cytolytic granules released from CTl is also under host cell control - however there is an 
additional caspase-independent pathway which is able to result in direct cleavage of 
downstream substrates and cell death (Sarin et al., 1997). This may be an advantage for the 
host, since lysis of host cells harbouring infectious pathogens which have adapted to 
intracellular survival would lead to release of the invading organism and the ability to be 
taken up by activated ?!nd possibly more competent host macrophage cells. lysis of the host 
may also affect pathogen viability, and in this way CTl function would be pivotal in aiding 
clearance (Oddo et al., 1998). The granulomatous lesion always consists of an inner core of 
macro phages surrounded by a mantle of T lymphocytes. Containment of disease must 
therefore reside within the functional capabilities of these two cell types (Kaufmann and 
Andersen, 1998). The most likely scenarios are either T cell activation of infected 
macrophages via cytokine release resulting in containment of infection, or direct cell-to-cell 
contact. Reports regarding the ability of macrophages to contain mycobacterial growth are 
conflicting, however several recent reports have demonstrated the ability of activated 
macro phages to reduce the numbers of infectious organisms - either via cytokine modulation 
(Bonencini-Almeida et al.. 1998) or via interaction with T cells (Silver et al., 1998). This latter 
report emphasises direct cell-to-cell interaction. Such interaction may well be cytolytiC. 
A direct role for CTl in the containment of tuberculosis is difficult to demonstrate. This is due 
to the occurrence of two populations of T cells mediating target lysis, i.e. CD4+ and CD8+. In 
addition, yo T cells have cytolytic ability (Kaufmann and Andersen, 1998). Gene knockout 
studies are problematiC due to this redundancy, therefore CD8+ (~2-microglobulin) 
knockouts, still possess CD4+ cells, which themselves may compensate for the lack of CTl 
activity. lack of CD4+ cells, such as in HIV, results in high levels of TB infection, however, 
whether this is predominantly due to cytokine deprivation, or lack of CTl function, is 
unknown (Jones et al., 1993). Knockouts which address particular pathways of lysis, granule­
vs. Fas-mediated, also pose the problem of compensation. Mice deficient in perforin 
(laochumroonvorapong et al., 1997), or granzyme B (Cooper et al., 1997), are not more 
susceptible to infection. However, these mice may have developed other mechanisms of 
target cell lysis e.g. a compensatory entry mechanism independent of perforin, or the use of 
other granzymes or granulysin, instead of granzyme B. In a similar way, Fas knockout mice, 
which also do not show added susceptibility to infection, may predominantly use the granule­
secretion mechanism (Cooper et al., 1997). 
Even though a direct demonstration of the pivotal role for CTl in control of M. tuberculosis 
infection has not been possible, it seems likely that these cells are involved. This is due to 
the nature 6f the granuloma (T cell mantle always associated with the infected macro phages) 












potential (Lorgat et al., 1992). The current study addresses the nature of this cytolytic activity, 
and how the activity of such cells may control mycobacterial spread. 
It has recently become apparent that CTL may possess dual mechanisms of target cell lysis. 
Originally CD8+ CTL were classified as granule releasing, and CD4+ CTL as being Fas­
dependent. This dichotomy was accepted due to the fact that most CD8 CTL activity was 
Ca2+-dependent, and the CTL contained serine proteases. CD4 CTL on the other hand 
generally operated independently of Ca2+, and se, ine protease activity was lacking. This clear 
cut differential was consistent with the idea that CD8 CTL are primarily involved in clearance 
of virally infected and/or transformed cells. CD4 CTL activity was assigned to 
immunoregulation and the control of proliferative responses at the periphery. This dichotomy 
has now been disputed. CD4+ CTL have been described which use a predominantly granule­
mediated mechanism (Vergelli et al., 1997), and CD8+ CTL which utilise Fas have also been 
described (Esser et al., 1997; Ju et al., 1994). Populations of CTL possessing both 
mechanisms have also come to light recently (Sevilir-Williams and Engelhardt, 1996). These 
findings have led to a reappraisal of CTL activity, especially within the CD4+ population. 
In infections involving long term survival of intracellular organisms which are not viral (I.e. 
bacteria, protozoa and other parasites), presentation of antigen to classically MHC-I 
restricted CD8+ CTL is unlikely. In M. tuberculosis infection this question is keenly debated, 
however the fact remains that CD8+ T cells are always the minority population in this disease 
(Schluger and Rom, 1998). Soluble or secreted antigens of M. tuberculosis and other 
intracellular parasites would normally be presented via MHC class II (Orme et al., 1993). This 
precludes CD8+ cells as major role players. Originally this led to a down-playing of CTL 
activity in this disease. With the discovery of cytolytic CD4+ cells, a reappraisal was 
necessary. In infections involving intracellular bacteria, MHC II-restricted CD4+ CTL could 
mimic the activity of CD8+ CTL in viral infections. Such a scenario is consistent with findings 
to date, and re-emphasises the pivotal role of CD4+ cells in TB (Sevilir-Williams and 
Engelhart, 1997). 
Since M. tuberculosis preferentially infects macrophage cells, it is the lysis of these cells by 
CTL that is of central concern. The concept of CD4 CTL operating predominantly via Fas­
FasL interaction is problematic when it comes to macrophages, since these cells express low 
levels of CD95 (Kiener et al., 1997). Various groups have published this finding, and even 
with pre-activation, levels of expression <25% have been observed (Liles et al., 1996). 
Infection with M. tuberculosis has been shown to decrease Fas expression (Oddo et al., 
1998). With Fas expression being sub-optimal on macrophages, CD4+ CTL utilising such a 
mechanism of activity would be restricted functionally. It thus appears that Fas-mediated 













CD4+ CTL which contain cytolytic granules have been reported by several groups 
(Lewinsohn et a/., 1998; Sevilir~Wiliiams and Engelhart, 1996). The occurrence of such cells 
may be an adaptation to a lack of CD8+ CTL expansion (Sevilir-Williams and Engelhart, 
1997), or a specific adaptation for controlling intracellular infections such as TB. The fact that 
granule mediators such as granzymes can directly kill target cells independently of host 
control mechanisms bypasses any possible adaptation by the invading organism to enhance 
anti-apoptotic mediator activity. 
The possibility that cytolytic granule contents themselves are microbicidal has recently been 
demonstrated with granulysin. Granulysin is component of cytolytic granules and has been 
shown to be both bactericidal and mycobactericidal (Pena and Krensky, 1997; Stenger et a/., 
1998). Earlier reports demonstrated that lytic components of NK cells were bactericidal 
(Garcia-Pennarubia et a/., 1989). Due to homology between NK-Iysin and granulysin, similar 
components may be responsible for the bactricidal effects in both populations. The ability of 
other cytolytic granule components to kill bacteria and mycobacteria needs to be 
investigated. The recent characterisation of granulysin emphasises the need to examine 
other cytolytic granule components which may also mediate microbicidal effects (Kaufmann, 
1999). 
The question remains - is it the lysis of the target cell (normally via apoptosis) or the granule­
mediated pathway specifically, that is important in mediating microbicidal activity. A recent 
report showed that FasL mediated lysis of macrophages led to a reduction in viable 
organisms (Oddo et al., 1998). This suggests that target cell apoptosis itself may be pivotal. 
Another study involving CD8+ CTL, showed that granule mediated lysis had the same effect. 
The latter study (Stenger et a/., 1997) implicates cytolytic granule contents, specifically 
granulysin, as the mediator of microbicidal activity. The current study has revealed that either 
mechanism of induction of apoptosis can lead to a reduction in organism viability. However, 
since Fas plays a lesser role, it is the predominant granule-mediated pathway that is 
ultimately responsible for organism clearance in this disease. 
1.2.6. Potential modulation of cytotoxic immune function: prospects for disease 
control 
Identification of the factors which lead to formation, recruitment and activation of cytolytic 
CD4+ cells, particularly those with granule-secreting activity, is an area of potential disease 
control. Factors which enhance and promote CTL activity e.g. particular antigenic 
determinants favouring CTL expansion, or the ability to override host cell protective 
mechanisms may be important in optimising CTL activity (Kaufmann and Andersen, 1998). 
The exact nature of such control factors needs further investigation. In addition, isolation of 
cytolytic factors (granzymes, pertorin, granulysin) may offer additional scope for anti­












themselves, may allow for exposure of organisms released following target cel! lysis, thus 
aiding clearance of organisms remaining after apoptosis. In this way natural host defences 
are augmented by a successful delivery mechanism for anti-tuberculous drugs. 
Lack of CTL activity may be a marker for disease severity or susceptibility. Identification of 
particular CTL markers, e.g. expression of serine proteases (e.g. granzyme B) in C04+ CTL 
challenged with mycobacterial antigen may be important. If disease susceptibilty is linked to 
inadequate or inappropriate CTL activity, therapies involving enhancement strategies could 
be implemented. The actual signal transduction processes in both T cell activation and 
macrophage death need to be elucidated, which will allow for optimal manipulation of the 
system for successful disease control. 
1.3. Immunosuppression and suppressor T cells 
1.3.1. Immunosuppression and tuberculosis 
Primary pulmonary infection with M. tuberculosis induces long-term protective immunity in 
the large majority of infected individuals. Lifetime risk of reactivation of latent infection is less 
than 5% in immunocompetent subjects (Barnes and Modlin, 1996). Alveolar macrophages 
are the natural hosts for M. tuberculosis and as discussed in detail above, it is the interaction 
between macrophages, T cells and various cytokines that leads to control of infection via a 
strong Th1 delayed type hypersensitivity (OTH) reaction. 
The role of type-2 responses and humoral immunity in M. tuberculosis infections is 
considered to be marginal. Reports on both in vivo and in vitro production of type-2 cytokines 
are inconsistent and there is no conclusive evidence of suppression of type-1 responses via 
type-2 cytokines (Zhang et a/., 1995; Lin et al., 1996). Even though Th2 or anti-inflammatory 
cytokines appear to playa marginal role in tuberculosis immunity, an unusual phenomenon 
of pulmonary TB is the fact that features of anergy or suppression occur during immune 
activation (Vanham et al., 1998). Active pulmonary TB is characterised by signs of systemic 
immune activation such as polyclonal hyper-gammaglobulinemia, increased serum TNF 
levels and up-regulation of HLA-OR on circulating T cells (Kaplan and Freedman, 1996; 
Vanham et al., 1996). Paradoxically there is also simultaneous evidence for antigen-specific 
hyporesponsiveness. Up to 20-25% of patients with non-HIV tuberculosis show a negative 
skin test (anergy). More accurate assessments of immune activation such as PPO -induced 
lymphocyte proliferative responses show reduction in values of 50% of healthy PPO reactors. 
In addition IL-2 and IFN-y production is reduced (Toossi et al., 1986; Vilcek et a/., 1986). 
Several models can be proposed to explain this apparent paradox of concomitant activation 
and immune depression. These include (i) dysregulation of APC function - reduced antigen 












may induce refractoriness to stimulation and predisposition towards apoptosis, (iii) antigen­
specific cells may be compartmentalised in the sites of infection leading to less responsive 
cells being recovered from the periphery (Vanham, et al., 1996; van Parijs and Abbas, 1998). 
In addition to these models, antigen-specific suppressor T cells may be operative. Although 
well characterised in leprosy, such cells have hitherto not been described in TB. The mode of 
action of such cells may be via lysis of Th cells, competition for APC or down-regulation of 
APC function, induction of hyporesponsiveness in Th cells via specific receptor-mediated 
processes, or via the release of type~2 cytokines. These various mechanisms of anergy 
induction/suppression are discussed in more detail below. 
Immunosuppression is a feature of tuberculosis only in certain clinical cases. The majority of 
persons infected with M. tuberculosis do not develop clinical disease. The majority of those 
who do develop disease are reactivation cases Le. they have had an earlier exposure to the 
organism and subsequently there has been a reactivation. Most cases are localised to the 
lungs and treatment is successful in clearing infection. In a small minority of cases the 
pattern of disease development is different. There is rapid spread and dissemination of 
infectious particles, the patient becomes severely ill and shows signs of generalised 
immunosuppression (Ellner, 1997). 
Why these different clinical patterns occur has been an area of great interest. The discovery 
of the Th1ITh2 dichotomy of cell-mediated immunity in infectious states in the mouse and "­
subsequent parallel situations in the human led to the supposition that such a situation may 
apply in tuberculosis as well. Disseminated disease possibly being related to a Th2, as 
opposed to a Th1, pattern (Romagnani, 1992; Rook and Bloom, 1994). As discussed above, 
the Th1 response is normally predominant in diseases involving bacteria and viruses, 
whereas the Th2 response predominates in certain parasitic and helminth diseases and in 
allergic responses (Romagnani, 1994). The mycobacterial disease leprosy presents clinically 
with a very interesting picture. There are two possible outcomes for this disease - a 
tuberculoid form or a lepromatous form. Tuberculoid leprosy is strongly Th1 driven, the 
disease is localised and less severe. In lepromatous leprosy there is dissemination of 
infection and severe immunosuppression which is linked to severe weight loss, fever etc. 
The lepromatous form of leprosy is Th2 predominant (Hopewell, 1995; Bloom, 1994) .. The 
detection of whether a form or type of disease is Th1 or Th2 driven is made from analysis of 
T lymphocyte function in vitro of cells derived from the sites of pathology. 
In tuberculosis, analysis of T lymphocytes from sites of pathology (usually pleural effusions) 
has clearly demonstrated that Th1 cytokines are most strongly represented (Barnes et al., 
1993; Sieling and Modlin, 1994, Lin et al., 1996). These analyses are generally performed on 
patients presenting with classical tuberculosis. Tuberculosis patients who are 











that initiation of either a Th1 or Th2 pathway of cellular immunity will affect disease outcome. 
Research in this area has now revealed that IL-12 is pivotal in this regard. Infection of 
macrophages with M. tuberculosis usually results in release of IL-12. This cytokine appears 
to recruit andlor activate Th1-type T cells which in turn produce IFN-y which activates 
macrophages. Activated macrophages then also produce TNF-o. and other cytokines, all of 
which seem important in the containment of disease (Sieling et al., 1994). In a Th2 response 
this sequence of events would not occur. Rather. there would be predominance of Th2 
cytokines such as IL~. IL-5 and IL-10. These cytokines do not recruit and activate Th1 cells 
but instead stimulate B cells and switch off or down-regulate the inflammatory response (Del 
Prete et al .. 1994). Why would this inappropriate sequence of events occur in a disease 
where a Th1 response is important for infection clearance? 
1.3.2. Suppressor T lymphocytes 
1.3.2.1. Origin and function of suppressor T cells 
The concept of suppressor T cells was first proposed by Gershon and co-workers in 1972 
(Gershon et al., 1972). These cells were hypothesised to playa role in the switching off of 
immune responses and/or in the induction of tolerance. The clearest evidence of T cell­
mediated suppression derives from adoptive transfer models in transplantation. It has been 
noted in several experimental systems that tolerance to allogeneic tissue can be transferred 
from a tolerant to a syngeneic naive recipient animal if T cells are injected together with the 
specific antigen. Both CD4+ and CD8+ T cells have been implicated in mediating these 
regulatory effects in different systems (Frasca et al.. 1997). 
How suppression operates is still open to debate. Whether the suppressive effect of the 
suppressor T cell is via deletion of reactive T cells by cytolysis. induction of anergy via 
competition for APC or IL-2, or direct immunomodulation via localised release of classical 
type-2 cytokines (e.g. IL-4), or an undefined receptor-ligand interaction, is still not understood 
(Webb et al.• 1994). In addition. specific suppressor factors (SF) are produced by certain 
suppressor T cells following exposure to antigen. These SF are distinct from other cytokines 
in that they are only produced by suppressor cells in response to a specific antigen (O'Hara, 
1995). Classically, cytokine production is not antigen specific. 
In addition to their role in normal immune function and in autoimmunity, suppressor T cells 
are implicated in infectious diseases as well. Mycobacterial diseases are no exception, the 
existence and role of suppressor T cells in leprosy has been well studied. Infection with M. 
lepraemurium in mice led to the development of CD8+ splenic lymphocytes which could 
inhibit proliferation of splenocytes from u!1infected mice to both specific antigen and mitogen 
stimulation. Culture of spleen cells from infected mice produced supernatants containing 
IFN-y. TNF-a and lymphotoxinrrNF-p (Lemieux et a/., 1990). Suppression could be reduced 













cells in vitro to produce soluble mediators of suppression (Sussman and Waddee, 1991). 
CD8+ Ts clones derived from leprosy patients have been shown to be antigen-specific and 
able to block responses of CD4+ antigen-specific clones. These T cells produced IL-4, and 
antibody to IL-4 could abrogate the suppressive effect (Bloom et al., 1992). Other diseases in 
which Ts cells have been demonstrated include infection with the fungus Cryptococcus 
neoformans (Masih et al., 1991), and several parasitic diseases including those caused by 
Toxoplasma gondii (Pomeroy et al., 1991), and Trypanosoma cruzi (Tarleton, 1988). 
1.3.2.2. Phenotypic characterisation of Ts clones 
A stumbling block in the study of suppressor T cell activity in vitro has been the difficulties 
encountered when attempting to clone such cells. These difficulties may stem from the non­
responsiveness of Ts clones to antigen and the difficulty of expansion of populations of cells. 
Despite these difficulties various groups have reported the generation and characterisation of 
Ts clones with differing phenotypes. In the murine model both CD4+ and CD8+ Ts clones 
have been described (Utsunomiya et al., 1989; Hu et al., 1992). In addition, dual positive 
(CD3+, CD4+, CD8+) (Nanda et al., 1990) and dual negative (CD3+, CD4-, CD8-) 
(Takahashi, 1990) Ts clones have also been reported. 
In the human the phenotypic characterisation. of Ts clones has yielded divergent findings as 
well. A dual positive (CD4+CD8+) Ts clone derived from a contact dermatitis patient has 
been described (Kalish and Morimoto, 1988). Of more interest to the current study are the 
reports of mycobacterial antigen specific Ts clones derived from leprosy patients. One series 
of studies showed Ts clones to be CD4+ and MHC class II-restricted (U et al., 1990). These 
Ts clones produced IFN-y and lacked CD28. Leprosy patient-derived CD8+ Ts clones have 
been characterised and shown to be HLA-DQ-restricted and produce mainly IL-4 (Salgame 
et al., 1991 b). 
Many studies have shown that CD8+ T cells can suppress immune responses, hence the 
term cytotoxic/suppressor T cell. Initial work in experimental animal models showed that 
transfer of mice T cells which had been made tolerant to sheep red blood cells would 
suppress the response of naive mice to the same antigen, but not to horse red blood cells or 
other unrelated antigens (Webb et al., 1994). Subsequently it was shown that the 
suppressive cells were CD8+, and that CD8+ T cells from mice actively immunised with 
sheep red blood cells also had suppressive activity. These findings led to the formulation of 
the hypotheSiS that CD8 T cells as part of their normal function have the ability to suppress 
immune responses in an antigen-dependent manner. Another important animal model of 
suppressor activity has been demonstrated by the ability of rats which had been fed myelin 
basic protein (MBP) to generate CD8+ T cells which secreted TGF-(3 and suppressed 
experimental allergic encephalomyelitis (Miller et al., 1992). In the human, similar cells have 












leprae, and thus prevent successful infection control. In both the leprosy model and the 
MBP model in rats, the suppressor CD8+ Tcells recognise peptides bound to MHC class II 
molecules and secrete cytokines typical of Th2 cells. Suppression thus appears to be a 
manifestation of the inhibition of generation or activation of inflammatory CD4+ T cells. 
other examples of CD8+ suppressor T cells have been reported. An important feature of 
these cells is that in certain diseases they may be benefiCial e.q. in experimental 
autoimmune encephalomyelitis (Miller et al., 1992). Elimination of CD8-! T cells by antibody 
treatment or gene knockout leads to more severe disease. A similar situation may apply in 
human multiple sclerosis, where disease exacerbation may correlate with CD8+ T cell 
deficiency (Kumar and Sercarz, 1993). 
1.3.2.3. Mechanisms of CD8+ T cell-mediated suppression 
Many studies have indicated that suppressor cell activity is antigen-specific, however the 
mechanism of antigen recognition remains controversial. This is particularly apparent in lieu 
of the finding that CD8+ Ts clones are dependent on MHC class II components (particular1y 
DR or DQ). In addition, it has proven very difficult to identify specific effector molecules 
involved in suppression, thus the way in which the suppressive effect is produced also 
remains uncertain. Possible mechanisms of CD8 T-cell mediated suppression include lysis 
of APC and/or CD4+ T cells and release of soluble suppressor factors (SF) which down­
regulate effector cell responses. Other possible mechanisms include cytokine mediation 
(e.g. Il-4, Il-5, Il-10, TGF-P), competition for MHC molecules on APC and/or Il-2 
depletion, and down-regulation of important co-receptors on APC or effector cells which 
would induce anergy (e.g. B7 components and CD28) (Webb et al., 1994; van Parijs and 
Abbas, 1998). 
The cytolytic model originally focussed on APC lysis. lysis of APC by cytolytiC CD8+ T cells 
following recognition of antigen presented via MHC class I molecules is a well established 
phenomenon. lysis of APC could lead to loss of activation of CD4+ T cells and lead to a 
situation akin to suppression. This model does not explain how a CD4+ T cell can be 
directly suppressed by CD8+ cells - a phenomenon observed in the animal model of mouse 
responses to insulin (Webb et al., 1994). 
It is possible to demonstrate that CD4+ T cells can be controlled by cytotoxiC CD8 T cells. 
Immunisation with peptides derived from TCR variable regions can elicit CD8+ T cells that 
recognise these peptides bound to MHC class I molecules on the surface of CD4+ T cells. 
The CD8+ T cells can then lyse the CD4+ T cell expressing the correct receptor. This is the 
only known CD4+ T cell antigen that has been used successfully as a target for CTl. 
CytotoxiC CD8+ T cells of this kind have been shown to suppress the autoimmune disease 











attempts to raise similar cells by immunisation of patients with multiple sclerosis have given 
encouraging results (Kumar and Sercarz, 1993). 
Not all the observations on CD8+ T cell suppression are readily explained by proposing that 
they kill APC or CD4+ T cells. Early studies in suppression showed that direct binding of the 
suppressor cells to intact antigen molecules linked to insoluble substrates in the absence of 
APC or MHC molecules was possible. Soluble products released by these cells were found 
to mediate suppression and also to bind directly to antigen (O'Hara, 1995). Detailed 
biochemical characterisation of these molecules has not been forthcoming. Indirect evidence 
suggests that they may contain TCR a-chains. Antibodies to TCR a-chains can be used to 
remove suppressive activity from the supernatants of suppressor cell cultures. Although 
intriguing, these data are inconclusive. It seems unlikely that TCR a-chains are the sole 
component of the suppressive factor, since TCRs do not bind to intact antigen and a 
mechanism for a chain secretion has yet to be found (Kuchroo et al., 1991). 
Although the exact mechanism of suppression remains unknown, the presence of 
immunoregulatory CD8+ T cells cannot be questioned. The existence of such a population of 
T cells is important since manipulation of immune responses via modulation of the activity of 
these cells may provide a novel therapeutic strategy in many diseases. In the case of 
autoimmune disorders, activation of suppressor T cells would be beneficial to the host. The 
best-characterised model of this is multiple sclerosis (Hafler et al., 1997). In infectious 
diseases, however, such suppressor cells would down-modulate inflammatory responses 
and could have dire consequences (e.g. lepromatous leprosy). A clearer understanding of 
the origin, function and mechanism of action of suppressor T cells is essential if such cells 
are ever to be manipulated so as to produce a more favourable outcome for the host in 
whichever particular disease. 
There are basically two circumstances in which suppressor T cells have been defined. In the 
first. individuals fail to respond to a particular antigen when T cells are present, and 
responsiveness is restored by removing T cells. Original experiments by Gershon and Kondo 
(Gershon and Kondo, 1971) described such a phenomenon. The second circumstance is the 
induction of unresponsiveness in individuals otherwise capable of responding. This is 
achieved by introduction of antigen generally in a particular form for presentation e.g. through 
use of low doses of soluble antigens, chemical modification of antigens, or coupling to self­
antigens. Both CD4 and CD8 T cells have in varying situations been reported to transfer 
suppression adoptively, but no single mechanism has emerged (Webb et al., 1994). 
Suppressor cells have been described in various animal models. The first human suppressor 
T cell (Ts) clone was reported by Bensussan et al. (1984), to be CD8+ and antigen-specific 












consistent finding with several reports of Ts cells appears to be the lack of CD28, the co­
stimulatory receptor required for T cell activation (Li et aI, 1990; Bloom et al., 1992). All other 
prospective markers for Ts cells have not been consistently expressed. The confusion 
regarding phenotypic characterisation becomes even more complex when function is 
assessed. In addition, Ts cells produce an array of cytokines which makes clear-cut 
classification of such cells on the basis of cytokine production difficult. 
The isolation of suppressor T cells from lepromatous leprosy patients may explain the lack of 
responsiveness of T cells in these patients. In addition, the excess of type-2 cytokines would 
augment any anti-inflammatory activity mediated by Ts cells. Generation of Ts clones from 
these patients has shown them to be MHC class II-restricted CD8+ or CD4+, CD28- cells 
(Modlin et al., 1986; Otten hoff et al., 1986). 
The restriction of CD8+ suppressor cells to MHC class II is unexpected and unusual (Bloom 
et al., 1992). Traditionally CD4+ T cells are class II-restricted, CD8+ are class I-restricted. 
Both CD4+ and CD8+ Ts have been described, and both DR- and DO-restriction have been 
observed. In lepromatous leprosy patients both DR- (Li et al., 1990) and DO- (Salgame et al., 
1991) restriction have been described for a single disease. Such divergent findings further 
complicate an already controversial field of research. How does MHC class \I playa role in 
CD8+-mediated events? Do Ts cells kill APC or CD4+ T cells? Do Ts induce a state of 
anergy in CD4+ antigen-responsive cells? 
1.3.3. Cytokines and suppression 
Original work on suppression focused on antigen specific suppressor factors as the prime 
mediators of non-responsiveness. With the exponential growth of research on cytokines and 
their activities, it has becom  apparent that several T cell-derived cytokines are 
immunosuppressive and may contribute to the phenomenon of antigen-specific suppression. 
The major difference between type-2 or anti-inflammatory cytokines and suppressor factors 
is the antigen-specificity of the release of the latter {O'Hara, 1995}. With more detailed 
understanding of cytokines, their production, receptor binding and effects on other cells, it 
has become apparent that certain of the effects assigned to suppressor cells may be 
mediated or enhanced by cytokines. Of particular interest are IL-4, IL-5, IL-10 and TGF-~ {Le 
Gros and Erard, 1994}. 
TGF-~ is the name applied to a family of multifunctional polypeptide growth factors with 
varying effects. TGF-~1 is the best characterised of the family of 5 members. This cytokine is 
produced by a wide range of cells, with platelets being a major source. Almost all mammalian 
cells possess receptors for TGF-~, and both stimulatory and inhibitory activities have been 
assigned to this cytokine (Wahl, 1992). The effect of TGF-~ on immune cells (B and T 












potent inhibitor of both Band T cell proliferation and has been reported to inhibit NK activity 
and anti·microbial activities of macrophages. Localised production of TGF·~ may playa role 
in down·regulating the immune response, and thus in immunosuppression (Sporn and 
Roberts, 1992; Letterio and Roberts, 1998). 
IL4 was originally characterised as a B cell stimulatory factor. Subsequently it has been 
shown that lL4 is a pleiotropic cytokine which modulates the function of diverse cell types, 
including T cells, me locytes and macrophages. IL4 is produced mainly by CD4+ T cells, but 
also CD8+ T cells, mast cells and basophils. IL4 binds to the IL4 receptor (IL4R) which 
initiates transmembrane signalling processes. IL4 is anti·inflammatory and is an important 
modulator of differentiation of CD4+ cells into either Th1· or Th2·populations. A major 
function is the suppression of cytokine production by Th1 cells, thus suppressing cell· 
mediated immunity (Keegan and Pierce, 1994). 
IL·5 was originally also thought to be a B cell stimulatory factor, however it has subsequently 
been found to have diverse activities. IL-5 is not as well characterised as IL4, but appears to 
be produced by T lymphocytes, eosinophils and mast cells. IL·S is best characterised in its 
role in switching CD4+ T cell differentiation to a type-2 pattern. This is especially important in 
helminth infections, where eosinophils are an important component. IL-S, like IL4, has 
suppressive effects on Th1 cytokine production (Takatsu, 1992). 
IL·10 is produced by T lymphocytes (Th2 CD4+ predominantly), macrophages, B cells and 
other cell types. IL-10 operates via binding to the IL·10R. IL-10 is inhibitory to Th1 cytokine 
production, however this effect is indirect, operating via inhibition of accessory function and 
antigen presentation. In addition to inhibition of cytokine production, IL-10 inhibits proliferation 
of all antigen-specific T cell populations. This cytokine is therefore potently suppressive in its 
activity, and may thus be an essential component of the suppressor activity previously 
ascribed to suppressor T cells (Moore et al., 1993). 
1.3.4. Antigen-specific suppressor factors (SF) 

The isolation and characterisation of suppressor factors produced by suppressor T cells has 

been an area of intensive research. The increased emphasis on cytokines as mediators of 

many immune functions including suppression has detracted focus from suppressor factors. 

SF from both suppressor T cells and APC have been reported (O'Hara, 1995). 

Biochemical characterisation and purification of a specific Ts-derived suppressor factor (SF) 
was an area of intensive research is the early 1980's. This SF bound free antigen in the 
absence of MHC protein. Further study indicated that the SF and Ts cells themselves shared 
antigen specificity, which led to the hypothesis that SF represented a soluble form of T cell 












receptor is mediated by the TCR-a chain. Expression of TCR-a chain was essential for 
suppressor activity of T cell hybridomas (Kuchroo et aI, 1991). The TCR-a chain required for 
suppression has been found not to differ from normal TCR-a chains (Kuchroo et aI, 1991). 
The linking of suppression to a suppressor factor which is related to the TCR-a chain has 
clarified certain issues regarding this factor. However, the mechanism whereby a TCR chain 
binds free antigen independent of MHC processing is unknown (O'Hara, 1995). Of major 
concern is how a soluble TCR component can act as a suppressor factor, and whether the 
SF (TCR-a chain) acts alone, or forms a c.meric structure with a second chain. The 
universality of suppression operating via a SF which is related to the TCR has also not been 
clarified. 
1.3.5. Models of immune regulation and the role of Ts cells 
Switching off of the immune response is an important process. Mechanisms whereby this 
occurs are slowly being elucidated. The better characterised mechanisms such as apoptosis 
of expanded T cells at the periphery via Fas-FasL interactions are now generally accepted. 
Inappropriate switching off (anergy or suppression) is less well characterised. Certain 
diseases are characterised by states of apparent immunosuppression, TB being a prime 
example {Scotteta/., 1994}. 
A model for the role of Ts cells in the termination of the inflammatory response in TB can be 
envisaged, with inappropriate activation of such cells being responsible for disseminated 
disease and anergy induction. In a normal sequence of events, following initial expansion of 
T cells at the site of infection and production of type-1 cytokines, activation or lysis of 
macrophages and localised disease containment, a switching off process is required. Apart 
from T cell apoptosis which accounts for reduction of clonally expanded populations (Ellner, 
1997), Ts cells could be envisaged to play. an active role. Ts cells are antigen specific, 
however their antigen requirements differ from those needed for immune activation. Ts cells 
respond to sub-optimal levels of antigen presentation, or modified forms of antigen. When 
the disease has been contained, levels of antigen are decreased. Such a reduction in antigen 
presentation may induce activation of Ts cells. This activation could involve the release of SF 
or cytokines, or the deletion of T cells or APC. This is a hypothetical model of suppressor cell 
activity in a disease such as TB. To date no suppressor cell activity has been characterised 
in TB, even though the presence of such cells has been proposed. In the current study a Ts 
clone was isolated from a TB patient. The fact that the patient presented with a classical 
reactivation type picture of the disease with associated pleural effusion was not indicative of 
Ts cell activity. However, if normal immune responses are dependent on such cells for 
switching off, this finding is not as unexpected as it may seem. Inappropriate activation of 
such cells in severe forms of the disease would confirm the hypothetical model of Ts cell 














The current study describes the generation and characterisation of a CD8+ suppressor T 
lymphocyte clone from a tuberculosis patient. Similarities and differences between this clone 
and clones derived from leprosy lesions are outlined and discussed in relation to the 
important role such cells may play in the induction of anergy or unresponsiveness in certain 
situations. 
1.4. Aims of the study 
The aims of the current study were to characterise T lymphocyte-mediated function in 
tuberculosis. Although much is known about the importance of T lymphocytes in this disease, 
there are areas still not clearly understood. These include the lack of consensus on any 
definitive role for cytotoxic CD4+ T lymphocytes, and an absence of any reported suppressor 
cell activity in TB, despite a clinical course which would suggest the occurrence of these 
cells. 
The majority of work in human tuberculosis has used healthy PPD-positive or -negative 
subjects as donors of lymphocytes. There are limitations in both the use of healthy donors 
and peripheral blood as a source of lymphocytes for in vitro studies. Due to this fact, this 
study has focused on using lymphocytes derived from a disease-associated site (tuberculous 
effusion) of a tuberculosis patient. The inherent problems of using bulk populations of 
antigen-primed lymphocytes has also been circumvented by the use of clones. 
A panel of clones was generated from the mycobacterial-antigen stimulated population of 
effusion lymphocytes. All the CD4+ clones obtained were strongly Th1, and thus capable of 
mediating protective immunity. The majority of these cells were found to be cytolytic and the 
cytolytic activity of the CD4+ T cell clones was found to reduce mycobacterial viability. The 
mycobactericidal CD4+ CTL clones possessed a predominant granule exocytosis killing 
mechanism. No antigen-specific C8+ cytolytic activity was detected. Both type-1 and type-2 
cytokines were produced by a CD8+ clone which appeared unresponsive to antigeniC 
stimulation. This clone was able to inhibit autologous T cell proliferation via a cytokine- and 
receptor-dependent suppressor mechanism. 
This study has clarified a role for CD4+ CTL in tuberculosis and has also demonstrated the 
occurrence of suppressor cells, which may account for the non-responsiveness observed in 













Comparison of cellular immune activity of peripheral blood- and 
effusion-derived mononuclear cells and generation and 
characterisation of effusion-derived T lymphocyte clones 
( 
2.1. Introduction 
The primary site of infection in tuberculosis is the lung (Rook and Hernandez-Pando, 1996). 
The majority of clinical cases are reactivation TB, and this often involves extra-pulmonary 
sites (Dannenberg and Rook, 1994). Tuberculous pleuritis which accounts for 28% of all 
extra-pulmonary cases, involves the invasion of the pleural space by infectious material from 
the granulomatous lesion (Hopewell, 1994; Toossi and Ellner, 1992). The pleural effusion­
derived mononuclear cell population is readily accessible by pleural aspirate, thus affording 
an opportunity to assess cellular function at a disease-associated site. 
Tuberculous pleural effusions generally contain increased numbers of T lymphocytes, 
particularly of the CD4+ lineage (Barnes et a/., 1989). Previous studies have indicated that 
pleural effusion-derived lymphocyte populations from a majority of patients with active 
tuberculosis display accelerated proliferation kinetics to mycobacterial antigens (Lorgat et 
a/., 1992a). In addition, accelerated kinetics of in vitro induction of antigen-specific cytotoxic 
activity as well as activation marker expression and cell cycle progression have also been 
reported (Lorgat et al., 1992b; Lukey et al., 1996). Limiting dilution analysis (LDA) of pleural 
effusion populations has revealed increased responder cell frequency (Lukey et al., 1998). 
Together these findings suggest that antigen-specific T cells are selectively expanded in the 
pleural effuSion, and that these cells are antigenically primed in vivo. 
Although the phenomenon of accelerated proliferation kinetics has been observed in a 
majority of tuberculosis patients, this pattern of response is not universal. Effusion-derived 
lymphocyte populations have been divided into three groups based on the kinetics of 
proliferation, namely, non-responders, normal (non-accelerated) responders, and 
accelerated responder populations (Lukey et al., 1996, 1998). No significant correlation 
between responder cell frequency and kinetics of response has been observed, suggesting 
that other factors are involved in determining the kinetics of response (Lukey et al., 1998). 
Characteristic v-shaped LDA curves have been noted in some non-responder populations, a 
finding which suggests the activity of antigen-specific suppressor cells within the pleural 












I Therefore, although several features of immune activation have been noted in effusion­
derived lymphocytes, evidence of active suppression of immune responses has also been 
observed. The patient in the current study was unique because elements of both immune 
activation and suppression were observed in the same pleural effusion. At the level of 
immune activation there was an expansion of the CD4+ component of T lymphocytes within 
the effusion as well as an enhanced frequency of PPD responsive cells in the effusion as 
compared to the peripheral blood. Proliferation kinetics were more rapid than normal, but did 
not reflect the classical pattern of accelerated kinetics. Accelerated induction of cytotoxic 
responses in vitro was observed in the effusion, but not the peripheral blood. The LDA of the 
effusion, however, suggested the activity of suppressor cells. The activity of such suppressor 
cells may also have accounted for the unique proliferation kinetics of the effusion. Based on 
these findings, a more detailed characterisation of cellular activity in the effusion was carried 
out at the clonal level. Both CD4+ and CD8+ clones were generated. The majority of CD4+ 
clones were cytolytic, whereas no antigen-specific cytolytiC CD8+ clones were generated. 
The CD8+ clones were only weakly responsive to mycobacterial antigens, and one particular 
clone uniquely produced the cytokine IL-4. These findings led to further assessment of the 
relevance of CD4+ T cell-mediated cytotoxicity and CD8+ T cell-mediated suppression in 
tuberculosis (chapters 3 - 5). 
This chapter presents a comparison of the activity of effusion- and peripheral blood-derived 
mononuclear populations. The generation and characterisation of the T lymphocyte clones 












2.2. Materials and Methods 
2.2.1. Isolation of mononuclear cells from peripheral blood and pleural fluid 
Peripheral blood and pleural fluid were collected from a TB patient presenting with a pleural 
effusion who was admitted to Groote Schuur Hospital, Cape Town. Venous blood was 
collected in 10 ml blood collection tubes (Becton Dickinson, Meylan, France) to which 0.5 ml 
of heparin (final concentration 5 IU/ml of blood, (Calciparine, Sanofi, Winthrop, France)) had 
been added. A total of 50 ml of blood was collected prior to chemotherapy, from which the 
mononuclear popul,'tion was used in the generation of the clones. All subsequent peripheral 
blood was collected following chemotherapy. Pleural fluid was collected in 50ml tubes (Bibby 
Sterilin. Stone, Staffordshire, UK) containing 2.5 ml of heparin. The pleural fluid was 
assessed for cellular density and viability by trypan blue exclusion staining prior to 
mononuclear cell isolation. Mononuclear cells were isolated from both peripheral blood and 
pleural fluid by density gradient centrifugation using Hypaque-Ficoll (Sigma, St. Louis, USA). 
Peripheral blood separation: Peripheral blood mononuclear cells (PBMNC) were isolated as 
previously described (Lorgat et a/., 1992b). Fresh heparinised venous blood was centrifuged 
at 300 x gravitational attraction (g) for 12 minutes in the blood collection tubes, to obtain 
leukocyte buffy layers. The buffy layers (4ml) were removed and resuspended in an equal 
volume (4ml) of phosphate buffered saline (PBS; Dulbecco, Oxoid, Unipath Ltd., Hampshire, 
England) and gently layered onto 4ml of Hypaque-Ficoll (Sigma, St. Louis, Mo.) in round­
bottomed centrifuge tubes (Bibby Sterilin, Stone, Staffordshire, UK). The gradient was then 
centrifuged at 400 x g for 30 minutes. The mononuclear cell interfaces were removed and 
transferred to conical centrifuge tubes (Bibby Sterilin). PBS was added to each tube, and the 
mononuclear fraction was washed three times by repeated centrifugation (200 x g for 10 
minutes) and resuspension in PBS. The washed mononuclear cell fractions were finally 
resuspended in RPMI 1640 m dium (Flow, ICN Biomedicals, Costa Mesa, CA, USA) 
containing 20mM HEPES, 100 U/ml penicillin G and 100 ~g/ml streptomycin sulphate 
(Sigma). RPMI 1640 medium was supplemented with 10% pooled, heat inactivated (56°C for 
1 hour) human AB serum (Western Province Blood Transfusion Services, Cape Town). The 
mononuclear cells were enumerated by staining with Turks fluid (0.02% crystal violet 
(Sigma), 7% glaCial acetic acid (Merck) in distilled water). The cell concentration was 
adjusted to 106 cells/ml. 
Pleural fluid separation: The fresh heparinised pleural fluid (8ml) was layered directly onto 
Hypaque-Ficoll (4ml) without dilution in PBS. The separation of pleural effusion monuclear 
cells (EMNC) was then carried out exactly as for peripheral blood. 
Cryopreservation of PBMNC and EMNC: Freshly isolated PBMNC and EMNC were 
aliquoted and frozen for later use. Mononuclear cells were resuspended in human AS serum 















Aliquots (1 ml) were added to cryopreservation tubes (Nunc, Denmark) and frozen at -80°C. 
After 24 hours frozen cells were transferred to liquid nitrogen. 
2.2.2. Phenotyping of PBMNC and EMNC populations 
Freshly isolated PBMNC and EMNC cells were assessed phenotypically by flow cytometry. 
Cells (100 III of 106/ml) were incubated for 10 minutes with 5111 of FITC- (fluorescein 
isothyocyanite) or RD- (rhodamine) coupled monoclonal antibodies or isotype controls 
(Coulter Corporation, Hialeah, FL, USA). A , 3t of antibodies and their isotypic controls is 
presented in Table 2.1. The cells were then fixed in 1 % fresh paraformaldehyde for at least 1 
hour (Merck, Darmstadt, Germany) and analysed on a flow cytometer (Coulter, Epics Profile 
II). A total of 10000 events were analysed. 
Table 2.1. Mouse anti-human monoclonal antibodies used for phenotyping PBMNC 
and EMNC populations 
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2.2.3. Proliferative responses of pleural effusion- and peripheral blood-derived 
lymphocytes 
Proliferation kinetics were assessed by examining the proliferative responses of the 
mononuclear cell fractions from both the effusion and peripheral blood over a seven day 
period. The mycobacterial antigen PPD (purified protein derivative of M. tuberculosis, 
Central Veterinary College, Weybridge, England) was used at 3l1g/ml. 
Streptokinase/streptodornase (SK-SD, Lederle laboratory, Wayne, NJ) was used at 250Ulml 
streptokinase and 62.5U/ml streptodornase. SK-SD was heated at 56°C for 1 hour to 
remove enzymatic activity. The mitogen phytohaemagglutinin (PHA, Wellcome Reagents, 
Beckenham, England) was used at a concentration of 5.75 x 10.3 mitogenic units/ml. Both 
PBMNC and EMNC proliferations were assessed in triplicate in round-bottomed 96-well 
microtitre plates (Greiner, Frickenhausen, Germany), each well containing 200111 of medium 
including 105 mononuclear leukocytes, with or without antigen or mitogen. 
After incubation at 37°C in a 5% CO2 humidified incubator for the specified time period, 21lCi 
of 3H-thymidine (185Mbq/mmol; Amersham International, Aylesbury, UK) was added to each 
well for the last 18 hours of culture. Mononuclear leukocytes were harvested onto filter paper 
(Macherey-Nagel, Germany) using a cell harvester (Titertek, Flow Laboratories). Dried filter 











scintillation fluid (insta-Gelll, Packard, USA) was added to each tube and the 3H-thymidine 
incorporation was measured in a liquid scintillation p-counter (Tricarb Analyser 1900CA, 
Packard). Results are expressed as Llcpm (delta counts per minute) which represents the 
antigen or mitogen stimulated count minus count in absence of mitogen or antigen. 
2.2.4. Limiting dilution analysis (LOA) of PBMNC and EMNC 
LDA was carried out according to the methodology of Lukey et al. (1998). Cryopreserved 
PBMNC and EMNC (obtained at time of patient diagnosis) were thaVv'1d and viability was 
assessed by trypan blue exclusion staining. Cells with a viability >95% were then cultured in 
round-bottomed 96 well microtitre plates (Greiner). Growth medium (10% human AB serum 
in RPMI 1640) was supplemented with 5U1well recombinant human IL-2. The addition of IL-2 
ensured that the only limiting factor was the presence or absence of an effector cell 
(Sharrock et a/.• 1990). Freshly isolated autologous PBMNC were irradiated (30Gy) and 
added at 5 x 104/well as antigen-presenting cells. PBMNC and EMNC cells were plated over 
a range of cell concentrations (20000/well to 10/well) in replicates of 16 wells per each cell 
concentration. LDA was performed both in the presence and absence of antigen (PPD at 
3~g/ml, and SK-SD at 250Ulml streptokinase, 62.5U1ml streptodornase). Each well 
contained a total volume of 200~1. After 7 days of culture. 3H-thymidine was added 
(2~Ci/well) for the last 18 hours of culture. Cells were harvested and thymidine incorporation 
determined by scintillation counting as described above. LDA was performed twice to 
confirm reproducibility of estimated responder frequency. 
Statistical analysis of LDA: Responder frequencies were calculated according to Fazekas de 
St Groth (1982), using the maximum likelihood solution and expressed as multiplicity (Le. the 
inverse of frequency). A culture well was considered positive when the counts per minute 
(cpm) measured for that well exceeded the mean plus 3 standard deviations of its 
corresponding control (cultures with the same cell concentration and IL-2 but without 
antigen). Responder frequencies were considered significantly different if their 95% 
confidence limits did not overlap. -l values were >0.05 and were consistent with single-hit 
kinetics (Fazekas de St Groth. 1982). A computer programme was designed to assist in 
calculation of responder cell frequencies. This was done with the help of the Department of 
Statistics. University of Cape Town. 
2.2.5. Cytotoxic activity of PBMNC and EMNC populations 
Both PBMNC and EMNC were assessed for cytotoxic activity by determining their ability to 
lyse autologous adherent macrophages exposed to various mycobacterial antigens. Effector 
cells were generated by incubating PBMNC and ErviNC (10ml of 106/ml) at 37°C for 6 days 
in the presence of PPD (3~g/mJ). PBMNC adherent macrophages derived from patient 
PBMNC prior to chemotherapy were used as antigen presenting cell (APC) targets for both 











by plating 100,".11 of 106/ml PBIVINC per well at the same time that effector cultures were 
initiated. On day 5 (120 hours after plating), the adherent macrophage cells were labelled 
with 6f..lCi per well of 51Cr (Sodium chromate; Amersham, Aylesbury, UK) in the presence or 
absence of antigen. Mycobacterial antigens included PPD (3f..lg/ml), M. bovis BCG (Trudeau 
Institute, Seranac Lake, USA) at 105 CFUlml (equivalent to 1 organism per macrophage), 
and M. tuberculosis H37Rv (ATCC #27294, Rockville, MD, USA) at 105 CFUlml. Following 
overnight incubation, labelled target macrophages were washed thoroughly with warm PBS 
(supplemented with 5% FCS) to remove non-adherent cells and unincorporated label. The 
day 6 (144 hours) antigen (PPD)-primed EMNC and PBMNC were pelleted by centrifugation 
(200 x g), enumerated by trypan blue exclusion staining (0.02% trypan blue (Riedel-de­
Haen, Seelze, Germany) in distilled water), and added to the target adherent macrophages 
at effector to target ratios of 10:1,3:1 and 0.3:1. All effector to target ratios were set up in 
triplicate wells. Spontaneous 51Cr release was measured in wells containing target cells, but 
no effector cells. Following 16 hours of incubation in a 37°C CO2 incubator, the supernatants 
were harvested and placed into disposable Durham tubes (Greiner) and levels of 
radioactivity were determined using a y-counter (Tricarb, Packard). Maximal 51Cr release 
was assessed by lysis of the remaining target cells with 5% triton X-100 (Merck, Darmstadt, 
Germany) for 4 hours. The Iysates were harvested and counted in the same way as the 
supernatants. Percentage killing for the mean of triplicate wells was calculated as follows: 
percentage specific lysis = [mean test cpm/(mean test cpm + mean cpm after triton X 
treatment of same welisH x 100% - percentage spontaneous release. The percentage 
spontaneous release was calculated as foll ws: mean cpm in spontaneous release 
wells/(mean cpm in spontaneous release wells + mean cpm after triton X treatment of same 
wells) x 100%. Spontaneous release was always <20% of maximal release. 
The kinetics of in vitro induction of cytotoxic activity was assessed by determining cytolytic 
activity of day 4 and day 6 PPD-primed effector cells. Experiments were carried out as 
above, except that two effector cell cultures were initiated for each population. Day 4 
effectors were initiated 48 hours after day 6 effectors. Target adherent macrophages were 
cultured and radiolabelled as described above and all cytotoxicity assays were performed 
simultaneously. 
2.2.6. Generation of CD4+ and CD8+ mycobacteria-specific EMNC T cell lines 
Mycobacterial antigen-specific EMNC-derived effector cells were generated by incubating 
fresh EMNC (10ml of 106/ml) with M. bovis BCG (105CFUlml) at 37°C for 7 days, followed 
by the addition of recombinant human IL-2 (Cetus. Emeryville, USA) at 100 IUlml for an 
additional 3 days. CD4+ and CD8+ lymphocyte subsets of the expanded population of 
antigen-specific EMNC were isolated using antibody-coupled magnetic beads (Minimax 
Separation 'System, lVIiltenyi Biotec, Bergisch Gladbach, Germany). EMNC (107 in 80f..l I of 












microbeads (Le. either anti-CD4- or anti-COB-coupled magnetic beads) and incubated for 15 
minutes in a refrigerator (5°C). The separation column (Minimax) was washed through with 
500~1 of PBS-EDTA-BSA buffer (described above) and then placed on the magnetic stand 
(Minimax). Labelled cells (100~1) were then layered onto the washed column. The effluent 
(negative fraction) was collected in a 5ml tube. The column was then washed through with 
three 500~1 aliquots of buffer. Effluent from the first wash was pooled with the negative 
fraction, and the remaining two wash fractions were discarded. The positive fraction 
(consisting of the cells attached to the magnet via the bound beads) was extracted from the 
column using a plunger to force 1 ml of buffer through the column after removal from the 
magnet. Flow cytometric assessment of the purity of the CD4+ and CDS+ fractions was 
carried out prior to cloning. The monoclonal antibodies (anti-CD3, anti-CD4, anti-CDS, anti­
CD56) and their isotypic controls are listed in Table 2.1. 
2.2.7. Limiting dilution cloning of CD4+ and CD8+ EMNC fractions 
Following separation of activated effector cells into CD4+ and CDS+ fractions and 
assessment for population purity by flow cytometry, the EMNC cells were cloned by limiting 
dilution. Cloning was carried out in RPMI 1640 medium (Flow Laboratories) to which the 
following was added: 2mM L-glutamine (Highveld Biologicals, Johannesburg, SA), 10mM 
non-essential amino acids (Highveld Biologicals, Johannesburg, SA), 5x10,sM 2­
mercaptoethanol (BDH Chemicals, England), 1mM Sodium Pyruvate (Highveld Biologicals, 
Johannesburg, SA). This cloning medium was supplemented with 10% autologous serum. 
Autologous feeder cells (PBMNC) were prepared from fresh heparinised venous blood, 
diluted to a concentration of 106/ml and irradiated at 40 Gray. M. bovis BCG was added to 
the feeder cells at a ratio of 1 bacteria per cell or approximately 10 bacteria per macrophage 
(106CFU/ml). 100 IU/ml recombinant human IL-2 (Cetus) was also added to the feeder cells. 
Aliquots (10~1) of feeder cells were plated into Terasaki well plates (Becton-Dickinson, 
Mountain View. CA) using a cloning gun (Titertek multi-channel microdispenser). The T-cells 
(EMNC-derived CD4+ and CDS+ populations) were then plated (10~1) into the wells 
containing feeder cells at ratios of 5, 1 and 0.3 cells per Terasaki well. Each well contained a 
final volume of 20 ~1. Stacks of 10 plates were wrapped in foil and some sterile distilled 
water was added to each wrapped stack to ensure that the wells did not dry out. Plates were 
incubated at 37°C in a 5% CO2 incubator. After 10 days the plates were assessed for growth 
and the contents of the wells showing positive growth were expanded into 96-well round­
bottomed plates (Greiner). Each well of the 96-well plates contained freshly prepared feeder 
cells (irradiated PBMC), BCG and r1L-2 in a final volume of 200~lIweli. Following further 
expansion into 1 ml volumes in wells of 24-well plates (Becton-Dickinson), clones were 
phenotyped by flow cytometry, cytokine production was assessed, and they were screened 
for proliferative responses (3H-thymidine incorporation) and cytotoxic activity (51 Cr-release). 
Aliquots of 1-5 x 106 cells were cryopreserved in human AB serum containing 10% DMSO 











Clones were maintained in culture by weekly restimulation with fresh irradiated APC 
(PBMNC), antigen (M. bovis BCG or M. tuberculosis H37Rv) and IL-2. Clones were cultured 
in 24-well plates containing 500J.l1 of 106/ml clone cells and 500J.l1 of 106/ml irradiated feeder 
cells. Mycobacterial antigen (2 x 105 CFU/ml of M. tuberculosis H37Rv or 1 x 106 CFU/ml of 
M. bovis BCG) and recombinant IL-2 (100 IU/ml) were added to the feeder cells. After 72 
hours, fresh IL-2 (100 IU/ml) was added to the clone cells together with 1ml of fresh medium. 
To dislodge cell aggregates, the contents of the wells were resuspended using a 1 ml 
pipettor. Clones we:e used for cytotoxicity assays 48 hours after the IL-2 restimulation. 
2.2.8. Phenotyping of clones and assessment of cytokine production 
The phenotype of expanded clones was assessed by flow cytometry as described in section 
2.2.2. Markers examined included CD2, CD3, CD4, CD8, CD16, CD19, CD29, CD56, CD25, 
and HLA-DR. The antibodies and their isotypic controls are listed in table 2.2. 
The cytokine production profile of the clones was assessed by ELISA determination of 
cytokine content of clone supernatants (SNF). Levels of production of both the Th1 cytokine 
IFN-y and the Th2 cytokine IL-4 were determined. Antibodies and recombinant protein were 
purchased from Pharmingen (San Diego, CA, USA). Supernatants were harvested from 24­
well plates, each well containing 2ml of medium consisting of 106 clone cells, 106 fresh 
irradiated APCs and antigen (BCG). No IL-2 was added to the cultures. Supernatants (1 ml) 
were harvested 48 hours after restimulation of clones with fresh irradiated APC (PBMNC) 
105infected with BCG at a ratio of 2 bacteria to 1 macrophage (2 x CFU/ml). Control 
supernatants were also collected from wells containing medium alone, clone cells alone, and 
irradiated feeder APC alone. Supernatants were frozen at -20°C until ELISA assays were 
performed. ELISA assays were carried out in flat-bottomed 96-well ELISA plates {Maxisorb, 
Nunc, Denmark} according to antibody manufacturer's instructions. Mouse anti-human 
cytokine capture antibodies were bound to the surface of the wells prior to addition of 
supernatants or recombinant protein standards. Biotinylated anti-cytokine detecting 
antibodies were then added to each of the wells, followed by the addition of streptavidin 
coupled with the enzyme horse radish peroxidase (HRP) {Dako, Denmark}. The substrate 
ABTS (Sigma, St. Louis, Mo.) was finally added together with hydrogen peroxide {MerCk, 
Darmstadt, Germany}. Concentrations of antibodies, incubation times, washing steps etc. 
were carried out according to manufacturer's instructions. Levels of cytokine production 
were determined by absorbance readings at 405nm using an automated ELISA plate reader. 
Following an initial screen for IL-4 and IFN-y, certain clones were assessed for the 
production of IL-5, IL-10 (both Pharmingen), and TGF-~1 (Promega, Madison, WI, USA). 











2.2.9. Proliferative and cytotoxic responses of CD4+ clones 
Proliferation was assessed in triplicate wells of 96-well microtitre plates. Each well contained 
a final volume of 200111 of medium and included 105 clone cells (100111 of 106/ml) together 
with 104 irradiated feeder cells (50111 of 2 x 10s/ml) with and without antigen or mitogen (50 
Ill). The mitogen phytohaemagglutinin (PHA) was used at a final concentration of 5.75 x 10-3 
mitogenic units/ml. PPO was used at 3119/ml and streptokinase/streptodornase (SK-SD) at 
250U/ml streptokinase and 62.5U/ml streptodornase. M. tuberculosis H37Rv and M. bovis 
BCG were used at a ratio of 2 bacteria per uacrophage (2 x 105 CFU/ml) and 10 bacteria 
106per macrophage (1 x CFU/ml), respectively. After incubation at 37°C in a 5% CO2 
humidified incubator for 2 days (42 hours), 211Ci of 3H-thymidine (185Mbq/mmol, Amersham, 
Buckinghamshire, England) was added to each well for the last 8 hours (42-50 hours) of 
culture. Levels of radio-isotope incorporation were determined as described in section 2.2.3. 
Cytotoxic activity of the clones was assessed in a modification of the standard 16 hour 51Cr_ 
release assay (Section 2.2.5.). Autologous adherent macrophage target cells were prepared 
by plating 105 (100 III of 106 PBMNC/ml) freshly isolated PBMNC in microtitre plates as 
described above. On day 4 (96 hours), adherent macrophages were labelled with 51Cr 
(6I1Cilwell) and antigen (PPD, SK-SD, M. tuberculosis H37Rv or M. bovis BCG) for 24 hours. 
Prior to addition of CTL clones, the macrophages were washed 3 times with warm PBS 
(supplemented with 5% FCS) to remove residual 51Cr, organisms, antigens and/or detached 
macrophages. Effector EMNC clone cells were activated by incubation with fresh irradiated 
PBMNC and antigen (H37Rv or BCG) supplemented with 100 IU/ml IL-2. After 72 hours, 
fresh IL-2 was added to re-stimulate the cells. The activated clones were used in cytotoxicity 
assays 48 hours after the re-stimulation with IL-2, 120 hours after the addition of feeder 
cells. The clone cells were washed, counted, and added to 51Cr labelled target macrophages 
at effector to target ratios of 10:1,3:1 and 0.3:1 in triplicate wells. Spontaneous 51Cr release 
was measured in wells containing target cells alone. Following 16 hours of incubation in a 
37°C CO2 incubator, the supernatants were harvested and counted. Maximal 51 Cr release 
was assessed following lysis of remaining target cells with 5% triton X-100 (Merck, 
Darmstadt, Germany). Percentage lysis for the mean of triplicate wells was calculated as 












2.3.1. Clinical overview of the patient 
Due to the difficulty in finding patients who were prepared to donate blood weekly over an 
extended period. this study focused on a single, fairly young patient, who was prepared to 
commit himself to the project for several years. The patient was a 29-year-old male who 
presented with a non-productive cough. pleuritic chest pain, reduced effort tolerance, 
shortness of breath, and moderate night sweats. Clinical examination and chest X-ray 
confirmed the presence of right lung associated pleural effusion. Pleu, '11 fluid was aspirated 
and pleural biopsy material was removed. The pleural fluid was straw coloured and 
contained viable mononuclear cells (2.4 x 108 cells in 400ml of fluid). Neither the pleural fluid 
nor the biopsy material revealed any acid fast bacilli (AFB) by Ziehl-Nielsen (ZN) staining. 
The pleural fluid was also culture negative. Diagnosis of tuberculosis was made on the basis 
of biopsy histology. The material showed caseating granulomatous inflammation. 
Confirmation that the infectious agent was M. tuberculosis was provided by polymerase 
chain reaction (PCR) detection of organism DNA within the pleural fluid. The patient was HIV 
negative. A six-month combination anti-tuberculosis chemotherapy consisting of rifampicin, 
isoniazid, pyrazinamide, ethambutol and pyridoxine was prescribed. The patient responded 
well to treatment and has remained healthy for several years with no recurrence of illness. 
The peripheral blood and effusion material from which PBMNC and EMNC populations were 
derived was obtained prior to the patient receiving any anti-tuberculosis treatment. The T 
lymphocyte clones were also generated from these populations obtained at the time of 
diagnosis. 
2.3.2. EMNC, but not PBMNC, displayed a unique kinetic pattern of accelerated 
proliferation to PPD 
The proliferative responses of both PBIVINC and EMNC over 7 days are illustrated in Figure 
2.1. Responses to mycobacterial antigen (PPD). streptococcal antigen (SK-SD) and mitogen 
(PHA) are illustrated. Data are presented as .6.cpm (cpm in presence of antigen or mitogen 
minus cpm in absence of antigen or mitogen). Positive proliferation responses conSistently 
indicated stimulation indices (SI) > 3. The pattern of accelerated EMNC PPD-reactivity 
peaking on day 5 in this patient is intermediate between the previously described day 3 or 
day 4 accelerated, or normal day 6-7 response (Lorgat et a/., 1992a; 1992b; Lukey et al., 
1998). 
Accelerated proliferation of effusion-derived mononuclear cells which is indicative of in vivo 
antigen priming. has previously been described in patients with tuberculous pleuritis and 
pericarditis (Lorgat et al., 1992a; 1992b; Lukey et al., 1998). Normal antigenic proliferative 
responses of lymphocytes peak at day 7 (144-162 hours) after initiation. with mitogenic 












theoretically would include any population of cells which reaches peak antigen response 
before day 6. In kinetic studies of EMNC responses a significant proportion of patients 
displayed maximal PPD-specific proliferative response on day 3 or day 4 of in vitro culture 
(Lorgat et aI. , 1992a; 1992b; Lukey et aI., 1998). The day 3 or day 4 difference here relates 
to the time points at which the tritiated thymidine was added, or at which time point the 
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Figure 2.1. Proliferative responses of PBMNC (_ ) and EMNC (+ ) to PHA (A), PPD (B) , and 
SK-SD (C). Data are expressed as C1cpm (cpm with antigen - cpm without antigen). 
Proliferation was measured over a 7-day period . Background cpm values 9in the absence of 
antigen) were consistently < 2000 
The tuberculosis patient in the current study showed peak PBMNC proliferation to PPD on 
day 7 (C1cpm = 27097), which is indicative of normal (non-accelerated) in vitro antigenic 
response kinetics. The day 4 proliferative response of PBMNC to PPD was poor ((C1cpm = 
968) . In the EMNC population , peak proliferative response to PPD was detected on day 5 
(L'>cpm = 27504) . The day 4 EMNC proliferative response to PPD (C1cpm = 12409) was less 
than day 7 ((C1cpm = 21544), therefore this pattern did not constitute the classic day 4 
accelerated response reported previously. Accelerated proliferative responses are not 











a normal kinetic pattern of PPO-reactivity, have also been described (Lukey et al., 1998). 
The unique kinetics of in vitro responsiveness to PPO observed in this patient in the EMNC 
population alone, whereby peak response occurred on day 5 of in-vitro culture, is a novel, 
intermediate pattern not previously observed . The finding is suggestive of a dual effect: 
elements of in vivo activation were present in the EMNC population, which allowed for 
optimal antigenic responsiveness 48 hours earlier than normally observed. However, the 
delayed peak response (day 5 instead of day 4) may suggest the activity of suppressor 
factors in the effusion, which may have inhibited an optimal accelerated response . 
The kinetics of the proliferative responses to SK-SO were normal (non-accelerated) for both 
EMNC and PBMI\JC populations. The PBMNC population displayed a consistently higher 
response to this antigen as compared to the EMNC popu lation. Proliferative responses of 
the PBMNC population peaked on day 6, whereas the EMNC population only peaked on day 
7, however no significant differences in the two response patterns were observed. 
The PBMNC proliferative response to mitogen (PHA) peaked at day 4 (t.cpm of 213228) , as 
normally observed. The EMNC population produced no significant proliferation in response 
to mitogenic stimulation. This flat response was unique and difficult to account for in the light 
of strong PPO reactivity by the same effector cells. The finding was suggestive of mitogen­
enhancement of suppressor activity in the effusion. 
2.3.3. LOA of EMNC, but not PBMNC, produced a 'V'-Shaped Curve 

LOA affords the opportunity of determining the frequency of responder cells in a population . 

Increased responder cell frequency in any particular part of the body suggests 

compartmentalised expansion of antigen-specific cells. 

LOA was carried out on both EMNC and PBMNC populations in order to determine 
responder frequencies of cells in both groups. Frequency of responder cells was calculated 
using the maximum likelihood method of Fazekas de St Groth (1982) , and data are shown in 
Table 2.2. 
Table 2.2. Responder cell frequency of PBMNC and EMNC as determined by LOA 
Population Antigen Frequency* 95% confidence# Significant diff.S 
PBMNC PPO 1/9279 6529-12029 Yes 
SK-SO 1/3993 2920-5066 Yes 
EMNC PPO 1/515 392-637 Yes 
SK-SO 1/7909 5718-10105 Yes 
Note.' *Frequency of responder cells expressed as inverse of mean of mutiplicity; #95% 
confidence interval for mean frequency value; $Significant difference between PPO and SK­













LDA was performed using both PPD and SK-SD in order to assess antigen-specificity of 
responder cells. Although only PPD responder cell frequency was increased in the EMNC 
population, differences between EMNC and PBMNC population responder cell frequencies 
for both PPD and SK-SD were considered significant, since there was no overlap of 95% 
confidence intervals. It should, however, be noted that difference in responder frequency to 
PPD (18 fold higher in the effusion as compared to blood) was much greater than for SK-SD 
(only 2 fold higher in the blood as compared to the effusion) . 
The LDA responses are presented graphically in Figure 2.2. Data are presented as percent 
negative wells for the dilution of cells plated (cells/well). Plotting of the LDA data in this way 
produced a classic 'V'-shaped curve for the EMNC population (Figure 2.2.A.). This pattern 
has previously been described, and has been ascribed to complex regulatory influences 
(Lefkovits and Waldman, 1979; Fazekas de St Groth, 1982; Lukey et a/., 1998). The LDA 
curve of the PBMNC population did not mirror that of the EMNC population (Figure 2.2.B.), 
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Figure 2.2. LDA responses to PPD of both EMNC (A) and PBMNC (B) populations. The 
percentage of negative wells at each leukocyte concentration was plotted. Each curve 
represents one experiment. Note different scales of the x-axes 
2.3.4. EMNC T lymphocytes were predominantly CD4+, but displayed low levels of 
activation marker expression 
Comparison of phenotype of EMNC and PBMNC populations was performed to assess any 
marked differences in the cellular composition and activation status of the two cell 
compartments. Flow cytometry data are presented in Table 2.3, showing both percentage 
positive cells and mean channel number counts (i.e. fluorescent intensity) for a number of 
markers. 
The EMNC population showed a marked increase in the number of CD3+CD4+ positive cells 
as compared to the PBMNC population (50.6% vs. 33.3%). Conversely, there was a 











PBMNC population (18.1% vs . 27 .9%). The CD4:CD8 ratio in EMNC was 2.8, whereas in 
PBMNC it was 1.2. The expansion of the CD4+ population in EMNC was confirmed by the 
CD3 data, which showed an increase in CD3+ cells from 63.3% in PBMNC to 75.1 % in 
EMNC. The EMNC population did not show evidence for cell activation, with HLA-DR 
positivity of 20% being largely accounted for by the presence of B-cells (18.3% CD19+ 
cells). Both EMNC and PBMNC populations showed negligible positivity for CD4+HLA-DR+, 
which indicated that the CD4+ fraction did not account for the HLA-DR expression . The 
absence of T cell activation was confirm€ by the low levels of CD25 (IL-2 receptor) I 
observed . 
Table 2.3. Flow cytometric analysis of PBMNC and EMNC , showing both percentage 
positive cells and mean channel number (MCN) 
Percent positive (%) Mean channel number 
PBMNC EMNC PBMNC EMNC 
CD19 6.3 18.3 4.62 4.01 
CD2 86.0 86.8 25.00 25.51 
CD3 63.3 75.1 8.87 7.54 
CD3CD4 33.3 50.6 17.70 17.88 
CD3CD8 27.9 18.1 28.91 30.09 
CD29 32.5 20.7 3.09 2.99 
CD4CD29 3.2 9.8 
CD16 52.5 50.4 3.62 3.07 
CD56 32.4 7.5 7.25 7.46 
CD16CD56 23.4 2.9 
CD25 0.3 0.6 
CD4CD25 0.1 0.2 
HLA-DR 9.6 20.0 7.11 7.84 
CD4HLA-DR 0.6 1.6 
The PBMNC had a high proportion of NK cells, 32.4% of cells positive for CD56 as opposed 
to 7.5% in the EMNC population. The numbers of B cells were higher in the EMNC 
population, with 18.3% of cells positive for CD19, as compared to 6.3% in the PBMNC 
population . Although the percentage of cells expressing the memory cell marker CD29 was 
higher in the PBMNC population (32.5% as opposed to 207% in the EMNC population) , the 
CD4+ memory component was enhanced in the EMNC population (9 .8% as opposed to 
3.2% in the PBMNC population). 
Mean channel number (MCN) or mean fluorescent intensity values , which are indicative of 
intensity of staining and therefore of receptor marker expression, were similar for the two 
groups for all the markers examined . 
2.3.5. Both EMNC and PBMNC displayed cytotoxic activity 
Both EMNC and PBMNC displayed cytolytic activity. Levels of lysis of M. tuberculosis 
H37Rv- infected macrophages by day 3- and day 6-primed PBMNC and EMNC are 











Comparable levels of M. tuberculosis-specific lysis of macrophages by day 6 effectors at an 
effector to target ratio of 10:1 were obserJed with both EMNC and PBMNC populations. 
EMNC effectors lysed 25% of macro phages in an antigen-specific manner, and PBMNC 
effectors lysed 31 % of target cells. Maximal levels of antigen-specific lysis were generally 
<35%. This was due to high levels of non-specific killing (30-40% lysis in the absence of 
antigen) which may have been attributable to Iymphokine-activated killer (LAK) cell activity. 
There was some evidence of accelerated induction of cytotoxic activity in the EMNC 
population. At day 4, EMNC cells were able to lyse 19% of infected macrophages at an 
effector to target ratio of 10: 1. PBMNC were only capable of lysing 14% of macrophages at 
the same effector to target ratio. In the EMNC population there was thus only a 6% increase 
in cytolytic activity from day 4 to day 6, with day 4 activity accounting for 76% of maximal 
day 6 activity I n the PBMNC population this increase between day 4 and day 6 was 17%, 
with day 4 activity accounting for only 45% of maximal day 6 activity. These findings suggest 
compartmentalised , partially accelerated induction of cytotoxic activity in the EMNC 
population . 
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Figure 2.3. Cytolys is of M. tuberculosis H37Rv- infected macrophages by primed EMNC (+ ) 
and PBMNC (. ) populations. A. Antigen-specific lysis of macrophages by EMNC and 
PBMNC after 4 days of antigen stim Ulation in vitro. B. Antigen-specific lysis of macrophages 
by EMNC and PBMNC after 6 days of antigen stimulation in vitro. Data are shown as mean 
% antigen-specific lysis. Data in A are from one experiment, data in B from 3 experiments ± 
standard deviation 
2.3.6. CD8+ EMNC clones were difficult to generate and maintain, and were not 
cytotoxic 
Both CD4+ and CD8+ fractions of T lymphocytes from the EMNC population were cloned by 
limiting dilution . Although 5 CD8+ clones were expanded into microtitre plates, only 2 











The cloning efficiency differed markedly for the CD4+ and CD8+ sub-populations. 15 Plates 
(900 wells) of each population were plated at 0.3 cells/well. Positive growth in 300 wells 
would represent 100% cloning efficiency. 66 wells (i.e. 22% of possible positive wells) were 
positive in the CD4+ group, whereas none (0%) were positive in the CD8+ group. This 
represents cloning efficiencies of 22% and 0% for the two populations, respectively. At a 
cloning dilution of 1 cell/well,S wells (0.6% of a total of 900 possible positive wells) of the 
CD8+ group were positive, which indicates a cloning efficiency of 0.6%. Cloning efficiencies 
of 22% and 0.6% for the CD4+ and CD8+ populations ensured clonality according to 
Poisson distribution. Estimation of clonality was determined according to the zero term of 
Poisson distribution Fo=e'u, where Fo is the fraction of negative cultures, e is the base of the 
natural log, and u is the average precursor cell number. This translates to a cloning 
efficiency of <37% being considered indicative of cionality (Lefkovits and Waldmann, 1984). 
The two surviving CD8+ clones were difficult to maintain and expand in vitro. Neither of the 
clones showed any mycobacterial- (PPD-) antigen specific cytolysis in assays that screened 
for cytotoxicity activity (Table 2.3) Proliferative responses were also generally poor. The 
cytokine production patterns differed from those of the CD4+ clones, with one CD8+ clone 
uniquely producing fairly high levels of the Th2 cytokine lL-4. These findings are discussed 
in Section 2.3.7. 
2.3.7. CD4+ EMNC clones all proliferated to mycobacterial antigens, and the majority 
were cytotoxic 
The 68 clones (66 CD4+ and 2 CD8+) were screened for proliferative and cytotoxic activity. 
Neither of the CD8+ displayed antigen-specific cytotoxic activity «10% macrophage lysis). 
Similarly, these clones had poor proliferative responses to a range of mycobacterial 
antigens. These findings are discussed in detail in Chapter 5. 
All the CD4+ clones displayed good proliferative responses to mycobacterial antigens 
(stimulation indices - i.e. cpm in presence of antigen divided by cpm in the absence of 
antigen - were consistently> 3). Table 204. illustrates the varying cytolytic ability of the CD4+ 
clones. The clones were arbitrarily divided into strong killers (>20% antigen-specific lysis), 
weak killers (10-20%), and non-killers «10%). A majority of CD4+ clones were cytotoxic 
(36/66 or 54.5%). Of these, 15 (22.7%) showed antigen-specific (BCG) lysis of macrophages 
of >20%. Several clones from this group of 15 (3.2D, 1004C, 11.2E, 14.6B, 14.10C, 15.3A) 
were selected for more detailed characterisation of both their mechanism of killing (Chapter 
4) and their mycobactericidal potential (Chapter 3). Approximately 45% of the CD4+ clones 
did not lyse BCG-infected macrophages, suggesting that cytolytic potential" was not a 












Table 2.4. Cytolytic activity of C04+ and C08+ clones against BCG infected macrophages 
C04+ C08+ 

Total Clones 66 2 
>20% Ag-specific cytolysis 15 (22.7%) o(O%) 
10-20% Ag-specific cytolysis 21 (31.8%) 0(0%) 
<10% Ag-specific cytolysis 30 (45.5%) 2 (100%) 
2.3.8. Cytokine production profiles of CD4+ EMNC clones were strongly type-1, 
whereas those of CD8+ clones were either type-1 or type-O 
The production of the cytokines IL4 and/or interferon-y by T cells is an important indicator of 
whether cells are type-1 (Th1) or type-2 (Th2). In the current study the terms type-1 and 
type-2 are used in preference to Th1 and Th2 to describe interferon-y and IL-4 producers 
respectively. This is because both C04+ and C08+ clones were categorised according to 
cytokine production. The use of Th1 and Th2 to describe C08+ clones is inaccurate. Type-O 
cells or clones refers to those cells which produce both these defining cytokines. 
All of the C04+ clones (66/66) produced high levels of IFN-y. All clones produced in excess 
of 10000 pglml, with a range of 10500 pglml - 59200 pg/ml being observed. Both COS+ 
clones produced IFN-y, however clone 2.90 produced higher levels (22500 pg/ml) than 
clone 11.5A (SOOO pg/ml). None of the C04+ clones (0/66), nor C08+ clone 2.90, produced 
detectable levels (>16 pg/ml) of IL4. The COS+ clone 11.5A produced 150 pglml of IL4. All 
the C04+ clones were thus strongly type-1 (Th1). whereas one COS+ was type-1 (2.90), the 
other type-O (11.5A). 
2.3.9. A sub-population of CD4+ EMNC showed strong cytolytic activity 
Cytotoxic activity mediated by C04+ cells has been described in EMNC populations (Lorgat 
et al., 1992a). Cytotoxic C04+ clones derived from EMNC populations have not however 
been well characterised. 
The majority (55%) of C04+ clones generated in the current study were cytotoxic. A sub­
population of the cytotoxic clones (22.7%) showed strong (>20%) antigen-specific lysis of 
BCG-infected macrophages (Section 2.3.7.). These clones were subsequently assessed for 
possible mycobactericidal activity and their mechanism of target cell killing was also 
investigated (Chapters 3 and 4). The proliferative and cyto~oxic responses of 3 such clones 
(3.20, 10.4C and 15.3A) are illustrated in Figure 2.4. A-C. All of the cytolytic C04+ clones 
showed strong mycobacterial antigen-specific killing ability. PPO, M. tuberculosis H37Rv, 
and M. bovis BCG were used as mycobacterial antigens. No killing was observed against 
macrophages pulsed with irrelevant antigen SK-SO. The proliferative responses for the 
different mycobacterial antigens varied. but generally good proliferation was observed. In 
certain cases, PPO proliferative responses approximated mitogenic (PHA) responses 
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Figure 2.4. Proliferative and cytolytic responses of 3 CD4+ clones 3.2D (A), 10.4C (B), and 
15.3A (C). Proliferative data are illustrated as mean cpm/min values ± SD of 3 experiments. 
Cytotoxicity data are illustrated as mean % lysis in the absence of antigen {_}, or in the 
presence of SK-SD (O), BCG (e). PPD (A), or Rv (+). Cytotoxicity data are representative 













Comparisons of immune parameters in both pleural effusions and peripheral blood in 
tuberculosis patients have provided some insight into the constituents of protective immunity 
and also the immunopathogenesis of the disease. Previous studies have indicated that there 
is a compartmentalisation of immune responses to sites associated with disease (Rossi et 
a/., 1987; Fujiwara and Tsuyuguchi, 1989; Manca et a/., 1991). Pleural effusions contain 
highly PPD reactive, interferon-y-producing (Th1) memory cells. The localised occurrence of 
these cells may indicate that they play all important role in the localised cell-mediated 
immune response to M. tuberculosis infection (Barnes et a/., 1989). 
Localised expansion of T cells in pleural fluid is predominantly restricted to the CD4+ 
lymphocyte subset (Barnes et al., 1989). This recruitment of CD4+ cells is accompanied by 
enhanced PPD-responsiveness and interferon-y production, suggestive of a pivotal role for 
Th1 CD4+ lymphocytes in protective immunity (Fujiwara and Tsuyuguchi, 1989; Riberaet 
aI., 1988). Effusion mononuclear cells from a majority of TB patients exhibit accelerated 
kinetics of reactivity to PPD in vitro (Lorgat et a/., 1992a). In addition, induction of antigen­
specific cytotoxic activity is also accelerated (Lorgat et a/., 1992b). These findings suggest 
that effusion-derived cells are primed in vivo, with accelerated in vitro responses 
representing cell re-priming. 
In the present study, the effusion mononuclear cells displayed an unusual form of 
accelerated reactivity to PPD. Peak responsiveness on day 5 of stimulation constitutes a 
response intermediate to normal day 7 kinetics and accelerated day 4 kinetics (Lorgat et a/., 
1992a; Lukey et a/., 1998). The effusion-derived cells also displayed unique non­
responsiveness to PHA, a phenomenon not noted in previous studies (Lukey et a/., 1996; 
Lukey et a/., 1998). The lack of PPD-reactivity of pleural effusion cells has previously been 
linked to suppressor activity (Lukey et al., 1998). It is possible that the unique observation of 
day 5 accelerated response was also indicative of concomitant suppressor activity. Pleural 
effusions, including the one in the present study, contain numerous cell types other than 
CD4+ lymphocytes. In particular, CD8+ T lymphocytes have been observed. Although these 
cells have been implicated in cytotoxic activity (Stenger and Modlin, 1998; Lalvani et al., 
1998), the lack of enrichment in CD8+ cell numbers at disease sites may suggest that these 
cells have a less prominent role in protective immunity. CD8+ suppressor T cells derived 
from lepromatous leprosy lesions have been characterised (Kaplan et a/., 1987), and it is 
possible that the activity of similar cells was responsible for the distinctive response kinetics 
observed in the present study. The suppression of effusion cell responsiveness to PHA was 
not attributable to T cell anergy, since the cells were responsive to PPD. Suppression 
mediated by monocytes or macrophages was also unlikely, because normal SK-SD 












suppressor activity in the effusion was confirmed with the isolation of a CD8+ T cell clone 
capable of suppressing autologous T cell proliferation (chapter 5). 
The presence of active suppression within the effusion was also confirmed by limiting 
dilution analysis. A characteristic v-shaped LDA curve was generated from the effusion 
population atone. V-shaped LDA curves have been associated with suppression in several 
studies (Lefkowitz and Waldman, 1979; Dozmorov et a/., 1995; Dozmorov and Miller, 1996; 
Lukey et al., 1998). In the latter study, these curves were associat€. ,i with non-responsive 
effusion cells derived from patients with active TB. The occurrence of an effusion associated 
v-shaped curve in the present study may help to explain the unique kinetics of proliferative 
response. The intermediate pattern of day 5 accelerated response to PPD may be due to 
simultaneous presence of enhanced T cell reactivity and active suppression. The flat PHA 
response of the effusion cells suggests optimal stimulation or activation of suppressor cells 
by PHA, such that suppressor activity was sufficient to almost completely abrogate T cell 
responsiveness to the mitogen. PPD may have been unsuccesful as an antigenic stimulus 
for suppressor cells due to the requirement of CD8+ cells for MHC class I presentation of 
unique mycobacterial peptides. 
The effusion contained a high frequency of PPD-responsive cells. LDA indicated that 1 in 
515 cells were responsive, a finding that compares favourably to the range of frequencies 
(mean of 1 in 519) observed in patients with accelerated kinetics of reactivity (Lukey et a/., 
1998). Patients with normal response kinetics generally had lower frequencies of responder 
cells (mean of 1 in 840). The high frequency of responder cells confirms that this effusion 
displayed evidence of localised recruitment of antigen-responsive T cells. It also suggests 
that in the absence of any suppressor activity, accelerated reactivity of the classical day 4 
pattern would have been detected. Induction of significant effusion cell cytotoxic activity in 
vitro was already detectable on day 4 of in vitro culture, a finding also previously associated 
with enhanced responsiveness of T cells in the effusion population (Lorgat et a/., 1992a). 
Although a detailed seven-day assessment of kinetics of induction of cytotoxiC activity was 
not performed, the increased cytotoxic potential of the effusion cells on day 4 (compared to 
PBMNC) suggests increased cytotoxic T-cell reactivity. 
The localised expansion of the CD4+ T cells occurred in the absence of any significant 
activation marker expression. This lack of activation marker expression has been found in 
other studies (Lukey et a/., 1996). Although some increase in HLA-DR expression was 
observed, this was largely due to B-cells, and no CD4+ T cells displayed activation markers. 
However, a localised increase in the CD4+ memory cell component was noted in the 
effusion. The accumulation of memory T cells in the absence of any detectable T cell 
activation may be due to low responder cell frequency. Detection of activation in a 












would be detected in about 0.2% of cells. In addition, factors in the effusion may have limited 
activation of T cells. Limiting T cell activation could minimise tissue damage caused by 
release of cytokines such as TNF-a. 
Cloning from pleural effusions affords the opportunity to assess cellular immune function of 
cells derived from a disease-associated site in detail. The majority of T cell clones generated 
from the effusion mononuclear cell population were cytotoxic. Cytotoxic activity in pleural 
effusions has previously been linked to the activity of C04+ cells (Otten hoff and Mutis, 1990; 
Lorgat et a/., 1992a). The C04+ cytotoxic T cell clones were all potent producers of 
interferon-y and responded to a range of mycobacterial antigens. The localised increase in 
C04+ T cells coupled with the findings that both in vitro induction of PPO-specific cytotOXiC 
activity was enhanced and that the majority of C04+ clones generated were cytotoxic, 
suggested an important role for these cells in successful infection clearance. 
It has previously been suggested that cytolytiC C04+ T lymphocytes may play a role in 
infection clearance due to their ability to lyse infected macrophages. This lysis could be 
envisaged to result in either the simultaneous death of the infecting bacilli, or their release 
from host macrophage cells. The released organisms would then be engulfed by freshly 
recruited macrophages possibly more competent in killing the organisms or inhibiting their 
replication. Repetition of this cycle could result in a reduction of organism numbers at 
disease sites (Ottenhoff and Mutis, 1990; Orme et al., 1992). In the current study, cytotoxiC 
C04+ effusion-derived T cell clones were found to reduce the numbers of viable organisms 
following lysis of infected macrophages (chapters 3 and 4). The finding that cytotoxic C04+ 
cells are mycobactericidal is important in that it defines a pivotal functional role for the 
expanded C04+ population at the disease-associated site. 
Generation of COS+ clones was more problematic. Of two COS+ clones generated, one was 
unique in that it produced IL-4 and only low levels of interferon-yo This clone was found to be 
poorly responsive to a range of mycobacterial antigens, but responded well to PHA 
stimulation. This finding, together with the detection of strong inhibition of effusion cell 
proliferation in the presence of PHA, led to more detailed analysis of suppressor activity 
mediated by this clone (chapter 5). It was found that the clone could indeed suppress 
autologous T cell proliferation in response to various mycobacterial antigens and to PHA. 
In summary, this chapter has highlighted several important features of the effusion-derived 
mononuclear cell population. Evidence of a compartmentalised recruitment and priming of 
lymphocytes was coupled with certain unique findings suggestive of active suppression. The 
generation of C04+ and COS+ clones has enabled the assignment of important functional 













lysis of M. tuberculosis~infected macrophages by CD4+ CTl clones is 
associated with reduced mycobacterial viability 
3.1. Introduction 
CD4+ T lymphocytes are expanded at sites of infection in tuberculosis (Barnes et al., 1989; 
Munk and Emoto, 1995). There is also an increase in the frequency of antigen-responsive 
cells at disease sites (Lukey et aI., 1998). The function of CD4+ T lymphocytes in 
tuberculosis has traditionally been linked to the production of cytokines (Schluger and Rom, 
1998). CD4+ T lymphocytes derived from pleural effusions are strongly Th1, producing high 
levels of interferon-y (Barnes et al., 1989; Ribera et al., .1990). Activation of infected 
macrophages by cytokines such as interferon-y has been implicated in killing of intracellular 
mycobacteria. Although activated murine macrophages do appear to be mycobactericidal, 
human macrophages have not been found to be able to kill intracellular bacilli, even after 
stimulation with interferon-y (Dannenberg and Rook, 1994). Since the granulomatous lesion 
is generally succesful in containing bacillary spread (Dannenberg, 1991), an alternative 
mechanism to cytokine-mediated macrophage activation must be operative in order for 
infection to be contained in the human. Indeed, successful control of mycobacterial infection 
has recently been shown to depend on the activity of primed lymphocytes as well as 
interferon-y (Bonencini-Almeida et al., 1998). This finding confirms reports that CD4+ T 
lymphocytes are essential for prevention of organism replication and spread (Silver et al., 
1998; Yoneda and Ellner, 1998). 
Cytolytic activity in tuberculous pleuritis is enhanced, and has been shown to be due to the 
CD4+ population (Lorgat et aI., 1992a). In the absence of successful cytokine-mediated 
macrophage killing of intracellular organisms, cytotoxic activity may account for the 
containment of infecting organisms at disease sites. Lysis of infected macrophages by CTL 
could, however, result in either of two options, organism death or organism spread. Cytotoxic 
activity may thus represent a double-edged sword, with either beneficial or detrimental 
consequences for the host organism. The lysis of infected cells in the absence of 
concomitant organism death poses a danger for the host, unless released organisms are 
rapidly engulfed 
<"
by adjacent macrophages. 
Several studies have illustrated that induction of host macrophage apoptosis by various 
agents such as ATP (Molloy et aI., 1994; Lammas et al., 1997), H20 2 
(Laochumroonvorapong et al., 1996, 1997) or soluble FasL (Oddo et al., 1997), is 












circumstances, lysis of infected macrophages would aid in organism clearance. Although 
cytolytic CD4+ cells have been reported to have no effect on mycobacterial viability (Fazal et 
aI., 1994; Pithie et al., 1995), CD8+ CTL have indeed been linked to organism death 
(Stenger et al., 1998). The defining feature of mycobactericidal CD8+ CTL activity is the 
presence of a granule-mediated cytolytic pathway involving the activity of the granule 
component granulysin (Stenger et al., 1997; Pena et al., 1997). 
The majority of CD4+ CTL activity has been associated with Fas-mediated apoptosis of 
target cells. Recent reports have, however, highlighted the ability of CD4+ CTL to utilise 
granule-mediated cytolytic pathways (Sevilir Williams and Engelhard, 1996; Vergelli et a/., 
1997; Lewinsohn et a/., 1998). The occurrence of a killing mechanism in CD4+ CTL common 
to that utilised by mycobactericidal CD8+ CTL is interesting and begs more detailed 
investigation. CD4+ CTL activity in diseases involving intracellular infection by bacteria may 
in fact be analogous to CD8+ CTL activity in viral infections (Smyth and Trapani, 1998; Harty 
and Bevan, 1999). 
The present chapter characterises cytolytic and mycobactericidal activity of effusion-derived 

CD4+ clones. The mycobactericidal activity was associated with macrophage cell death. The 

. kinetics of target cell death and reduction in viable mycobacteria were similar, and blocking 

of target cell death abrogated any mycobactericidal activity. These findings are the first report 















3.2. Materials and methods 
3.2.1. Growth and maintenance of M. tuberculosis cultures 
M. tuberculosis H37Rv strain # 27294 was obtained from the American Tissue Type 
Collection (ATTC) (Rockville, MD, USA), and M. bovis BCG from the Trudeau Mycobacteria 
Collection (Saranac lake, NY, USA). Stock cultures were grown in Middlebrook 7H9 broth 
(Difco, Detroit, Michigan) supplemented with 10% OADC enrichment media (State Vaccine 
Institute, Cape Town, SA) and 0.5% glycerol (Merck, Darmstadt, Germany). Cultures were 
grown at 37°C in a 5% CO2 incubatc;' with periodic shaking. Growth was monitored by daily 
assessment of culture absorbance readings (450nm). When cultures reached mid-log phase 
of growth (day 4-6), 5% of sterile glycerol was added and 100,..11 aliquots frozen in liquid 
nitrogen. The bacterial concentration was determined by plating out freshly thawed aliquots 
following disruption of clumps by passing the vial contents through a fine gauge syringe 
needle. 100J..l1 aliquots were plated at various dilutions in 7H9 broth (10" to 10-6) on 7H11 
agar plates (Difco, Detroit, Michigan) supplemented with 10% OADC and 0.5% glycerol. For 
infection of adherent macrophages, aliquots were thawed, clumps were disrupted and 
mycobacteria were diluted in growth medium (RPMI 1640 supplemented with 10% pooled 
human AB serum) prior to the addition to the macrophage cultures. 
3.2.2. lysis of M. tuberculosis infected macrophages by CD4+ CTl clones 
lysis of adherent macrophages by CD4+ CTl clones was carried out in a modified version of 
the 16 hour cytotoxicity assay described in Section 2.2.5. Clones were stimulated with fresh 
5irradiated autologous PBMNC, M. tuberculosis H37Rv (10 CFU/ml) and recombinant human 
Il-2 (100 IU/ml) for 72 hours, followed by addition of fresh Il-2 (100 IU/ml) in RPM I 1640 
medium supplemented with serum. Clones were used 48 hours after second addition of Il-2, 
120 hours after addition of feeder PBMNC. This ensured that clones were activated and that 
no significant numbers of contaminating feeder cells were present. Adherent macrophages 
were cultured in 96 well microtitre plates (Greiner) by plating fresh PBMNC (1 o o J..l1/weII of 106 
PBIVINC/ml). On day 4 (i.e. 96 hours) following initial plating, macrophages were infected with 
H37Rv (2 organisms per macrophage, 2 x 105 CFU/ml) and simultaneously labelled with 5'Cr 
(6J..lCi per well). The level of infection of macrophages was monitored periodically by ZN 
staining of H37Rv-infected macrophages cultured in chamber well slides (Nunc, Denmark). 
ConSistently >80% of macrophages were infected with between 1 and 5 organisms. After 
overnight labelling, macrophages were washed 3 times with warm PBS containing 10% foetal 
bovine serum (FBS, Delta Bioproducts, Johannesburg, South Africa), and clone cells were 
added to macrophages at effector to target ratios of 10:1, 3: 1 and 0.3: 1. Effectors and targets 
were then incubated together for 16 hours. Calculation of % lysis was as described (Section 
2.2.5.). In kinetic experiments macrophage lysis was assessed at 4, 8, 12, 20 and 24 hours 












3.2.3. Effect of CTL-mediated macrophage lysis on M. tuberculosis viability 
Mycobacterial survival was determined following cytotoxicity assays as described above. 
Parallel sets of macrophages were cultured in 96 well microtitre plates (Greiner). One plate 
was used for standard cytotoxicity assays (slCr-release), the other for assessing 
mycobacterial survival. For the latter, the macrophages were not co-labelled with SlCr when 
infected with H37Rv. After overnight infection the macrophages were washed with PBS/10% 
FBS as described above. CTL clones (100fll) were than added to the infected macrophages 
.. 	at an effector to target ratio of 10: 1. Following exposure of inkGted macrophages to CTL for 
4, 8, 16 or 20 hours, the contents of each well was removed and triplicate well contents were 
pooled. SDS (Merck, Darmstadt, Germany) in PBS (final concentration 0.25%) was then 
added to each well. On dissolution of the residual macrophages (approximately 10 minutes), 
the well contents were removed and pooled with original well contents. In this way the total 
bacterial numbers were compared - with or without exposure to CTL clones. The pooled 
lysate was diluted (10.1 to 10.5) in 7H9 broth and 100fli aliquots plated on 7H 11 plates as 
described above (Section 3.2.1.). Colony counts were carried out after 3 weeks of incubation 
at 37°C. Standard slCr-release assays were always carried out in parallel to the CFU. 
experiments, so that the percentage target cell lysis could be related back to any changes in 
CFU counts. 
In addition to CFU plating, bacterial numbers were assessed by labelling pooled Iysates with 
3H-uridine (Amersham, Buckinghamshire, England), as previously described (Fazal et al., 
1994). Briefly, pooled Iysates were diluted (1 in 10) in 7H9 broth. Aliquots (100fll) were added 
in triplicate to round bottomed 96-well microtitre plates (Greiner), and 2).lCi/well of 3H-uridine 
was added. Cultures were incubated for 6 days at 37°C. Labelled mycobacteria were 
harvested onto filter paper (Machery-Nagel, Germany) using a Titertek cell harvester (Flow 
Laboratories, Norway). The filter paper discs were placed into scintillation vials, scintillation 
fluid (1ml) was added (Quicksafe A, Zinsser Analytic, Frankfurt, Germany), and the amount 
of incorporated label was assessed in a [3-counter (Tricarb 4640, Packard, Meriden, CT). 
To ensure that the CTL clones were directly mycobactericidal, control experiments were 
performed in which H37Rv-infected macrophages were lysed by the addition of SDS (final 
concentration 0.25%). The Iysates containing the released mycobacteria were then exposed 
to the CTL clones at an effector to target ratio of 10:1. CFU were assessed by plating on 
7H11 agar plates before and after exposure to the clones as described above. 
3.2.4. Kinetics of macrophage lysis and M. tuberculosis death 
The kinetics of macrophage death and associated M. tuberculosis death were assessed by 
measuring slCr-release and CFU growth and/or 3H-uridine incorporation at various time 











kinetics of these two processes enabled an assessment of which stage of target cell death 
was associated with mycobacterial death. 
3.2.5. Generation of PBMNC and EMNC CD4+ enriched cell lines 
Cell lines were generated from patient-derived EMNC and PBMNC populations. Thawed 
EMNC and PBMNC cells (10ml of 106/ml) were stimulated with M. tuberculosis H37Rv (2 x 
105 CFUlml) for 6 days. Recombinant human Il-2 (100 IU/ml) was added for an additional 3 
days. The lines were then enriched for CD4+ lymphocytes by magnetic bead separ.ltion 
(Minimax, Miltenyi Biotec, bergisch Gladbach, Germany) as discussed in Section 2.2.5. 
Population purity was assessed by flow cytometry (>90% for both lines), and lines were 
restimulated and expanded with fresh irradiated autologous PBMNC (feeder cells), H37Rv (2 
x 105 CFU/ml) and Il-2 (100 IU/ml). Lines were then maintained in the same way as the 
clones, with weekly restimulation with feeder celis, antigen and Il-2. 
3.2.6. Analysis of mechanism of macrophage death 
In addition to s'Cr release, the mechanism of macrophage death triggered by exposure to the 
Cll clones was assessed by flow cytometry of annexin V and propidium iodide stained cells 
(Apoptosis Detection Kit, R&D, Minneapolis, MA; Annexin-V-FlUOS Staining Kit. Boehringer 
Mannheim, Mannheim, Germany). Following the addition of effector CTl for 4, 8, or 16 
hours, adherent macrophages were washed free of CTl clones with warm PBS 
supplemented with 5% AB serum. The adherent monolayer was then removed by the 
addition of 0.25% EDTA. Macrophages whiqh did not detach were removed by gentle 
scraping using the rubber end of a sterile 1 ml syringe plunger (Omnican 100. Braun Petzold, 
Melsungen, Germany). Detached macrophages (approximately 1 x 106) were washed three 
times with cold PBS and cell pellets were labelled with annexin V and propidium iodide 
according to the manufacturer's protocol. This inVOlved adding 100111 of reaction mixture 
containing FITC-Iabelled annexin V and propidium iodide in Ca2 + buffer (binding buffer) to 
cells for 10 minutes at room temperature in the dark. FCM analysis was performed with a 
Coulter Epics Profile II flow cytometer. Control untreated adherent macrophages were used 
to gate on the macrophage population. T lymphocytes did not occur within the gated 
macrophage region. This was confirmed by staining macrophages with FITC-Iabelled anti­
CD3 (Coulter) after exposure to CTl clones. and determining the number of CD3+ cells 
within the gated macrophage region. less than 10% of cells within the gated region were 
CD3+. 
Annex!n V staining of adherent cells was also assessed by fluorescent microscopy. 
Macrophages were grown for 5 days from PBMNC (106/ml) on chamber well ~lides (Nunc, 
Denmark). Following cytotoxicity assay period, monolayers were washed with warm PBS and 












remove the staining mixture, air dried and viewed under a Fluorescent microscope (Zeiss, 
Axiophot, Germany). 
In addition to annexin binding, apoptosis levels in macrophages were assessed by TdT~ 
mediated dLlTP nick end labelling or TUNEL (in situ Cell Death Detection Kit, Fluorescein, 
Boehringer Mannheim, Mannheim, Germany). Macrophages were then analysed by 
fluorescent microscopy and flow cytometry. Adherent macrophages were cultured on 
chamber slides (Nunc, Denmark) and infected for 24 hours with M. tuberculosis H37Rv. 
Infected macrophages were then incubated overnight in the presence or absence of CTL 
clones (E:T ratio of 10 to 1). Control uninfected macrophages were also used in some 
experiments to determine whether M. tuberculosis infection had any effect on detectable 
levels of macrophage apoptosis. Macrophages were washed vigorously with warm PBS, air 
dried and fixed with fresh 4% paraformaldehyde in PBS (pH 7.4) for 30 minutes. The fixed 
cells were rinsed with PBS and permeabilised with 0.1 % Triton X-100 in 0.1 % sodium citrate 
for 2 minutes on ice. Slides were then rinsed twice with PBS and the 50111 of TUNEL reaction 
mixture (terminal deoxynucleotidyl transferase (TdT) together with FlTC~labelled nucleotide 
mixture) was added. A coverslip was placed over each sample to ensure even spreading of 
the reaction solution, and to prevent evaporation. The slides w re incubated at 37°C in the 
dark for 60 minutes. The stained slides were then rinsed 3 times with PBS, air dried and 
viewed under a fluorescent microscope (Zeiss, Axiophot, Germany). 
TUNEL labelling for flow cytometry involved detachment of adherent macrophage 
monolayers by EDTA treatment following exposure to the CTL clones, as described above 
for annexin V staining. The detached cells (approximately 1 x 106) were washed twice in 
PBS/1 % BSA at 4°C and then fixed with 1OO~d of 4% paraformaldehyde in PBS for 30 
minutes at room temperature. Cells were then washed free of fixative with PBS, and the cells 
were permeabilised by addition of 0.1% triton X~100 in 0.1% sodium citrate for 2 minutes on 
ice. Prior to the addition of the TUNEL label, cells were washed twice with PBS. TUNEL 
reaction solution (TdT and FITC-Iabelled nucleotide mixture) was added at 50111 per sample 
and incubated for 60 minutes at 37°C. Controls were set up using label solution (FITC­
nucleotide mixture) in the absence of enzyme solution (TdT). Labelled cells were finally 
washed twice and resuspended in PBS prior to analysis on a flow cytometer. 
Annexin and TUNEL staining were also carried out on adherent macrophages which had 
artificially been induced to undergo necrosis or apoptosis. Necrosis was induced by exposing 
macrophages to sterile distilled water for 30 minutes at 3rC, or by exposure to medium 
heated to 56°C for 20 minutes. Apoptosis was induced by treating macrophages with H20 2 
(1 mM) or ATP (2mM) for 90 minutes, after which they were re-incubated in complete growth 











3.2.7. Induction of macrophage apoptosis by ATP and H20 2 and assessment of effects 
on M. tuberculosis viability 
Adherent macrophage cultures were induced to undergo apoptosis by treatment with H20 2 or 
ATP. Dilution series of both treatments were carried out to determine concentrations and 
time kinetics for optimal induction of apoptosis. Optimal concentrations were then used to 
assess the affect of apoptosis induction by these agents on the survival of M. tuberculosis. 
For ATP treatment, adherent monolayers were pulsed with 2mM ATP (Sigma) for 90 
minutes, wc:shed with PBS and incubated for up to 16 hours in fresh RPMI 1640 medium 
supplemented with 10% AB serum. For H20 2 treatment, 1 mM H20 2 (BDH Biochemicals) was 
added to adherent monolayer cutures, and apoptosis assessed at various time points up to 
16 hours. 
Level of macrophage lysis was determined in a modification of the standard 16 hour 51Cr­
release assay (Section 2.2.4.). Adherent macrophages (day 5-7 post plating) were labelled 
with 6llCi/well 51Cr with or without simultaneous infection with H37Rv. After overnight 
incubation macrophages were treated with ATP or H20 2-, and at various time points specific 
51Cr-release measured as described above. Levels of apoptosis were assesse.d by flow 
cytometry following annexin V and PI staining and/or by fluorescent microscopy. For 
fluorescent microscopy, apoptotic adherent macrophages were stained with acridine orange 
(1Ilg/ml) and ethidium bromide (1Ilg/ml) (both Sigma) for 10 minutes, washed, mounted and 
viewed. 
The effect of either ATP- or H20 2-induced apoptosis on M. tuberculosis survival was 
assessed as described in Section 3.2.3. Instead of exposing infected macrophages to 
cytolytic clones, ATP or H20 2 was administered as described above. M. tuberculosis viability 
was monitored by both CFU counting and assessment of 3H-uridine incorporati9n. 
Infected macrophage Iysates (SDS-treated) were exposed to ATP or H20 2 (Section 3.2.3.) to 
assess whether the agents were directly mycobactericidal. The number of CFU's was 
determined by plating Iysates onto 7H11 agar plates before or after exposure to ATP or H20 2. 
Comparison of CFU counts enabled evaluation of the mycobactericidal activity of these two 
agents. 
3.2.8. Inhibition of macrophage apoptosis and the effect on M. tubercutosis survival 
Brefeldin A was used to inhibit apoptosis of macrophages following exposure to the cytolytic 
clones (Kataoka et al., 1996). Brefeldin A (Sigma) was prepared by solubilisationin 
methanol. Aliquotted stock solutions were later thawed and diluted into growth medium at a 
concentration of 10IlM. BFA was added to the cytotoxicity assays at the same time that the 
clones were added to the adherent macrophages. Solvent controls were included in initial 












were pre-incubated with BFA for 3 hours to prevent both FasL expression and cytolytic 
granule maturation. The effect of BFA on ATP and H20 2 induced apoptosis was also 
assessed. The viability of M. tuberculosis following inhibition of target macrophage apoptosis 
by BFA was determined by both CFU counting and 3H-uridine incorporation, as described 
above. 
Possible toxic effects to the macrophages in the presence of BFA were excluded by 
assessing macrophage viability folic ving treatment of macrophages for 16 hours. Trypan 
blue exclusion staining was carried out on EDTA-detached macro phages following BFA 
treatment. In order to exclude the possible BFA-mediated inhibition of macrophage antigen 
presentation, the ability of BFA-treated macrophages to induce CTL clone proliferation was 
assessed. As in cytolytic assays, BFA was added to H37Rv-infected macrophages at the 
same time as the clone cells. Assessment of clone cell proliferation was carried out in a 
modification of the standard procedure (Section 2.2.9.). Day 5 adherent macro phages (plated 
at 106 PBMNC/ml, 100Il"well) were infected with H37Rv (2 organisms per macrophage) for 
24 hours. Macrophages were washed and CTL clones (100111 of 106/ml) were added. 3H_ 













3.3.1. Lysis of M. tuberculosis-infected macrophages by CD4+ CTL clones was 
accompanied by a reduction in mycobacterial viabilty 
In order to assess whether the cytolytic activity of CD4+ effusion-derived clones had any 
effect on intracellular mycobacteria, viable bacilli were enumerated prior to, and following, 
exposure of the macrophages to the clones. The effect of lysis of mycobacteria-infected 
macrophages on the viability of M. tuberculosis is presented in Figures 3.1.(A) and 3.2. 
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Figure 3.1. Changes in CFU counts following 16 hour exposure of infected macrophages to 
CD4+ CTL clones (A), or the apoptogenic agents ATP (2mM) or H20 2 (1 mM) (B.). Change 
in CFU counts in the absence of clones or apoptogenic agents is represented as control. 
Reduction of CFU in the presence of H20 2, ATP and clone 14.1 DC was statistically significant 
(P < 0.05). Data represent 3 experiments 
The effusion-derived CD4+ CTL clones were able to potently reduce the number of viable 
mycobacteria. Although only clone, 14.1 DC, showed a statistically significant reduction (P < 
0.01), all the clones were able to reduce CFU counts by more than 30%. This compares 
favourably with the optimal levels of reduction of CFU counts in the presence of the 
apoptogenic agents ATP and H20 2 (Figure 3.1.B and Figure 3.2). The percentage reduction 
of viable mycobacteria by the four CD4+ clones illustrated in Figures 3.1 and 3.2. was as 
follows: 42% (±12) for clone 3.20, 32% (±8) for clone 10AC, 60% (±13) for clone 14.10C, 
and 38% (±7) for clone 15.3A All these values were determined using a clone (effector) to 
macrophage (target) ratio of 10:1. The apoptogenic agents ATP and H20 2 were able to effect 
levels of viable organism reduction of 57% (±13), and 67% (±8), respectively. The levels of 
reduction in CFU counts induced by macrophage exposure to both these agents was 
statistically significant (P < 0.01). 
The levels of antigen-specific lysis of macrophages were comparable for all 4 clones at an 
effector to target ratio of 10:1 (34-42%). There was, however, rio direct correlation between 
level of target cell lysis (51 Cr-release) and level of CFU reduction (Figure 3.2). The variance 












linked to the number of macrophages which were lysed. This finding suggests that the 
mechanism whereby the clones lysed the infected macrophages may be important in 
determining mycobactericidal potential. 
The CTL clones were themselves not directly mycobactericidal. Direct exposure of the clones 
to viable mycobacteria did not result in any reduction in CFU counts. Similarly, exposure of 
intracellular mycobacteria (released from macrophages by SDS treatment) to the clones had 
no effect on organism viability. Reduction in CFU counts was thus dependent on,:';TL­
mediated lysis of infected macrophages, and was not mediated by clone derived cytokines 
(Bermudez and Young, 1988; 1992). Inhibition of macrophage apoptosis by brefeldin A (BFA) 
was found to abrogate the mycobactericidal activity of the clones, a finding which appears to 
directly implicate target cell death or an associated event with CFU reduction (Section 3.3.6.) 
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Figure 3.2. Effect of lysis of M. tuberculosis-infected macro phages on mycobacterial viabilty. 
Percentage lysis after exposure to the clones, ATP or H20 2 is plotted on the left y axis and is 
indicated by the bars. Percentage organism survival (100 - % CFU reduction) is plotted on 
the right y axis and is indicated by the lines. Control illustrates the level of lysis of 
macrophages in the absence of any treatment, with organism survival of 100%. Data 
represent 3 experiments showing standard deviation 
3.3.2. Patient-derived CD4+-enriched EMNC line, but not PBMNC line, was also 
mycobactericidal 
The finding that effusion-derived CD4+ clones were mycobactericidal led to an assessment 
of whether the site of origin of the clones (i.e. the pleural cavity) was a determining factor in 
their unique functional activity. CD4+-enriched EMNC and PBMNC lines were generated 
from patient material obtained at the time of diagnosis. These lines were then assessed for 
mycobactericidal activity. 
Both EMNC and PBMNC CD4+-enriched lines were cytolytic. Levels of antigen-specific 
macrophage lysis induced by the two lines is illustrated in Figure 3.3(A). The cytolytic activity 
of the lines was comparable to that of the clones (mean antigen specific lysis of 25% and 












EIVINC cell line was mycobactericidal, reducing organism viability by 41±17%. The P6MNC 
cell line was unable to reduce mycobacterial viability following lysis of infected macrophages. 
The number of viable mycobacteria increased marginally during the period of macrophage 
exposure to the P6MNC line, a pattern observed in control experiments where no CTL cells 
were added. These findings are illustrated in Figure 3.3(6). The ability of the EMNC line and 
effusion-derived clones to reduce mycobacterial viability suggests that cells at the sites of 
infection differ functionally from their counterparts in the peripheral blood. 
2 4 6 8 10 
E:TRATIO 
oHours 16 Hours 
Figure 3.3. Comparison of cytolytic activity of CD4+ enriched EMNC and P6MNC cell lines 
(A.) and the effect of cell line-induced macrophage lysis on M. tuberculosis viability (6.). 
Mycobacterial antigen-specific lysis is illustrated at 16 hours for the PBMNC line (+) and 
EMNC line (.) at 3 effector:target ratios. Mycobacterial viability was assessed by CFU 
counting before (0 hours) and after (16 hours) exposure to the two cell lines for 16 hours at 
an effector to target ratio of 10: 1. The CFU counts after 16 hours in the presence of the 
EMNC line were statistically significantly reduced (P < 0.01) as compared to control (0) and 













3.3.3. Slow kinetics of CD4+ CTL-induced macrophage killing was accompanied by 
mycobacterial death at the later stages of target cell death 
The kinetics of C04+ CTL clone cytolytic activity was investigated by determining 51Cr_ 
release following macrophage exposure to the clones over a 24 hour time period. The level 
of macrophage cytolysis was determined at 4, 8, 12, 16, 20, and 24 hours post exposure to 
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Figure 3.4. Kinetics of 51Cr-release by M. tuberculosis infected macrophages following 
exposure to 3 different clones at an effector:target ratio of 10:1. 51Cr-release was assessed 
at 4 hourly intervals over a 24 hour period. Clones illustrated include 3.20 (....), 10.4C (-), 
and 15.3A (.). Oata are representative of 3 experiments. Error bars (SO) omitted for clarity 
but did not exceed 20% of the mean at time points> 12 hours 
Maximal 51Cr-release occurred at 24 hours for all the clones examined. The tapering off of 
the cytolysis curves after 16 hours was accompanied by a progressive increase in the level of 
non-specific macrophage lysis (spontaneous release). This was probably due to M. 
tuberculosis-induced lysis of macrophages after 40 hours (16 hours of cytolysis assay + 24 
hours of labelling) of infection. For this reason 16 hours was used throughout the study in 
evaluating optimal levels of cytolysis. Low levels of cytolysis were observed after 4 hours (1­
2% specific lysis) for all the clones. 
Increasing effector to target ratios to 20: 1 and 50: 1 resulted in a moderate increase in 
cytolysis levels. For example, for clone 3.20 levels of antigen-specific cytolysis of 28% at 
10:1 increased to 33% at 20: 1, and 36% at 50: 1. Effector to target ratios in excess of 20: 1 
were not considered physiological since it is unlikely that a single macrophage is exposed to 
more than 10 CTL in the granulomatous lesion (Oannenberg, 1991) or in the pleural space. 
In addition, since increased E:T ratios did not have a marked effect on percentage lysis, the 
E:T ratio was subsequently maintained at a maximum level of 10:1. 
The kinetics of killing of M. tuberculosis was assessed in parallel experiments over 20 hours. 
Both 3 H-uridine incorporation and CFU counting were used to assess reduction of viable 












induced killing of mycobacteria is illustrated in Figure 3.5. Similar results were obtained with 
all the C04+ CTL clones examined. Levels of reduction of organism viability mediated by 
clone 3.20 over 20 hours were as follows: 4 hours, 4.0%; 8 hours, 25.1 %; 16 hours, 53.1 %; 
20 hours, 51.2%. No significant increase in the levels of organism killing was observed when 
effector to target ratios were increased. At an effector to target ratios of 20: 1, clone 3.20 
induced a 54.6% reduction, and at 50:1 this only increased to 55.9%. This confirms the 
finding that higher E:T ratios did not significantly increase levels of lysis as measured by 51Cr_ 
release, and would appear to indico. =that E:T ratios >10: 1 could not significantly enhance 
the mycobactericidal activity of the clones. 
Optimal reduction in viable bacilli as determined by both 3H-uridine incorporation and CFU 
counting was observed at 16 hours. Although levels of 51Cr-release continued to increase up 
to 24 hours, no additional organism killing was observed beyond 16 hours (Figure 3.5.). 
Optimal killing of intracellular organisms (8 to 16 hours) occurred when the increase in 51Cr_ 
release was also maximal, a finding which suggests that mycobactericidal activity was 
associated with the later events in target cell death such as extensive membrane leakage, 
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Figure 3.5. Kinetics of M. tuberculosis death following exposure of infected macrophages to 
C04+ CTL clone 3.20. Organism viability was determined by 3H-uridine incorporation and 
data are expressed as counts per minute (cpm) .. Open bars illustrate numbers of viable 
intracellular mycobacteria over 20 hours in the absence of any CTL clone. Filled bars 
illustrate numbers of viable intracellular organisms after exposure to clone 3.20 over 20 
hours. Viability of the mycobacteria was determined at 4 hourly intervals. Oata are 
representative of 3 experiments ± standard deviation. 
3.3.4. Both ATP and H20 2 could induce macrophage lysis and were mycobactericidal 
ATP and H20 2 , agents which have both been reported to induce macrophage apoptosis and 
to reduce viable intracellular mycobacteria, were used to induce target macrophage cell 
death (Molloy et al., 1994: Laochumroonvorapong et al., 1996; 1997). The ability of these 
agents to induce apoptosis was confirmed in the current study (Section 3.3.5). Levels of 












were 53±7% and 51±9% of macrophages, respectively (Figure 3.2). As discussed in Section 
3.3.1, these levels of lysis were accompanied by mean reduction in CFU values of 57% and 
67% respectively. Since both agents induce the same form of cell death (i.e. apoptosis), 
osmotic lysis (exposure of the cells to H20) and heat shock, both of which cause cell 
necrosis, were also assessed to determine whether the mechanism of cell death was an 
important determinant of mycobactericidal activity. Osmotic lysis led to the death of >90% of 
macrophages, but had no effect on organism viability. Similarly heat shock led to the death of 
>85% of cells, but no effect on organism viability was o:'served. Necrotic death was 
confirmed by propidium iodide staining. 
Neither ATP nor H20 2 were directly mycobactericidal. Control experiments involving SDS 
lysis of infected macrophages prior to exposure to the apoptogenic agents showed that 
neither of the agents could directly kill mycobacteria. The mycobactericidal activity of these 
agents was thus dependent on active participation of the target cell. 
3.3.5. CD4+ CTL clones, EMNC and PBMNC lines, ATP and H20 2 all induced 
macrophage apoptosis as assessed by annexin v surface membrane expression 
Due to the finding that the induction of apoptosis (but not necrosis) was accompanied by a 
reduction in viable mycobacteria, the mechanism whereby the CTL clones killed infected 
macrophages was investigated further. More detailed assessment of cell death was carried 
out by flow cytometry and fluorescent microscopy of annexin V-propidium iodide- and also 
TUNEL-stained macrophages. Representative flow cytometric histograms of annexin V and 
propidium iodide binding by macrophages following exposure to clone 3.2D for 8 hours are 
illustrated in Figure 3.6. 
The annexin V binding by macrophages following exposure to CTL clones was monitored 
over time in order to establish the kinetics of apoptosis induction. These findings, together 
with the kinetics of HzOz and ATP-induced apoptosis induction are illustrated in Figure 3.7. 
The clones showed rapid induction of apoptosis, a finding which was confirmed by TUNEL <; 
staining, Table 3.1). The apoptogenic agents demonstrated a slower induction of apoptosis. 
The kinetic pattern of apoptosis induction by the clones differed from that of 51Cr-release and 
also of reduction of viable organisms. Although mycobactericidal activity was associated with 



















Figure 3.6. Flow cytometric analysis of Annexin V and propidium iodide stained 
macrophages in the absence (A.), and following exposure to clone 3.2D (E:T ratio:: 10:1) for 
8 hours (B.). Annexin V binding is plotted on the x-axis, and propidium iodide on the y-axis. 
The apoptotic population (lower right quadrant) increased from 7.1 % to 54.2% following 
exposure to the clone 
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Figure 3.7. Kinetics of macrophage apoptosis induction as determined by comparison of 
percentage annexin V positive (apoptotic) macrophages at various time points following 
exposure to CTL clones (3.20 and 10AC), H20 2, or ATP. Macrophages not exposed to 












The kinetics of apoptosis induction was also examined by flow cytometric analysis of TUNEL 
stained cells over a 16-hour time period. The kinetics of apoptosis induction as assessed by 
these two methods is presented in Table 3.1. Although fairly high levels of non-specific 
TUNEL positivity was detected by flow cytometry at all time points (34.5-36.6%), only low 
levels were observed by fluorescent microscopy (Figure 3.8). This discrepancy may have 
been due to different staining protocols used in the preparation of the cells for the two 
detection methods. Consistently low levels of non-specific annexin V staining «10%) were 
detected by flow cytometry. Despite differences in non-specific staining, levels of both 
annexin V-binding and TUt\IEL positivity increased following exposure of the macrophages to 
the clones or the apoptogenic agents. Comparison of treatment-specific staining (indicated in 
parentheses in Table 3.1), indicates that although high levels of annexin V staining was 
detected by 4 hours, TUNEL staining of comparable levels was only observed at 8 hours. 
This may be due to different kinetics of phosphotidylserine exposure and host cell DNA 
fragmentation. Annexin V binds to phosphatidyl serine (PS), which is exposed on the cell 
surface following induction of apoptosis (van Engeland et a/., 1996). Normally, PS moieties 
are restricted to the inner leaflet of the phospholipid bi-Iayer. On induction of apoptosis there 
is a loss of this membrane asymmetry, and PS is exposed at the cell surface. TUNEL detects 
DNA strand breaks, a feature associated with most forms of apoptosis. Labelled nucleotides 
are linked to DNA at the points of breakage via the enzyme TdT (Gavrieli et a/., 1992). Only 
apoptotic cells containing damaged DNA are labelled using this technique. 
How PS exposure is related to DNA degradation is unknown (Zwaal and Schroit, 1997), 
however it appears that the processes involved in induction of membrane changes and the 
other events of apoptosis occur independently (Zhuang et aI., 1998). Indeed, DNA 
degradation seems to be caspase-dependent in most systems and involves translocation of 
signals from the cell membrane to the nucleus (Green, 1998). PS exposure on the other 
hand is an early event in apoptosis and may be linked to mitochondrial membrane potential 
changes which have been described as being an important regulatory step in the apoptotic 
programme (Depraetere and Golstein, 1998). PS exposure generally precedes DNA 
degradation, which in turn may be reflected in the lower levels of TUNEL positivity. 
The levels of annexin V binding by macrophages after exposure to the CD4-enriched EMNC 
and PBMNC cell lines were also examined. After 8 hours both lines had induced levels of 
annexin V binding comparable to that seen with the CD4+ clones. This indicates that these 












Table 3.1. Comparison of percentage of macrophage cells stained with Annexin V or by 
TUNEL at 3 time points following exposure to clones, H20 2, and ATP. Control values 
represent untreated macrophages. Values in parentheses indicate treatment-specific staining 
(control minus treatment) NO = not determined 
4 Hours 8 Hours 16 Hours 
Annexin V TUNEL Annexin V TUNEL Annexin V TUNEL 
Control 6.6 34.5 7.1 34.7 8.0 36.6 
ATP 16.5 (9 .9) 46.6 (12.1) 54.2 (47.1) 80.2 (45.5) 58.3 (50.3) 83.3 (46.7) 
H20 2 19.7 (13.1) 45.8 (11 .3) 23.3 (16.7) 53.0 (18.3) 41.0 (33.0) 72A (35 .8) 
3.20 46.3 (39.7) 49.8 (15.3) 54.2 (47.1) 79.2 (44.5) 58.3 (50.3) NO 
10AC 48.2 (41 .6) 45A (10.9) 55.3 (48.2) 79.7 (45.0) 61.7 (53.7) NO 
PBMNC NO NO 49.7 (42.6) NO NO NO 




Figure 3.8. Fluorescent microscopy of TUNEL stained macrophages following exposure to 
CTL clone 10AC (A) or fresh PBMNC (B.) for 8 hours. Apoptosis was observed in the 











3.3.6. Inhibition of target cell apoptosis abrogated mycobactericidal activity of CD4+ 
CTL clones, ATP and H20 2 
Brefeldin A has been reported to inhibit target cell apoptosis at both the level of the effector 
cell and the target cell (Kataoka et al., 1996). In the effector cell BFA inhibits up-regulation of 
FasL and also transport and release of cytolytic granule contents. At the level of the target 
cell, BFA inhibits important intracellular transport processes involved in apoptosis, especially 
those implicated in gross morphological changes such as cell shrinkage and apoptotic body 
formation. The effect of brefeldin A on macrophage cell death and mycobacterial killing is 
presented in Table 3.2. Both percentage specific lysis and percentage reduction of viable 
mycobacteria are shown. 
Brefeldin A inhibited lysis of infected macrophages by between 82A% and 100%. This was 
accompanied by an abrogation in CFU reduction by between 90.3%and 100%. Levels of 
inhibition of macrophage lysis in the presence of BFA of 92.5% and 90.2% were observed for 
ATP- and H202-mediated cell death, respectively. Complete abrogation of ATP- and H20 2­
mediated mycobactericidal activity was observed in the presence of BFA. 
Table 3.2. Effect of brefeldin A (10IJM) on 51Cr-release and annexin V binding by 
macrophages at various time pOints following exposure to CTL clones, ATP, or H20 2. No 
reduction in CFU (mean value) indicated by an asterisk (*) 
% Specific lysis % Reduction 
{51 Cr-release ~ {CFU~ 
-brefeldin A + brefeldin A - brefeldin A + brefeldin A 
ATP 53±7 4±4 57±13 -9±15* 
H20 2 51±9 5±3 67±8 -1±8* 
3.2D 34±7 6±3 42±7 1±9 
10AC 44±6 3±2 31±6 3±7 
14.10C 39±6 2±2 37±7 -3±10* 
15.3A 35±8 0±2 38±6 -12±14* 
BFA did not cause loss of cell viability nor did it in any way inhibit the ability of macrophages 
to present antigen if only added 24 hours after macrophages were exposed to antigen. The 
viability of BFA-treated macrophages was assessed by trypan blue exclusion. Macrophage 
viability was conSistently >80%. PBIVINC treated with BFA after 24 hour exposure to antigen, 
were stifl capable of supporting CD4+ CTL clone proliferation. Therefore the inhibitory effect 
excluded toxicity toward macrophages, inhibition of antigen presentation, or interference with 












CD4+ effusion-derived CTL have been demonstrated to induce apoptosis of M. tuberculosis­
infected macrophages and to concomitantly reduce the number of viable intracellular 
mycobacteria. Although an effusion-derived CD4+ enriched line was found to mimic the 
clones in this mycobactericidal activity, a peripheral blood-derived line did not. These findings 
suggest that effusion-derived CD4+ cells possess unique mycobactericidal activity which 
may implicate these cells in organism clearance at disease-associated sites. 
The mycobactericidal activity of the CD4+ CTL clones was confirmed by both CFU counting 
and tritiated uridine incorporation. Although the level of reduction of intracellular organisms 
varied between the clones, all the clones examined were able to decrease the number of 
viable intracellular bacteria after 16 hours by at least one third. The levels of reduction in 
viable organisms effected by the clones were comparable to levels induced by the strongly 
apoptogenic agents ATP and H20 2 , as observed in this and other studies (Molloy et al., 1994; 
Laochumroonvorapong et al., 1996, 1997). The ability of some of the clones to decrease the 
number of infecting organisms by up to 50% highlighted the potency of this mycobactericidal 
activity. Any reduction in infecting organism numbers at this level in a localised site would be 
sufficient to clear the infection if the process were repeated several times (Molloy et al., 
1994). In the granuloma, such repeated cycles of infected macrophage lysis may indeed 
occur. The core of the granuloma is dominated by macrophages containing engulfed 
mycobacteria (Dannenberg and Rook, 1994). Induction of apoptosis of these infected 
macrophages by CD4+ CTL, which lie predominantly adjacent to the macrophages in the 
mantle zone, would result in the creation of apoptotic bodies as well as the possible release 
of intracellular organisms following secondary necrosis. Subsequent uptake of released 
organisms and/or apoptotic bodies by neighbouring macrophages could initiate another cycle 
of CTL-mediated lysis. If each cycle of macrophage lysis was accompanied by a significant 
reduction of organisms, the activity of the CTL at the disease site could successfully clear the 
infection. 
The mycobactericidal activity mediated by the CD4+ CTL clones was also observed in a 
CD4+-enriched EMNC line, but not a CD4+-enriched PBMNC line. This finding suggests that 
the ability of the clones and EMNC line to kill mycobacteria was due to a unique feature of 
the pleural milieu. The inability of the PBMNC line to reduce numbers of viable organisms 
confirms the findings of earlier studies, where peripheral blood-derived CD4+ CTL clones 
had no demonstrable mycobactericidal activity (Fazal et al., 1994; Pithie et al. t 1995). 
Although these studies used heterologous HLA-matched APC, the findings clearly indicated 
that Cd4+ CTL could not effect any changes in organism viability. The mycobactericidal 
activity of the clones and EMNC line in the present study was not linked to the level of 
macrophage cytolysis, since both cell lines displayed similar levels of cytotoxic activity. On 












mediator of mycobacteridal activity. Both of the cell lines as well as the clones induced 
macrophage apoptosis, as assessed by membrane phosphatidyl serine expression on the 
cell surface. It remains possible that later events associated with the apoptosis process 
could be preferentially involved in mycobactericidal events mediated by effusion lines and 
clones. Any downstream differences would not necessarily be mirrored by differential 
annexin v expression. 
Late events in the macrophage apoptotic death programme were associated witi'i the 
reduction of viable intracellular organisms. Although apoptosis was initiated rapidly after 
exposure to the CD4+ CTL clones, as demonstrated by detectable annexin V binding by 4 
hours, organism death was optimal at only 16 hours. The kinetics of organism killing 
therefore correlated with macrophage 5'Cr-release rather than with the initiation of apoptosis. 
The slow kinetics of target cell lysis observed in this study. can be linked to the target cell 
type involved (adherent macrophages), and the mechanism of death (apoptosis). Necrotic 
cell death is always rapid since it involves cell swelling accompanied by early loss of cell 
membrane integrity (Majno and Joris, 1995. A hallmark feature of CD8+ CTL activity has 
always been the rapid death of target cells by apoptosis (Shresta et a/., 1998). This rapidity of 
apoptotic induction and subsequent cell death has also been observed with CD4+ CTL 
(Trapani, 1998). Critical factors in the kinetics of target cell death seem to be the type of 
target cell involved, and the mechanism whereby the CTL induces apoptosis (Trapani, 1998). 
Many in vitro assays of cytotoxity utilise transformed cell lines as targets. These cells divide 
rapidly, are non-adherent, and generally also die rapidly by apoptosis. Macrophages, on the 
other hand,are terminally differentiated cells (Cotter et a/., 1994). They do not usually 
replicate following differentiation, and their metabolism is slower than other cell types. Due to 
these cells not being in an active replicative state cell death following the induction of 
apoptosis appears to take longer (Hahn et a/., 1995). Optimal detection of macrophage cell 
death by 51Cr-release following induction of apoptosis has previously been reported to be 
maximal from only 16 hours onwards (Lewis et a/., 1995), a finding confirmed in the present 
study. 
The close association between infected macrophage apoptosis and killing of mycobacteria 
was strengthened by the ability of brefeldin A to inhibit both target cell death and 
mycobacterial death. Brefeldin A potently inhibited macrophage lysis by the clones and 
cytolytiC agents. This inhibition was accompanied by abrogation of mycobacterial killing. The 
activity of BFA was not due to toxicity toward the macrophages or T cells, or inhibition of 
antigen presentation. Without apoptosis, no organism killing was observed. BFA, however, 
blocks all induction and execution steps of the cytotoxiC process (Kataoka et a/., 1996). 
These findings do not, therefore, clarify whether inhibition of granule release from CTL, or 












The finding that effusion- and peripheral blood-derived cells both induced apoptosis confirms 
that this cell death process was not the sole mediator of organism death. It seems rather that 
reduction in numbers of viable mycobacteria was dependent on an apoptosis-associated 
event, resulting in organism death concomitant with the late stages of host cell death. Late 
events in the apoptotic death programme include cell shrinkage, fusion of different cellular 
compartments, destruction of organelles, formation of apoptotic bodies, and permeabilisation 
of the cell membrane (Majno and Joris, 1995; Lincz, 1998). The fusion of cellular 
compartments, may be an important component of anti-microbial activity. Fusion of 
mycobacteria-containing phagosomes with Iysosomes has been observed in the later stages 
of apoptotic cell death (Laochumroonvorapong et al., 1997). The fusion of these two cell 
compartments, a process which is actively prevented by pathogenic mycobacteria under 
normal conditions (Schaible et a/., 1999), would expose the organisms to potent host cell 
lysosomal enzymes. Although this is an attractive model which may explain apoptosis-related 
mycobactericidal activity mediated by agents such as ATP and H20 2 , it does not account for 
the difference in anti-mycobacterial activity between the two CD4+-enriched cell lines. It 
remains possible that the CD4+clones and ATP have distinct mechanisms of mycobacterial 
killing. 
Another important late apoptotic event is secondary necrosis-associated membrane 
permeabilisation (Majno and Joris, 1995). Changes to cell membrane permeability may also 
result in rupture of the membrane-bound phagosomal compartment. The mycobacteria,could 
then be released into the cytoplasm to be exposed to various toxic cell components. Levels 
of mycobacterial killing resulting from exposure to cytolytic granule components may be 
enhanced when apoptotic fragments containing surviving mycobacteria are engulfed by 
adjacent intact macrophages. The uptake of M. avium-containing apoptotic fragments by 
macrophages has been reported to reduce organism viability (Fratazzi et a/., 1997). Surviving 
organisms are possibly "weakened" after exposure to toxic cell components or cytolytic 
granule contents. Uptake by newly recruited activated macrophages may be sufficient to kill 
them. Alternatively, induction of a new cycle of CTL-mediated cytolysis could be envisaged to 
result in clearance of organisms from the disease site. 
Cytolytic granules have been found to contain a range of components, including periorin and 
granzymes (Page et al., 1998). Although these two proteins have been extensively studied, 
the activity of most of the granule components has not been clarified. Of particular 
importance would be exposure to cytolytic granule components such as granulysin, The latter 
cytolytic granule component has been shown to be directly mycobactericidal (Stenger et a/., 
1998). If granulysin or a similar mycobactericidal cytolytic granule component were present 
only the in effusion-derived cell line and clones, it could account for the apoptosis-associated 
killing of intracellular organisms observed at the late stages of macrophage death. The 












and clones. However, since mycobacterial antigen-responsive CD8+ CTL utilise granule 
exocytosis as the mechanism of apoptosis induction, suggests that a similar mechanism may 
may occur in CD4+ CTL exhibiting comparable mycobactericidal activity. It is likely that 
granulysin, or a similar as yet undefined component, was present in the effusion-derived cells 
in concentrations sufficient to kill more than one third of viable organisms. 
The effusion-derived CD4+ cells were uniquely mycobacteridal, a finding that suggests that 
the site of origin was responsible for induction of this activity. Cells initially enter the pleural 
cavity from the lung, therefore cells in the pleural effusion are representative of cells occuring 
at the disease site. The pleural effusion of this patient showed a localised expansion of CD4+ 
cells, increased numbers of antigen-responsive cells, increased numbers of CD4+ memory 
cells, accelerated kinetics of response to PPD, and accelerated kinetics of induction of 
cytolytic activity in vitro (Chapter 2). All these findings were suggestive of in vivo priming. 
Cells primed in vivo by macrophages infected with a virulent clinical strain of M. tuberculosis 
within a unique cytokine milieu could be stimulated to produce unique cytolytic granule 
components, or to produce higher concentrations of such components. Re-stimulation of 
these cells in vitro may then expand an already unique population of cells. Peripheral blood­
derived cells, on the other hand, were not primed in vivo, nor were they contained within a 
unique disease-associated site. Primary stimulation in vitro with a laboratory strain of M. 
tuberculosis, and in the absence of a unique cytokine milieu, may be insufficient to initiate 
production of the unique cytolytic granule component. 
The findings discussed in this chapter have defined a novel role for CD4+ T cells at the 
disease site. The role of these cells in cytokine production for the recruitment and/or 
activation of other cells is well-defined (Barnes and Modlin, 1996). A probable link between 
the predominance of CD4+ cells at sites of disease, and the enhanced cytotoxic potential of 
ex vivo-derived cells led to an assessment of the role of cytolytic CD4+ T lymphocytes at the 
clonal level. The majority of CD4+ T cell clones generated in this study were cytolytic. This 
cytolytic activity was associated with potent mycobactericidal ability, a finding that implicates 
CD4+ T cells directly as key mediators of organism clearance from disease sites. The 
present findings then would extend the function of CD4+ cells beyond cytokine release and 
macrophage activation activities, to also include CTL associated mycobacterial killing as an 
important component of the protective cellular immune response at the site of infection. 
The phenomenon of different T cell-mediated cytolytic pathways (Fas versus granule 
release) having different functional roles was investigated further to determine whether a 
particular killing mechanism could account for mycobactericidal activity. Detailed assessment 
of the mechanisms of cytotoxicity employed by the cytolytic CD4+ T cell clones, as well as 
CD4+-enriched lines, and the association between killing mechanism and mycobactericial 











Chapter 4 . 
. Mycobactericidal C04+ CTL clones possess dual granule- and Fas­
(COgS) mediated mechanisms for killing macrophages 
4.1. Introduction 
The pivotal role of CD4+ T cells in the successful containment and clearance of infection in 
TB is well established (Boom, 1996; Kaufmann and Andersen, 1998). The major roles for 
CD4+ are in the provision of cytokines for macrophage activation, and cytotoxic activity 
(Boom et al., 1991). Although the importance of helper CD4+ cells in the control of TB is 
undisputed, the exact role and mechanism of action of CD4+ CTL in this disease remains 
somewhat speculative (Tan et al., 1997; Schluger and Rom, 1998). However, the fact that M. 
tuberculosis-specific CTL cultured in vitro are CD4+ (Ottenhoff and Mutis, 1990) and that 
CD4+ cells derived from the site of disease display enhanced cytolytic activity (Lorgat et al., 
1992), suggest a role for such cells in protective immunity. 
Cytolytic T cells are able to kill target cells by either of two major mechanisms, cytolytic 
granule release and receptor-ligand binding (Kagi et al., 1994; Trapani and Jans, 1999). In 
cellular immunity, receptor-ligand killing is predominantly mediated by interactions between 
the Fas receptor (CD95) and its ligand (FasL). Additional receptor-ligand interactions 
involving TNF-a and its receptor TNF-R1 (Zheng et al., 1995; Wallach et al., 1998) and ATP 
and its purinergic receptor P2x7/P2z (Lammas et al., 1997) have also been reported. 
While CD4+ and CD8+ CTL both utilise these two major mechanisms of killing, granule­
exocytosis appears to predominate in CD8+ CTL and Fas-FasL interactions in CD4+ CTL 
(Henkart, 1994; Podack, 1995; Trapani, 1998). Fas-mediated cytotoxicity is important in 
immunoregulation and in processes of clonal deletion (Krammer et aI., 1994; Winoto, 1997). 
Deletion of populations of cells via FasL-Fas interactions is less stringently controlled then 
granule exocytosis. Once an effector cell has been stimulated to express FasL, no 
subsequent antigen presentation pathways are required. Any cell expressing Fas can then be 
targeted by another cell expressing FasL (Depraetere and Golstein, 1997; Nagata, 1997). T 
cell populations, expanded at sites of infection or at the periphery, may in this way be rapidly 
deleted by one another preventing excessive cellular congestion and swelling (Krammer, 
1999). The primary function of Fas-mediated T cell killing therefore seems to be in 
homeostasis. Granule exocytosis on the other hand appears to have evolved for the 
elimination of infected or transformed cells (Kagi et al., 1996; Trapani and Jans, 1999). This 
mechanism of killing is more stringently controlled. Granule release is dependent on antigen 











followed by complex signalling events in the effector CTL culminating in granule release. 
Potentially detrimental bystander cell killing is minimised in this way (Hahn et al., 1995; 
Darmon et al., 1999). 
Both mechanisms of CTL cytotoxicity result in target cell apoptosis (Shresta et al., 1998). Fas­
killing and granule exocytosis merge at the point of caspase cascade activation (Trapani and 
Jans, 1999). Interestingly, the granule exocytosis mechanism, particularly as mediated by 
granzyme B, also includes a caspase independent pathway (.-;arin et al., 1997). Granzyme B 
can efficiently cleave substrates downstream of the caspases, and inhibitors of caspase 
activity do not block apoptosis mediated by this granzymecomponent (Andrade et al., 1998; 
Talanian et al., 1997). The caspase-independent mechanism of target cell killing may 
represent an additional back-up cytolytic pathway circumventing any anti-apoptotic signalling 
(such as that mediated by bcl-2 and related proteins), and its presence would ensure cytolysis 
of the target cell (Trapani and Jans, 1999). The anti-apoptotic proteins have been found to 
operate in numerous apoptotic pathways, including that of Fas ligation, and they may be 
manipulated by invading organisms such as intracellular bacteria and viruses (Kagi et al., 
1996; Smyth and Trapani, 1998). Maintenance of cytolytic activity in the presence of invadi,ng 
organisms is essential for the host, therefore the occurrence of granule-mediated killing which 
could bypass host control mechanisms would represent an important component of protective 
immunity (Podack, 1995). 
Due to the fact that the majority of CTL kill via either granule exocytosis or Fas-FasL 
interactions, and since both mechanisms have been implicated in mycobactericidal activity 
(Stenger et al., 1997; Oddo et aI., 1998), the relative contribution of these two pathways to 
macrophage killing by the CD4+ CTL clones was investigated. The clones were found to 
possess both Fas- and granule exocytosis--mediated killing mechanisms, however the latter 
was predominant. Inhibition of either mechanism of killing resulted in both a reduction of 
target cell lysis and of associated mycobacterial death. Since granule-exocytosis was the 
major component of CTL killing and organism eradication, it seems that this mechanism may 
represent an adaption by CD4+ cells to ensure optimal clearance of intracellular organisms. 
These findings have major implications in prospective immunomodulatory therapies in that 
enhancement of mycobactericidal killing via manipulation of CTL activity could ensure rapid 












4.2. Materials and methods 
4.2.1. Assessment of the role of calcium (Ca2+) in cytolytic activity of the clones 
The importance of Ca2 + in the cytolytic activity of the clones was assessed using the Ca2+_ 
chelating agent EGTA (Sigma, S1. Louis, MI, USA). Clones were passaged as discussed 
(Section 3.2.2.), by adding fresh irradiated antigen presenting cells (PBMNC), antigen (M. 
tuberculosis H37Rv) and IL-2. After 72 hours, fresh IL-2 was added, and 48 hours later the 
clones were used in cytotoxicity assays. Target adherent macrophages were cultured as 
discussed in Section 3.2.2. Briefly, fresh PBMNC (106/ml) were plated (1 OO~I/well) in round 
bottomed 96-weU microtitre plates (Greiner). Following an initial culture period of 96 hours the 
adherent macrophages were simultaneously infected with H37Rv and labelled with s'Cr 
overnight. Growth medium containing EGTA was then used to determine the effect of Ca2+­
removal on clone-mediated cytolytic activity. 
EGTA (6mM) and 3mM MgCI2 (both from Sigma, St. Louis, Mo.) were added to RPMI 1640 
medium (EGTA medium). The pH was adjusted to 7.4 and the medium was filter sterilised. 
The EGTA medium was supplemented with 10% pooled, heat-inactivated, human AB serum 
in all experiments. The effect of Ca2+-removal by EGTA on cytotoxicity of the clones was 
examined under standard conditions of effector/clone activation, or following additional 
activation of the CTL clones using 20ng/ml of PMA and 400nM ionomycin (both from Sigma). 
Pre-activation with these agents was carried out for 4-6 hours prior to cytolytic assays to 
ensure optimal up-regulation of co-receptors and activation markers, including FasL. The 
importance of Ca2+ for the expression of FasL was investigated investigated by pre-incubating 
the clones in EGTA medium for 4 hours prior to cytolytic assays. The effect of prolonged Ca2 + 
deprivation on clonal cytolytic function was then assessed in standard 16 hour cytolytic 
assays, also in the absence of Ca2 +. 
Standard 16 hour s'Cr-release cytotoxicity assays were carried out for all experiments, as 
discussed in Section 3.2.2. Parallel control experiments were carried out in which clone 
viability was routinely assessed by trypan blue exclusion staining following incubation in 
EGTA medium for 16 hours. This ensured that any reduction in cytolytic activity was not due 
to any changes in clone viability. 
In order to assess the effect of EGTA (Ca2+ removal) on the mycobactericidal potential of the 
clones, parallel experiments were set up in which H37Rv-infected (non-s1 Cr-labelled) 
macrophages were exposed to the clones in the presence or absence of EGTA Total 
macrophage-associated organism numbers were determined with or without exposure to the 
clones. As described in Section 3.2.3., various dilutions of the pooled Iysates were plated (10' 













4.2.2. Detection of cytolytic granule activity in the CTL clones 

Cytolytic granule contents were functionally detected by an enzymatic assay for serine 

protease activity. 100l-.LI of 5 x 105/ml activated CTL clones (48 hours after IL-2 restimulation, 

120 hours after addition of fresh APC's, antigen, and IL-2) were degranulated by adding 

25mM SrCI2 for 10 hours. Degranulation was carried out in 96-well microtitre plates (Greiner) 

at 37°C. Supernatant (20IJI) was then removed and incubated with 35IJI of 1 mM BLT (Na­

CBZ-L-Lysine Thiobenzyl ester, Sigma), 35111 of 1mM nitrobenzoic acid (Sigma) and 0.1% 

triton X-1 00. The reaction mixture was incubated at 37°C for 30 minutes, and absorbance was 

read at 405nm. Non-cytolytic control cells (U937) were treated in the same manner, allowing 

comparison of absorbance values between CTL cells and non-cytolytic cells. Additional well 

containing no cells were used as a negative control. Data are presented as abs?rbance units 

for the various clones and the control cell population. 

The serine protease (esterase) enzymatic activity assay was also used to assess the level of 
granule release (degranulation) by the CTL clones following treatment with SrCI2 . The serine 
esterase activity both within the clones (ceillysates) and the supernatant fluid was determined 
before and after overnight (16 hour) inCUbation of the clones in the presence of SrCI2. 
Comparison of levels of enzymatic activity in the two sample groups enabled an evaluation of 
the extent to which degranulation had occurred (Section 4.2.3.) 
4.2.3. Inhibition of granule-mediated cytotoxicity by Cyclosporin A (CsA), 
concanamycin A (CMA) and strontium (SrCI2) 
The chemical and pharmacological agents CsA (Sandoz, Basel, Switzerland), CMA (Wako 
Chemical Co., Wako, Japan) and strontium (SrCI2) (Sigma) have been reported to inhibit 
granule-mediated CTL killing indifferent ways (Trenn et aI, 1989; Strack et aI., 1990; Kataoka 
et aI., 1996; Neighbour and Huberman, 1982; Stenger et aI., 1997). All 3 agents were 
analysed for their ability to inhibit CTL killing. CsA and CMA were both solubilised in ethanol 
and stored as stock solutions at -20°C. Stock solutions were diluted in growth medium prior to 
initiation of cytolytic assays. Strontium was solubilised in sterile distilled water and stored at ­
20°C. Initially, dose response experiments (based on published reports) were carried out for 
each inhibitory agent to assess at which concentration optimal inhibition of killing occurred 
without affecting CTL viability. Viability of the clones prior to cytotoxiCity assays was 
determined using trypan blue exclusion staining. Optimal inhibitory concentrations (CMA 
100nM, CsA 500ng/ml, SrCI2 25mM) were subsequently used for all CTL cytotoxiCity assays. 
Solvent controls were tested for each agent and indicated no effect on cytolytic activity. 
CytotoxiCity assays were carried out as discussed in section 3.2.2. In certain experiments 
CTL clones were pre-activated for 4 hours with PMA and ionomycin, as discussed in section 
4.2.1. Inhibition of cytotoxic function by CMA and SrCI2 required pre-treatment of the clones to 











out for 4 hours using a 1mM CMA solution prepared in RPMI 1640 medium. To ensure 
optimal removal of granule contents by SrCb, CTL were incubated overnight in the presence 
of 25mM SrCI2. Viability was always monitored prior to the cytolytic assays by trypan blue 
staining. After treatment with SrCb clones were also assessed for their ability to proliferate to 
mycobacterial antigen to ensure functional responsiveness following the potentially toxic 
degranulation treatment. De-granulated and normal clones were tested for their ability to 
proliferate to M. tuberculosis H37Rv as described in Section 2. With all pre-treatments, CTL 
clones were washed prior to the cytotoxicity assays (pelleted, resuspended in fresh RPMI 
supplemented with human AB serum), counted, and then incubated for the duration of the 
assay in the presence of the agent at optimal inhibitory concentration. 
51Cr-release was measured as discussed in section 3.2.2. In certain experiments the granule­
exocytosis inhibitory agents were used in combination with a-Fas monoclonal antibody ZB4 
which inhibits Fas-mediated lysis in order to assess the combinatory effects of the two types 
of inhibitory agent (Section 4.2.5). 
The effect of inhibition of granule exocytosis killing by CsA, CMA and SrCI2 on the 
mycobactericidal activity of the clones was also determined. Parallel experiments to 
determine the CFU counts before and after exposure to the clones were carried out as 
discussed in Section 3.2.3. The effect of inhibition of granule release by these 3 agents on 
mycobactericidal activity was determined by comparing CFU reduction in the presence or 
absence of each agent. 
The effect of CsA, CMA, and SrCI2 on the cytolytic activity and mycobactericidal potential of 
the CD4+-enriched PBMNC and EMNC fines was determined as for the clones. The same 
inhibitory concentrations were used, and the lines were maintained and activated in the same 
way as the clones. 
4.2.4. Assessment of the contribution of the Fas pathway to CTL cytolytic activity 
4.2.4.1. Functional detection of FasL on CTL clones 
FasL expression was assessed functionally using Jurkat T cells (Vergelli et al., 1997). Jurkat 
cells constitutively express Fas and are lysed by effector CTL expressing FasL. Prior to using 
this cell line for cytotoxicity assays, Fas expression was confirmed by flow cytometry. Jurkat 
cells were stained with 5111 of anti-Fas monoclonal antibody ZB4 (lmmunotech, Marseilles, 
France), or an isotype control (normal mouse anti-human IgG1). Following washing by 
repeated centrifugation 100111 of goat anti-mouse FITC-conjugClted IgG was added. After 
labelling, excess stain was removed by repeated washing steps. cells were fixed in 1% 
paraformaldehyde and analysed on a flow cytometer (Coulter Epics profile II). The percentage 











CTl clones were assessed for their ability to lyse Jurkat cells, a process strictly dependent on 
the expression of FasL. Cytotoxicity assays were a modification of the standard 16 hour 
adherent target technique. Actively growing Jurkat cells (24 hours post passaging by dilution 
into fresh RPMI 1640 medium supplemented with 10% foetal bovine serum (Delta 
Bioproducts, Isandi, SA)), were labelled with S1 Cr (250~Ci) for 1 hour at 37°C with regular 
resuspension to preventing pelleting of the cells. After labelling, the Jurkat cells were washed 
3 times in fresh RPM I medium, counted and plated (100~1 of 106/ml Jurkat cells) in round­
bottomed microtitre plates (Greiner). The CTl clones (untreated or PMA I ionomycin 
activated) were washed, counted, and added to the Jurkat cells at ratios of 10:1, 3:1 and 
0.3:1. Plates were incubated for 16 hours at 37°C. Spontaneous release was determined from 
wells containing Jurkat target cells alone. Maximal release was determined from wells 
containing Jurkat cells exposed to 1% triton X-100. Supernatants from wells (140~1 of total 
200~1) were carefully removed following the assay period and counted in a y-counter. The 
percent specific lysis of Jurkat cells was calculated as follows: 100 x [(experimental cpm)­
(spontaneous cpm)]/[(maximum cpm)-(spontaneous cpm)], where spontaneous cpm was the 
cpm in the absence of effector cells, and maximum cpm is the cpm in the presence of 1 % 
triton X-1 00 (Sigma). Spontaneous release was consistently <20%. 
The effect of both EGTA and SrCI2 on CTl killing of Jurkat celis was assessed to ensure that 
granule-mediated killing was not operative in this system and that neither agent could affect 
Fas-mediated killing. EGTA-medium (6mM EGTA, 3mM MgCI2) was used to determine the 
effect of EGTA on Jurkat cell lysis. Degranulated CTl clones were exposed to Jurkat cells in 
the presence of SrCI2 to determine whether this treatment inhibited Fas-mediated killing. 
Experimental procedures were as described above. Comparison of the % lysis of Jurkat cells 
in the presence or absence of either EGTA or SrCI2 allowed for determination of the relative 
contribution of granule-exocytotis killing in this system and the effect of granule-exocytosis 
inhibition on Fas-mediated lysis. 
Anti-Fas monoclonal antibody ZB4 (Immunotec, Marseilles, France) was used to block killing 
of Jurkat cells. Jurkat cells were pre-incubated with 500ng/ml a-Fas for 1 hour prior to the 
addition of the CTl clones. Anti-Fas was then maintained in the culture wells for the duration 
of the assays. High levels of blocking of killing were taken as indicative of Fas being the 
mediator of lysis in this system. 
4.2.4.2. Detection of Fas on macrophages 
Fas expression on macrophages was assessed by flow cytometry following indirect labelling 
with ZB4. The level of Fas expression was monitored over several days (day 1 to day 7) 
following plating of macrophages in 24-well tissue culture plates (Becton-Dickinson). 
Macrophages were plated at 106 PBMNC/ml, 2ml per well. After incubation for 1-7 days, 












scraping using the rubber end of the plunger of a tuberculin syringe. labelling was carried out 
using 500ng/ml anti-Fas ZB4 (Immunotech), or an isotype control (lgG1). Following initial 
labelling, 100".11 of FITC-Iabelled goat anti-mouse IgG (Dako) secondary antibody was used to 
detect the primary anti-Fas antibody. The labelled cells were fixed in 1% paraformaldhyde 
prior to analysis on a flow cytometer (Coulter Epics Profile II). The effect of overnight infection 
with H37Rv (2 organisms per macrophage, 4 x 105 CFU/well) on day 4 adherent 
macrophages was determined in order to assess whether infection (as carried out in standard 
cytotoxicity assays) had any effect on Fas expression. AntibOi.l/ labelling of infected cells was 
carried out as above. 
4.2.5. Inhibition of Fas-mediated killing bya-Fas 
The effect of blocking Fas-Fasl interaction and therefore Fas-mediated CTl killing was 
assessed by binding anti-Fas blocking monoclonal antibody (ZB4) to the Fas molecules on 
the surface of the macro phages prior to exposure to CTl clones or lines. 
Adherent macrophages were labelled with 51Cr and infected with H37Rv as discussed in 
previous sections. Prior to the cytotoxicity assay, macrophages were washed and pre­
incubated with anti-Fas monoclonal antibody ZB4 (Immunotech, Marseille, France) for 1 hour. 
Initial dose response experiments to determine optimal blocking were carried out. 
Subsequently, the optimal blocking concentration (500ng/ml) was used. Control experiments 
using normal mouse IgG1 (isotype control) were also set up. CTl clones were added to the 
anti-Fas treated macrophages and standard 16 hour cytotoxicity assays were performed. 
levels of 51Cr-release in the presence or absence of anti-Fas were then compared. The 
functional activity of ZB4 was assessed by determining its ability to block Jurkat cell killing by 
CTl (section 4.2.4.1.), as well as the ability of ZB4 to block Jurkat cell apoptosis initiated by 
1!-Ig/ml of the pro-apoptotic monoclonal antibody CH-11 (Immunotech, Marseille, France). 
Anti-Fas antibody (ZB4) was used in combination with CsA, CMA and SrCI2 (as discussed in 
section 4.2.3.), to determine the combined effect of agents which block both granule 
exocytosis and Fas-mediated killing. 
Parallel experiments to determine the effect of blocking of CTl killing by anti-Fas on the 
mycobactericidal activities of the clones were also carried out as with the inhibitors of granule 
exocytosis. Total CFU counts were determined both before and after exposure of the infected 
macrophages to the clones in the presence of anti-Fas. Total (pooled) contents of triplicate 
wells were plated onto 7H 11 agar plates at various dilutions, as discussed in Se.ction 3.2.3. 












All experiments on the role of Fas-mediated killing in CTL clone activity were repeated using 
the CD4+-enriched EMNC and PBMNC lines. All experimental procedures were identical to 
those used in analysis of clone function. Both the level of inhibition of lysis and the effect on 
CFU numbers in the presence of anti-Fas were investigated. 
The role of Fas in CTL mediated lysis was further addressed by attempts to induce 
macrophage apoptosis using the apoptogenic anti-Fas monoclonal antibody CH-11 
(lmmunotech). Adherent macrophages (day 4) were infected with H37Rv and labellt:<1 with 
51Cr, as discussed previously. The macrophages were exposed to 1!lg/ml of CH-11 in RPMI 
1640 medium supplemented with human AB serum at the same time other macrophages 
were exposed to the CTL clones. After 16 hours the level of lysis was calculated as for a 
standard adherent cytolytic assay. Additional experiments using isotype control antibody 
(normal mouse IgG1) were set up to exclude possible non-specific antibody-mediated effects. 
Inhibition of anti-Fas induced lysis by the blocking antibody (ZB4) was determined by pre­
incubating adherent macrophages with ZB4 for 1 hour prior to exposure to CH-11. The effect 
of cycloheximide on Fas-induced lysis of macrophages is discussed below (Section 4.2.8.). 
4.2.6. Assessment of the role of ATP and TNF-a in CTL clone activity 
In order to determine whether ATP or TNF-a played any role in CTL clone mediated 
cytotoxicity, the effect of blocking of macrophage lysis induced by these agents was 
investigated. 
For ATP-mediated lysis, day 4 macrophages were labelled with 6!lCilweli of 51 Cr, as for 
standard cytotoxicity assays. On day 5, the labelled macrophages were washed and exposed 
to 2mM ATP in RPMI 1640 supplemented with 10% human AB serum for 90 minutes. The 
macrophages were then incubated for 16 hours and the level of lysis determined as for a 
standard 51Cr-release assay. ATP-mediated lysis of macrophages was blocked using the 
enzyme hexokinase (Sigma). Initial dose response experiments determined optimal blocking 
concentration at 2U/ml (I.e. optimal inhibition of ATP-induced lysis). This dose of hexokinase 
was then used in CTL clone assays to determine whether ATP-mediated lysis was operative, 
and to what extent The effect of the addition of hexokinase to cytolytic assays was 
determined by comparing the amount of 51Cr-release in the presence or absence of the 
enzyme. 
TNF-a-mediated macrophage lysis was also assessed in this way, with anti-TNF-a antibody 
(Promega). A range of concentrations of TNF-a was used to induce macrophage lysis, 
however poor lysis at all concentrations (maximal 10%) was observed. To ensure that TNF-a 
was functionally active, U937 cells were exposed to the cytokine at the same concentrations 
that the macrophages were. Both macrophage lysis and U937 lysis induced by TNF-a was 












labelled macrophages were pre-incubated with 500ng/ml of anti-TNF-a. Throughout the 
assay period (16 hours) the antibody was retained, and levels of macrophage lysis could then 
be compared in the presence or absence of the blocking antibody. Further experiments which 
address the effect of CHX on TI\lF-a-mediated lysis of macrophages are discussed in Section 
4.2.8. 
4.2.7. Assessment of the role of HLA-DR and CD1 molecules in clone cytolytic function 
HLA-DR restriction of the clones was assessed using the antibody L243. Proliferation of 
clones in response to M. tuberculosis H37Rv-infection was examined with and without the 
anti-HLA-DR antibody L243. A dose response using mouse ascites L243 indicated strong 
inhibition of proliferation at dilutions up to 10.6 . Clone proliferation assays were carried out as 
described in section 2.2.9. L243 antibody, or isotypic control antibody (lgG1), was added to 
the PBMNC 1 hour prior to the addition of the clones. Tritiated thymidine incorporation was 
assessed after 2 days as described above. 
CD1 expression on both infected and uninfected adherent macrophages was assessed using 
anti-CD1a, b, and c monoclonal antibodies (Immunotech, Marseille, France). Macrophages 
were examined on day 4-7 of culture, with and without overnight infection with H37Rv (at 2 
organisms per macrophage). Indirect labelling using anti-Cd1 a, b, and c monoclonal 
antibodies or isotypic controls (mouse IgG1) was carried out. A range of antibody 
concentrations were used (1 ng/ml - 1!lg/ml). The binding of anti-CD1 molecules to the 
macrophages was detected by a secondary FITC conjugated goat anti-mouse antibody 
(Dako). Levels of FITC binding were then determined by flow cytometry. The effect of IL-4 
(4mM) and GM-CSF (4mM) (Porcelli et aI., 1992) on CD1 expression was also examined. 
4.2.8. Effect of cycloheximide-mediated inhibition of protein synthesis on macrophage 
killing by CTL clones 
CHX was assessed for its affect on clone-mediated lysis of infected macrophages. CHX was 
solubilised in methanol and stored at -20°C. Stock solution was diluted into growth medium 
prior to cytolytic assays. In standard cytotoxicity assays, CHX (1 mM) was added to microtitre 
plate wells containing s1Cr-labelied and H37Rv-infected macrophages, prior to the addition of 
the clones. The level of lysis in the presence or absence of CHX was compared. Solvent 
controls were included, with no residual effect on cytolysis being observed. The effect of CHX 
on TNF-a- and anti-Fas-mediated lysis was also investigated by adding CHX (1 mM) to the 
adherent macrophages prior to exposure to these apoptogenic agents. 
Enhancement of CTL clone killing of macrophages was further investigated at the level of 
mycobactericidal activity. Total CFU counts were monitored before and after exposure to the 
clones or the' apoptogenic agents in the presence and absence of CHX. Whether a particular 











cytotoxicity in the presence of CHX was assessed by determining levels of CTL killing 
inhibition using anti-Fas and SrCI2. The inhibJtion assays were carried out as described in 













4.3.1. CTL clone-mediated lysis of infected macrophages was calcium-dependent 
The effect of Ca2 + on the cytolytic activity of the C04+ CTL clones was assessed using the 
Ca2 + chelating agent, EGTA. EGTA-mediated inhibition of infected macrophage killing by 
clone 3.20 is presented in Figure 4.1 . Similar patterns of inhibition were observed in all the 
clones examined (n = 6). 
EGTA strongly inhibited clone-mediated killing. Antigen-specific lysis of 31±6% mediated by 
clone 3.20 was reduced to 5±4% in the presence of EGTA at an effector to target ratio of 
10:1 . This was equivalent to an inhibition of 84%. Pre-treatment of the clones with PMA and 
ionomycin had little effect on the cytolytic potential of the clones (increasing clone-mediated 
lysis by only 4% at a 10: 1 effector to target ratio) . Inhibition of killing by EGTA was not 
affected by the PMAlionomycin pre-treatment protocol. Levels of EGTA inhibition following 
pre-activation were comparable to levels observed in the absence of pre-treatment (83% and 
84%, respectively) . Pre-incubation of the clones with EGTA for 4 hours prior to the assay led 
to complete abrogation of killing . Incubating of clones with EGTA prior to the CTL assays may 
have affected both killing pathways (granule- and Fas-dependent) , since Ca2 + is required for 
up-regulation of FasL expression on the cell surface, as well as for maturation, recruitment 


















Figure 4.1. The effect of EGTA on C04+ CTL clone 3.20-mediated lysis of infected 
macrophages. H37Rv antigen-specific lysis (_ ) was strongly inhibited in the presence of 
EGTA (0 ). PMA and ionomycin pre-activation did not significantly enhance clone-mediated 
macrophage lysis (e ). Pre-treatment of the clones with EGTA prior to the cytolytic assay led 
to complete abrogation of killing (. ). Data represent mean values of 3 experiments 
Residual killing represented the Fas-FasL pathway (Section 4.3.4.3) . EGTA had minimal 
effect on Fas-mediated killing if added at the beginning of cytolytic assays, but prior 
incubation for 4 hours resulted in inhibition of this component of CTL cytotoxic activity. This 
was probably due to the requirement for Ca2 + for persistent FasL up-regulation. Removal of 











optimally activated to express FasL. Lack of EGTA impact on Fas-FasL interactions was 
confirmed by the inability of EGTA to inhibit clone killing of Jurkat cells (discussed in Section 
, 	 4.3.4.3.). The strong inhibition of CD4+ CTL clone killing by EGTA therefore suggested that 
the majority of killing was attributable to Ca2+-dependent cytolytic granule release . 
4.3.2. CD4+ CTL clones possessed serine protease (esterase) activity 
Cytolytic granule activity was functionally demonstrated using an assay for BLT-esterase 
enzyme activity (Trapani, 1998). Since granzymes (which ar, serine proteases) are the most 
common constituent of cytolytic granules, assays for their specific activity are commonly 
performed as evidence for their presence within a particular cell type 
The presence of cytolytic granule serine proteases (BL T-esterases) was determined by 
enzymatic assay for BLT-esterase activity (Stenger et a/., 1997) The absorbance values 
(relative activity) of 4 clones are presented in Figure 4.2. U937, a non-cytolytic 
myelomonocytic cell line, was used as an ad ditional negative control. Cytolytic granule activity 
was present in all the clones , but not in the U937 cells . The clones gave absorbance readings 
of between 3.6 and 4.9 fold higher than U937 celis, which was indicative of enzymatic activity 
The absorbance readings generated by the clones were significantly different to those 
observed in the U937 cells (P < 0.01). The discrepancy between U937 absorbance readings , 
and those in the absence of any cells (0.07 and 0.01, respectively) may have been due to 
interference by other enzymatic pathways in the U937 cells. The presence of cytolytic 
granules is consistent with CTL activity involving granule exocytosis. 
Patient-derived CD4+-enriched EMNC and PBMNC lines both possessed serine protease 
activity. Absorbance readings of 0.32 ± 0.06 and 0.26 ± 0.07 were obtained for the EMNC and 
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Figure 4.2. Serine protease (BL T-esterase) activity of 4 clones compared to U937. The 
negative control (no cells) consisted of growth medium treated in the same way as the clones 
and the U937 cells. Absorbance readings for the clones varied from 0.25 to 0.34. U937 cells 
gave an absorbance reading of 0.07. Data represent mean values of 3 experiments showing 
standard deviations 
4.3.3. Inhibition of CTL clone granule-mediated cytotoxicity by CsA, CMA and SrCI 2 
The role of granule exocytosis was investigated using chemical and pharmacological agents 
previously shown to inhibit this pathway. Three agents, cyclosporin A (CsA), concanamycin A 
(CMA), and strontium (SrCI2), each of which inhibits cytolytic granule-mediated killing in a 
different way, were used to assess the involvement of this killing pathway. 
Representative profiles of CsA inhibition of cytolysis for 3 clones are illustrated in Figure 4.3. 
CsA inhibits cytolytic granule release (exocytosis) by blocking granule transport and release 
through inactivation of calmodulin binding protein (Trenn et al., 1989). Mean levels of 
inhibition of clone-mediated cytolysis between 51.5% and 74.3% were observed for the 3 
clones illustrated at an effector to target ratio of 10: 1 (n = 4). 
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Figure 4.3. CsA-mediated inhibition of macrophage lysis by 3 CD4+ CTL clones. Percent 
antigen specific (H37Rv) macrophage lysis by the clones following 16 hours of incubation in 
the presence (-) or absence (.) of CsA are indicated. Data represent mean values of 4 
experiments showing standard deviations 
Representative profiles of CMA inhibition of cytolysis for 3 clones are illustrated in Figure 4.4. 
CMA is an agent which prevents maturation of cytolytic granules by inhibiting vesicle 











clones with CMA for 4 hours, followed by the continued exposure to CMA for the duration of 
the cytolytic assay (16 hours), led to mean inhibition of levels of between 39.4% and 54 .3% at 
an effector to target ratio of 10: 1 for the 3 clones illustrated. I nhibition of cytolysis by CMA was 
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Figure 4.4. CMA inhibition of macrophage lysis mediated by 3 CD4+ CTL clones. Percent 
specific (H37Rv) macrophage lysis by the clones following 16 hours of incubation in the 
presence (.) or absence (.) of CMA are indicated. Data represent mean values of 4 
experiments showing standard deviations 
Representative profiles of SrCI2 inhibition of cytolysis for 3 clones are illustrated in Figure 4.5. 
SrCI2 induces degranulation of cytotoxic cells (Neighbour and Huberman, 1982; Stenger et 
a/. , 1997). This agent had the strongest inhibitory effect on clone-mediated macrophage 
killing. SrCl2-induced degranulation led to mean inhibition of levels of killing between 72.7% 
and 80.0% at an effector to target ratio of 10:1 for the 3 clones illustrated. 
Due to the high concentration SrCI2 required for optimal degranulation, both viability and 
proliferative responses of the clones were assessed following the overnight treatment. 
Minimal viability loss was detected by trypan blue staining following overnight degranulation. 
There was also only minimal interference in clone proliferative responses with and without 
degranulation treatment. Normal delta cpm values (cpm in the presence of H37Rv minus cpm 
in the absence of antigen) for clones 3.2D and 15.3A were 13309 ± 2407 and 11947 ± 1694. 
Following degranulation overnight, the values were 11441 ± 3106 and 10843 ± 2407, 
respectively. This illustrates that SrCI2 did not affect normal physiological functioning of the 
clones 
To ensure that SrCI2 treatment resulted in complete removal of cytolytic granules, functional 
granule activity was determined by serine protease enzymatic activity assays both before and 
after degranulation. Absorbance readings at 405nm following SrCI2 treatment were 
consistently below 0.06 (as compared to absorbances above 0.25 prior to treatment) . Levels 
of serine protease activity after degranulation were similar to those detected in the non­
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Figure 4.5. SrCI2 inhibition of macrophage lysis mediated by 3 CD4+ CTL clones. Percent 
specific (H37Rv) macrophage lysis by the clones following 16 hours of incubation in the 
presence (.) or absence (.) of SrCI2 are indicated . Data represent mean values of 4 
experiments showing standard deviation 
The inhibition of the granule-mediated pathway of killing by the agents CsA, CMA and SrCI2 
confirmed that this mechanism was predominant in the CD4+ CTL clones. Inhibition by 
strontium was greater than that observed using either CsA or CMA, but did not reach maximal 
levels observed with EGTA. A hierarchy of inhibition by various agents was thus established, 
with EGTA-mediated inhibition being strongest, followed by inhibition mediated by SrCI2 , CsA 
and CMA. 
All the agents which inhibit granule exocytosis showed strong inhibition of clone-mediated 
cytolysis . Although inhibition varied from approximately 40% to 70%, the presence of large 
granule-mediated component of killing was clearly illustrated . The importance of this 
component of killing in the mediation of mycobactericidal activity was investigated further 
(Section 4.3 .9) . A comparison of the levels of inhibition of CTL clone-mediated macrophage 
killing by the various agents and the effects on mycobacterial viability is presented in tabular 
form (Table 4.2) . 
4.3.4. Assessment of the contribution of Fas-mediated killing 
4.3.4.1. Flow cytometric analysis of Fas expression on macrophages 
The expression of Fas on the surface of cultured macro phages was assessed by flow 
cytometry. Levels of expression were measured over several days, and the effect of infection 
with M. tuberculosis H37Rv on Fas expression was also determined. Infection with H37Rv 
was found to decrease Fas expression at all time points assessed. Optimal expression of Fas 
was detected on days 5 and 6 of culture. The data are presented in Table 4.1, and indicate 
that a significant proportion of macrophages expressed the Fas receptor on their surfaces. 
Levels of Fas expression of >30% were detected after M. tuberculosis infection at day 5, the 
time point at which cytolytic assays were initiated, which indicated that macrophages were 
susceptible to the Fas-FasL-mediated cytolytic pathway. The role of this pathway in clone 












Table 4.1. Expression of Fas (CD95) on adherent macrophages. 




1 	 12.2 15.3 
2 	 24.3 22.5 
3 	 33.4 25.8 
4 	 41.2 30.5 
5 	 43.9 32.4 
6 43.5 31 .2 
Data illustrate the percentage of cells expressing Fas as determined by flow cytometry. 
Macrophages were assessed for Fas expression from 1 day up to 6 days after plating. The 
effect of infection of macrophages with H37Rv for 24 hours prior to assay time point is also 
indicated. 
4.3.4.2. Functional assessment of FasL expression on CTL clones 
FasL expression was demonstrated functionally by assessing the ability of the CTL clones to 
lyse Jurkat cells (Vergelli et al., 1997). Prior to these functional assays, the level of Fas 
expression on Jurkat cells was determined by flow cytometry following indirect labelling with 
anti-Fas. The level of Fas expression was 86 ± 11 % (n = 3). 
CTL clones showed strong cytolytic activity of 56-62% against the Jurkat target cells (Figure 
4.6.). Inhibition of Jurkat killing with anti-Fas blocking antibody (ZB4) was variable , with 
maximal blocking of lysis of 63% being observed with clone 15.3A at an effector to target ratio 
of 10: 1. The range of inhibition of cytolysis for all 3 clones was 52% to 63%. Pre-treatment of 
the clones with PMA and ionomycin did not Significantly affect the level of lysis observed, 
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Figure 4.6. Lysis of Jurkat cells by 3 CD4+ CTL clones , and the inhibitory effect of anti-Fas. 
Percentage specific lysis in the absence ( ..) and presence (e) of anti-Fas are illustrated . 
Data are representative of mean values of 3 experiments showing standard deviations 
4.3.4.3. Fas-mediated killing was not affected by EGTA or SrCh 
The effect of EGTA on clone 3.2D-mediated lysis of Jurkat cells was evaluated, and results 











Although treatment with SrCI2 showed optimal inhibition of lysis of macrophages by the CTL 
clones (Figure 4.5.), this agent had no effect on Fas-dependent Jurkat cell lysis. Taken 
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Figure 4.7. Effect of EGTA (- ) and SrCI2 (.6.) on lysis of Jurkat cells by CD4+ CTL clone 3.2D 
(+ ). Percent lysis was calculated after 16 hours. Spontaneous release of 51Cr was <20% in 
all experiments. Data represent mean values 3 experiments. (Error bars showing standard 
deviation omitted for clarity, at 10: 1 standard deviation was < 10% of the mean for all data 
points) 
4.3.5. Assessment of the contribution of the Fas pathway in CD4+ CTL clone-mediated 
lysis of macrophages 
Having shown target cell Fas expression and clone FasL expression , the contribution of Fas­
FasL interactions in CD4+ CTL killing of infected macrophages was assessed. The inhibitory 
anti-Fas monoclonal antibody (ZB4) was used to determine the level of Fas-FasL involvement 
in target cell death. The effect of binding of anti-Fas (ZB4) to macrophage Fas receptors on 
the cytotoxic activity of the CTL clones is presented in Figure 4.B. The functional activity of 
ZB4 was verified by examining its ability to block the ability of the pro-apoptotic CH-11 anti­
Fas antibody to induce macrophage apoptosis in the presence of CHX (Section 4.3.11). 
Levels of inhibition of lysis at a 10: 1 effector to target ratio varied between and 19% and 24% 
for the 3 clones illustrated. Maximal inhibition by anti-Fas (clone 10AC , 24A%) was 
significantly lower than inhibition by the various agents which block granule-mediated killing , 
No inhibition was observed when isotypic IgG1 control antibodies were added to the infected 
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Figure 4.8. Effect of anti-Fas antibody ZB4 (500ng/ml) on CTl clone-mediated lysis of 
H37Rv-infected macrophages. 3 clones are illustrated at 3 effector to target ratios. Data are 
representative of mean values of 3 experiments showing standard deviation. 
4.3.6. Inhibition of both granule exocytosis- and Fas-mediated pathways led to 
complete abrogation of macrophage lysis 
Detection of both granule- and Fas-mediated killing pathways in the CTl clones prompted an 
investigation into whether these two pathways accounted for all CTl cytolytic activity. 
Simultaneous inhibition of granule exocytosis and Fas-mediated killing by a combination of 
anti-Fas and SrCI 2 resulted in almost complete abrogation of clone cytolytic function as shown 
for clone 15.3A in Figure 4.9. This pattern of abrogation of cytolytic activity in the presence of 
these two agents was observed in all clones analysed (n = 6) , with mean levels of inhibition of 
cytolysis >93% consistently being detected. These data confirm that these two major 
mechanisms of lysis accounted for all c-rl-mediated lysis observed. TNF-a- and ATP­
mediated alternative pathways of cytolysis were also evaluated by the ability of inhibitory 














Figure 4.9. Effect of anti-Fas (500ng/ml) (- ), SrCI2 (25mM) (.A. ), and a combination of both 
(e ) on H37Rv-infected macrophage lysis by clone 15.3A (+ ). Mean percentage antigen­
specific lysis at 3 effector to target ratios is illustrated. Standard deviation values are shown 











4.3.7. CD4+ CTL clones were MHC class 11- (H LA-DR-) restricted 
CD4+ T lymphocytes are classically MHC class II-restricted. However, due to reports of 
mycobactericidal CD8+ CTL being CD1-restricted (Stenger et ai, 1997), the involvement of 
MHC class II-restricted antigen presentation was investigated. All the cytolytic CD4+ clones 
examined were MHC class 11-, HLA-DR-restricted in their activity. Mouse anti-human HLA-DR 
antibody (L243) was able to inhibit CTL clone proliferative responses to H37Rv by >96% (n = 
6). This complete abrogation of proliferation of the clones in the presence of L243 indicated 
that the clones were H LA-DR-restricted. No effect on clone proliferation was observed when 
an isotypic control (mouse IgG1) antibody was used. Since the clones were MHC class 11­
restricted, a role for CD1 molecules in clone activity was excluded. This was confirmed by an 
inability to detect CD1 molecules on M tuberculosis H37Rv-infected monocyte derived­
macrophages, even after treatment of macrophages with GM-CSF (4mM) and IL-4 (4mM), 
which has been reported to up-regulate CD1 expression (porcelli et aI., 1992). 
4.3.8. ATP and TNF-a were not components of CD4+ CTL clone killing machinery 
Both ATP (Zheng et aI., 1991; Blanchard et aI., 1995) and TNF-a (Laster et aI., 1988) have 
been implicated in the lysis of macrophages via induction of apoptosis. In addition, both these 
molecules have been implicated in apoptosis of mycobacteria infected macrophages 
(Lammas et aI., 1997; Keane et aI., 1997), and in mycobactericidal activity (Kindler et aI., 
1989; Bermudez and Young, 1992; Molloy et aI., 1994). The ability of ATP to induce apoptotic 
cell death in macrophages and to reduce l1ycobacterial viability has been confirmed in 
various experiments in the present study (Sections 3.3.1.,3.3.5., and 3.3.6.). In order to 
assess the contribution of these molecules in the mycobactericidal killing of the CD4+ CTL 
clones, inhibitors of both pathways (i.e. hexokinase and anti-TNF-a) were used. 
ATP was evaluated for its ability to lyse macrophages at various concentrations. Optimal 
induction of macrophage lysis (53 ± 5%) at a concentration of 2.5 mM was observed (Figure 
4.10). Hexokinase (Sigma) which catalyses the conversion of ATP to ADP was then assessed 
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Figure 4.10. ATP-mediated lysis of adherent (day 6) macrophages as determined by 51 Cr_ 
release. The level of lysis at various concentrations of ATP is illustrated (. ). The effect of 
hexokinase (2U/ml) on ATP-mediated lysis at the same concentrations is also indicated (- ). 
Optimal lysis was obseNed at an ATP concentration of 2.5mM. Data represent mean values 
of 3 experiments showing standard deviation 
Optimal inhibition of lysis (75%) induced by 2.5mM ATP was obseNed in the presence of 
2U/ml of hexokinase (53% lysis in the absence of kexokinase, reduced to 13% lysis). The 
same concentration of hexokinase was then used to determine whether ATP played any role 
in CD4+ CTL clone-mediated lysis (Figure 4.11). The figure illustrates the inhibitory effect of 
hexokinase on clone-mediated lysis of H37Rv-infected macrophages. No inhibition of clone 
mediated macrophage lysis was obseNed for any of the clones tested. The addition of 
hexokinase prior to the addition of clones to the CTL assays ensured inhibition of all ATP­
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Figure 4.11. Effect of hexokinase on clone 3.2D-mediated lysis of infected macrophages. 
Lysis in the absence of hexokinase (.A) was not inhibited by the addition of 2U/ml of 
hexokinase (_ ). Data are representative of mean values of 3 experiments showing standard 
deviation. 
Induction of macrophage lysis by TNF-a (Genzyme, Cambridge, MA, USA) was initially 
assessed at various concentrations. Optimal lysis was detected using 100ng/ml of TNF-a. 











antibody (Genzyme, Cambridge, MA, USA). Even though levels of lysis as determined by 
51Cr-release were poor (7 ± 4%), anti-TNF-a abrogated this lysis (down to 2 ± 3%, or mean 
inhibition of 71 %). The low levels of induction observed suggested minimal involvement of 
TNF-a in macrophage lysis. The low level of susceptibility of infected macrophages to TNF-a 
may have been due to low receptor expression. Alternatively, infected macrophages may 
have secreted soluble TNF receptors, which would have abrogated any TNF-a-mediated 
effects. Due to the low level of detection of TNF-a killing , additional experiments were 
carried out using U937 cells which are susceptible to TNF-a-induced apoptosis. TNF-a was 
able to cause lysis of 42 ± 6% of these cells . In the presence of anti-TNF-a only 12 ± 5% of 
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Figure 4.12. TNF-a-mediated lysis of adherent macrophages and U937 cells. Blue bars 
illustrate the level of 51Cr-release in the presence of 100ng/ml of TNF-a . Green bars illustrate 
the level of 51Cr-release with the addition of 1J.!g/ml of anti-TNF-a monoclonal antibody. Data 
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Figure 4.13. The effect of anti-TNF-a monoclonal antibody blocking on the level of 
macrophage killing mediated by clone 14.10C. Lysis in the absence of anti-TNF-a (+ ) was 
not significantly affected by the addition of 1 J.!g/ml of anti-TN F-a (- ). Data represent mean 











Confirmation that TNF-a did not playa significant role in clone-mediated killing was obtained 
by the inability of anti-TNF-a to affect clonecmediated lysis of macrophages The effect of 
anti-TNF-a on the cytolytic activity of clone 1410C is illustrated in Figure 4.13. Maximal 
inhibition of clone-mediated lysis of 9% at an effector to target ratio of 10 1 was detected. 
Similar data were generated from all the clones examined (n = 4), with maximal inhibition 
consistently < 10% The protein synthesis inhibitor, cycloheximide, enhanced the level of 
cytolysis of infected macrophages induced by ATP, TNF-a, and the CTl clones. These 
findings are discussed in Section 4.3.11. 
4.3.9. Both granule- and Fas-mediated pathways contributed to mycobactericidal 
activity of the clones 
Investigation of the mechanism of killin g employed by the CTl clones indicated that both 
Ca2+-dependent granule exocytosis and Fas-Fasl pathways were employed in the lysis of 
infected macrophages. It was therefore important to establish whether one or both of these 
pathways was responsible for the reduction in viable mycobacteria. The contribution of each 
cytolytic pathway in mycobactericidal activity of the clones was examined using the same 
inhibitory agents described above 
Table 4.2 summarises the effect of inhibition of clone-mediated macrophage lysis by various 
agents as well as the associated inhibition of mycobactericidal activity of the clones. Four 
clones are illustrated, data representing mean values of 6 experiments including standard 
deviation. The data summarised in this table is presented in graphic form in Figure 4.14. 
Table 4.2. levels of lysis of infected macrophages by 4 CD4+ CTl clones (% killing) in the 
presence or absence of 5 inhibitory agents. The simultaneous reduction in CFU counts (% 
CFU J..) is also shown The level of abrogation of both macrophage lysis and CFU reduction 
in the presence of the inhibitory agents is indicated by the percentage values in parentheses 
No GsA GMA SrGI2 aFas BFA 
Inhibitor (500ng/ml) (100nM) (25mM) {O.5l!:s/ml} (1O/lM) 
3.2D % Killing 34±7 10±6 17±6 8±5 26±6 6±3 
(70%) (50%) (76%) (24%) (82%) 
% CFU J.. 42±7 8±6 7±4 7±3 31±7 1±9 
(81%) (83%) (83%) (26%) (98%) 
10.4G % Killing 44±6 26±9 33±5 10±4 34±7 3±2 
(41%) (25%) (77%) (23%) (93%) 
% CFU J.. 31±6 14±3 13±4 4±4 24±4 3±7 
(55%) (58%) (87%) (23%) (90%) 
14.10G % Killing 39±6 20±7 25±6 9±4 30±5 2±2 
(49%) (36%) (77%) (23%) (95%) 
% CFU J.. 37±7 13±7 10±5 5±5 27±6 -3±10 
(65%) (73%) (86%) (27%) (100%) 
15.3A % Killing 35±8 11±7 16±4 7±3 28±5 0±2 
(69%) (54%) (80%) (20%) (100%) 
% CFU J.. 38±6 7±5 9±6 5±4 25±6 -12±14 











Inhibition of either Fas-, or granule-mediated pathways, led to a reduction in the level of 
mycobacterial killing . The mean levels of inhibition of CTL clone-mediated lysis of infected 
macrophages by cyclosporin A, concanamycin A and SrCI2 for the 4 clones illustrated was 
56%, 40% and 78%, respectively . This inhibition of macrophage lysis was accompanied by 
mean levels of abrogation of CFU reduction of 69%, 71 %, and 85%, respectively . Mean 
inhibition of macrophage lysis by anti-Fas was 22%, which was accompanied by a mean 
abrogation of CFU reduction of 29%. Brefeldin A, which inhibits target cell apoptosis, 
resulted in mean inhibition of macrophage lysis of 91 %. This inhibition resulted i .. a mean 
abrogation of CFU reduction of 95%. 
The level of inhibition of macrophage cytolysis correlated positively with the level of inhibition 
of CFU reduction for all 5 inhibitors (r =+0.994 for CsA; r =+0.925 for CMA; r =+0 .661 for 
SrCI2; r = +0.169 for aFas; r =+0.787 for BFA) This indicates that levels of CFU reduction 
were directly linked to levels of macrophage lysis. The hierarchy of inhibition of macrophage 
cytolysis (BFA > SrCI2 > CsAlCMA > anti-Fas ) was mirrored in the degree of abrogation of 
mycobacterial killing caused by the specific inhibitors. This finding is illustrated in Figure 
4.14. 
Inhibition of both cytolytic pathways (in clone 15.3A) by co-administration of anti-Fas and 
SrCI 2 led to inhibition of macrophage lysis of 96 ± 3%. This was accompanied by an 
abrogation of CFU reduction of 97 ± 2%. The two major pathways of cytolysis therefore 
accounted for all the clone-mediated cytotoxic activity and all the associated 
mycobactericidal activity . Brefeldin A inhibition of target cell lysis resulted in similar levels of 
abrogation of both macrophage and mycobacterial death . 
Box-and-whisker plots summarising the data generated using the inhibitory agents are 
presented in Figure 4.14 . The median % specific lysis and % CFU reduction values of 6 
clones are illustrated . The box indicates values within the 25th and 75th percentage , with 
min imum and maximum values being covered by the error bars. 
4.3.10. CD4+-enriched EMNC and PBMNC lines also possess dual killing mechanisms 
In view of the striking difference in mycobactericidal activity of the cytolytic CD4+-enriched 
PBMNC line as compared to the EMNC line (chapter 3), the mechanism of killing was 
compared . CD4+-enriched lines were used to exclude any non-CD4+-mediated cytolytic 
activity . Table 4.3. summarises the effect of various inhibitory agents on macrophage lysis 
mediated by both the EMNC- and PBMNC-lines. Granule exocytos is predominated in the 
EMNC line, and Fas-mediated killing in the PBMNC line, however both lines possessed both 
mechanisms of killing as observed with the clones . Mean inhibition of EMNC-mediated 
macrophage lysis by granule exocytosis inhibitors ranged from 56-64%, with mean inhibition 











61 %), with the granule exocytosis component accounting for 36-43% of the line killing. Thus, 
EMNC and PBMNC lines, enriched for CD4+ lymphocytes, possesed dual killing 
mechanisms. While the EMNC line appeared to posses a larger component of granule­
mediated killing , the opposite was true for the PBMNC line. In both cases, inhibition of 
granule-mediated- and Fas-FasL-kiliing accounted for all the cytolytic activity of the lines. 
The difference in mycobactericidal activity of the two lines (EMNC vs. PBMNC) may be 
related to differences in the components of the granules themselves, or in events linked to 
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Figure 4.14. Box and whisker plots of effect of inhibitory agents on CTL-mediated lysis of 
macro phages and on CFU reduction . A. Effect of the inhibitory agents on cytolytic activity of 
6 clones. B. Effect of the inhibitory agents on the mycobactericidal activity of the clones, 











Table 4.3. Levels of antigen-specific lysis of H37Rv-infected macrophages by C04+­
enriched EMNC and PBMNC lines. The effect of inhibition by 4 agents is also indicated The 
percentage reduction of lysis in the presence of the inhibitory agents is indicated in 
parentheses. Data are representative of mean values of 3 experiments showing standard 
deviations 

















4.3.11. Cycloheximide enhanced killing of macrophages by the CTL clones, TNF-a and 
anti-Fas 
Since cycloheximide has been reported to enhance lysis of macrophages and associated 
mycobactericidal activity mediated by soluble FasL (Oddo et aI., 1997), the effect of CHX on 
clone-, TI\lF-a- and anti-Fas-mediated lysis of macrophages was investigated. CHX was 
found to enhance the level of macrophage killing induced by the clones, as well as lysis 
mediated by TNF-a, and the anti-Fas pro-apoptotic antibody (CH-11). The effects of CHX on 
clone macrophage lysis following exposure to CTL clone 3.20, Tt\IF-a or anti-Fas are 
presented in Figure 4.15. 
1 mM CHX was found to enhance lysis following all treatments. For both TNF-a and anti-Fas, 
CHX treatment enhanced the level of macrophage lysis from <10% to >30%. The 
enhancement of clone killing was less dramatic, however mean lysis increased from 33% to 
46% for clone 3.20. CHX has been reported to inhibit the anti-apoptotic proteins such as bcl­
2 (Weil et aI., 1996), and the increased level of killing in the presence of CHX may be 
attributable to inhibition of such inhibitory influences. 
CHX treatment was also found to enhance the mycobactericidal activity of the clones. Figure 
4.15.(B) illustrates how CHX treatment resulted in enhancement of both TNF-a- and anti­
Fas- mediated mycobactericidal activity. Percentage reduction in CFU counts caused by 
TNF-a-mediated macrophage lysis increased from 3 ± 5% to 22 ± 9%. The reduction in CFU 
counts resulting from anti-Fas induced macrophage lysis increased from -3 ± 5% to 25 ± 
11 %. The mycobactericidal activity of the clone (3.20) was enhanced moderately in 
comparison, from 42 ± 9% to 50 ± 10% The level of enhanced mycobactericidal activity for 
these three treatments was proportional to the level of increase of macrophage lysis. This 
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Figure 4.15. Effect of cycloheximide on lysis of macrophages by cytolytic clone 3.20, anti­
Fas and TNF-a (A). Lysis in the absence of CHX, but in the presence of the clone (E:T 
10:1), anti-Fas (0.5Jlg/ml) , or TNF-a (100ng/ml) is shown by the blue bars. The addition of 
CHX (1 mM) enhanced the level of macrophage lysis in all three situations (red bars) . 
Enhancement of macrophage killing by CHX also resulted in an increase in CFU reduction 
(S.). CFU reduction in the absence of CHX (blue bars), was enhanced in all three situations 
following CHX treatment (red bars) . Data represent mean values of 3 experiments and 












This chapter investigated the mechanism of killing employed by the effusion-derived 
mycobactericidal CD4+ CTL clones. In addition the killing mechanisms of CD4+-enriched 
lines derived from peripheral blood and pleural fluid were also investigated to determine 
whether any particular cytolytic pathway was associated with the reduction in numbers of 
viable mycobacteria. All cytolytic CD4+ T lymphocyte populations assessed in this study 
possessed both granule-dependent and Fas-FasL-mediated mechanisms for killing of 
infected macrophages. An important distinguishing featu;e of the mycobactericidal clones 
and line was the predominance of the Ca2+-dependent granule exocytosis cytolytic pathway. 
This finding suggests that at the site of infection cytolytic CD4+ T lymphocytes acquired a 
predominant granule-mediated cytolytic pathway which was directly involved in the killing of 
intracellular mycobacteria. 
The importance of CD4+ lymphocytes in control of M. tuberculosis infection is undisputed 
(Kaufmann and Andersen, 1998). These cells are expanded at sites of disease and loss of 
CD4+ cefls in AIDS patients correlates with susceptibility to TB (Barnes et aI., 1989; 1991). 
In addition, the absence of functional CD4+ cells in mice results in rapid disease progression 
and death (Pedrazzini et aI., 1987; Ladel et al., 1995). Protective immunity can be 
transferred from one animal to another by immunocompetent CD4+ T cells (Orme and 
Collins, 1984). Functionally, CD4+ T cells are thought to contribute to protection against M. 
tuberculosis by antigen-specific production of cytokines which activate macrophages to kill 
intracellular mycobacteria (Orme et aI., 1993). Of particular importance is the cytokine IFN-y 
which appears to be a crucial effector molecule in both mice and humans (Flynn et al., 1993; 
Newport et al., 1996). Activation of infected macrophages by I FN-y is thought to be a pivotal 
step in clearance of infection (Barnes et aI., 1994). Although the activation of macrophages 
is sufficient for infection clearance in mice via the activation of reactive nitrogen 
intermediates (Rook et al., 1986a; Chan et al., 1992; Sypek et al., 1993), conclusive 
evidence that this occurs in humans has not been forthcoming (O'Brien et aI., 1996). Indeed, 
a recent report has indicated that both IFN-y and primed lymphocytes are necessary for 
induction of macrophage anti-mycobacterial activity (Bonencini-Almeida et aI., 1998). In the 
absence of conclusive proof that CD4+ T cell-derived cytokines such as interferon-y can 
activate macrophage mycobactericidal activity, cytolytic activity of CD4+ cells remains a 
viable alternative mechanism for control of organism replication and spread. 
The occurrence of antigen-specific CD4+ cytolytic T lymphocytes in tuberculosis has 
previously been described (Ab et aI., 1990; Ottenhoff and Mutis, 1990; Lorgat et al., 1992a; 
Tsukaguchi et al., 1995; Oftung et al., 1998). The relevance of the cytolytic effector 
mechanism in vivo has, however, remained elusive. The recent description of MHC class 11­
restricted CD4+ CTL isolated from BAL fluid may indicate the importance of such cells at the 











described (Ab et al., 1990), subsequent reports indicated that cytolytic CD4+ T lymphocytes 
had no effect on viability of intracellular mycobacteria (Fazal et al., 1995; Pithie et al., 1995). 
Recently, however, it has been. demonstrated that co-incubation of CD4+ T cells with 
infected monocytes led to a reduction in numbers of viable mycobacteria (Silver et aI., 1998; 
Yoneda and Ellner, 1998). Soluble factors could only partially account for this anti­
mycobacterial activity, suggesting that contact-dependent processes were important. This 
contact-dependent activity may involve CD4+ T cell-mediated macrophage lysis These 
findings taken together implicate cytolytic activity of CD4+ cells in localised conta:nment of 
infection. 
Although Fas-FasL interaction is considered the predominant mechanism of killing employed 
by CD4+ CTL (Trapani, 1998), recent reports have shown that these cells can kill by either 
Fas-FasL interaction, or granule exocytosis, or a combination of both pathways (Vergelli et 
aI., 1997; Sevilir-Williams and Engelhard, 1996; Lewinsohn et al., 1998). The cytolytiC 
granule-mediated pathway has been described in an allogeneic-responsive CD4+ CTL, and 
also in PPD-specific CD4+ CTL (Sevilir-Williams and Engelhard, 1996; Lewinsohn et al., 
1998). The description of mycobacterial antigen-specific CD4+ CTL which possess granule­
mediated killing mechanisms raises the possibility that this unique pathway may mediate 
important in vivo antimycobacterial activity. 
The majority of reports describing CTL which were able to effect a reduction in 
mycobacterial viability have focused on CD8+ CTL. Although HLA-DR-restricted CD4+ CTL 
have been shown to reduce viable intracellular mycobacteria (Ab et al., 1990), subsequent 
reports refuting this finding have resulted in a shift of focus onto CDB+ CTL. Murine CD8+ 
CTL have been reported to directly reduce infecting organism viability on lysis of bone 
marrow-derived macrophages. This study did not address the mechanism of killing 
employed by the CTL (De Libero et al., 1988). Human MHC class I-restricted CD8+ CTL 
which possess mycobactericidal activity have also been reported, however the mechanism 
of killing was not characterised in any detail (Lalvani et al., 1998). By far the best 
characterised mycobactericidal CTL activity has been that of CD1-restricted CD8+ cells 
(Stenger et al., 1997, 1998). These CTL killed infected macrophages exclusively by cytolytic 
granule release. The mycobactericidal activity of these cells was linked to a particular 
granule component - granulysin. Although these findings have important implications 
regarding CD8+ activity in TB, induction of CD1 expression on macrophages requires in vitro 
stimulation of these cells. Whether this pathway is of major significance in vivo has yet to be 
established. 
Not all triggers of cell death result in reduction of organism viability. Neither induction of 
necrotic cell death by high dose H20 2 (Molloy et aI, 1994), nor osmotic lysis (present study), 












accompanied by killing of intracellular organisms. Lysis of infected macrophages by T 
lymphocytes has been reported to be ineffective in reducing mycobacterial viability. This 
phenomenon has been observed with both CD4+ and CD8+ CTL (Fazal et al., 1995; Pithie 
et al., 1995; Stenger et aI., 1997). Studies on the effect of CD4+ CTL on mycobacterial 
viability did not address the mechanism of killing employed by the cells. Non­
mycobactericidal CD8+ cells killed infec~ed macro phages by Fas-FasL interaction. These 
findings indicate that the mechanism of killing employed by CTL may be important in 
determing mycobactericidal potential. 
The kinetics of ClL killing of macrophages (discussed in chapter 3) indicated that secondary 
necrosis or other late events of macrophage death could be important for maximising the 
reduction in organism viability (Laochumroonvorapong et aI., 1997). However, since all 
apoptotic cell death results in secondary necrosis, this process itself is unlikely to account for 
all mycobactericidal activity. Rather, it appears that the efficacy of late apoptotic events may 
depend on the triggering of certain anti-mycobacterial processes when apoptosis is induced. 
The strong correlation between level of killing of macrophages and reduction in organism 
viability by the CTL clones suggests that pathways linked to induction of apoptosis effect 
killing of mycobacteria. 
Although only granule exocytosis killing has been linked to CTL-mediated reduction of 
organism viability, it has been suggested that Fas-mediated killing may potentially be equally 
mycobactericidal (Kaufmann, 1999; Oddo et al., 1998). Induction of infected macrophage 
apoptosis in vitro by soluble FasL has been shown to be mycobactericidal. However, this 
reduction in numbers of viable mycobacteria occurred in the absence of any CTL. In addition 
optimal reduction in organism viability was only possible in the presence of cycloheximide. 
This suggests that under normal in vivo situations this Fas-pathway may be less important in 
organism clearance at the dis'ease site than granule exocytosis. Additional pro-apoptotic 
signals have also been linked to mycobacteridal activity. These include apoptosis induced by 
ATP, H20 2 and TNF-a (Lammas et aI., 1997; Laochumroonvorapong et al., 1997; Keane et 
al., 1997). This suggests heterogeneity in the apoptosis pathway, with mycobactericidal 
activity being dependent on the type and/or intensity of the apoptotic signal as well as the 
possible interference by anti-apoptotic proteins. The in vivo relevance of mycobactericidal 
apoptosis induced by agents such as ATP is still being investigated. Levels of ATP produced 
by T lymphocytes are much lower than doses required for induction of apoptosis (Zheng et 
al., 1991; Blanchard etal., 1995). 
The present study implicates granule-mediated killing of CD4+ T lymphocytes in 
mycobactericidal activity, and therefore in localised control of infection. Although the 
importance of CTL in control of viral infections is well established, the activity of these cells 












difficulty in conclusively proving that CTL are essential in protective immunity is due to the 
multiple cell types which mediate cytotoxicity coupled with multiple cytolytic pathways. No 
conclusive demonstration of the importance of CTL in the control of intracellular infection has 
been possible since elimination of all cytolytic cells and/or pathways would be catastrophic 
for the host. Studies with gene knockout mice have indicated that loss of either major 
cytolytic pathway had no significant effect on disease outcome. These studies have raised 
important questions as to the importance of cytolytic T cells in protective immunity in TB. 
Geno knockout mice lacking functional Fas, granzyme Band perforin have been examined 
(Laochumroonvorapong et a/., 1997; Cooper et a/., 1997), and in no case was disease 
susceptibility significantly affected. Although these findings appear to minimise the 
importance of CTL in tuberculosis, none of these gene deletions could successfully account 
for all cytolytic activity in the host animal. Loss of Fas-mediated killing 
(Laochumroonvorapong et a/., 1997) does not preclude the activity of granule-exocytosis. 
Likewise, perforin or granzyme B knockout mice (Cooper et a/., 1997; 
Laochumroonvorapong et a/., 1997) still retain functional Fas-mediated activity. In any of 
these models, cytolytic activity is not completely destroyed. Deletion of both Fas and 
perforin, results in death from excessive macrophage expansion and pancreatitis 
(Spielmann et a/., 1998). This has prevented detailed assessment of absence of cytolytic 
activity in tuberculosis. Due to the importance of granule exocytosis in mediating 
mycobactericidal effects as observed in the present study and others, the deletions of genes 
coding for perforin and granzyme B are of particular importance. Although the finding that 
loss of either of these proteins did not affect disease susceptibility appears to minimise a 
role for granule-mediating killing in disease control, compensatory pathways may have 
resulted in functional granule-mediated killing being unaffected. Granzyme A, or additional 
granule constituents such as granulysin, could compensate for loss of granzyme B. Perforin 
is primarily involved in granzyme release, activation and transport within the target cell 
(Trapani and Jans, 1999). Its importance for activation of other granule constituents (e.g. 
granulysin) is not known. In addition, alternative entry and activation pathways for cytolytic 
granule constituents may exist, minimising the importance of perforin as an essential 
component of granule-mediated killing. 
The importance of the localised disease site in containment of infection has been highlighted 
by the ability of only effusion-derived cells to mediate mycobactericidal activity. This activity 
is most dramatically associated with a predominant granule exocytosis mechanism of killing. 
CD4+ T cells possessing such a predominant granule-mediated killing mechanism may have 
evolved to control intracellular bacterial infections, similar to the activity of CD8+ CTL in the 
control of viral infection (Trapani, 1998). The generation of CD4+ CTL in the absence of 
functional CD8+ CTL which possess cytolytic granule components has been implicated in 
mediating acquisition of the granule-pathway in CD4+ CTL (Sevilir-Williams and Engelhard, 











antigen may occur in the absence of any significant expansion of CD8+ CTL. The absence 
of antigen-specific CD8+ CTl could somehow be envisaged to stimulate production of 
cytolytic granule components in the CD4+ T cells. 
A major debate in TB has revolved around whether lysis of infected macrophages leads to 
containment or spread of infection. The current study indicates that the former option is 
likely. Only in the absence of any mycobactericidal activity occurring at the time of host cell 
death would spread become a problem. The localised disease site appears to prime for the 
development of granule-mediated cytolytic celis, and the granule constituents thel"flselves 
may mediate organism killing. Only by killing the host cell, depriving the organisms of their 
protected niche, and exposing them to potent lytic agents such as granulysin, can the 
infection be controlled. These findings have important implications for possible future 
therapies, in that enhancement of the cytolytic activity may lead to rapid and efficient 
disease clearance. Further characterisation of particular antigenic proteins that stimulate 
CD4+ CTl is of great importance in the development of DNA-based vaccines. Introduction of 
immunogenic proteins that induce CD4+ T cells which produce cytokines and mediate 
mycobactericidallysis of infected macrophages, is likely to result in protective immunity. 
The CD4+ CTl clones in the present study are derived from a disease associated 
pathological site, and may thus closely approximate CTl activity in-vivo. The clones were 
generated from an effusion mononuclear cell population using live, virulent M. tuberculosis 
as antigen and autologous macrophages as antigen presenting cells. In addition the cells 
were MHC class II-restricted and infected macrophages did not require manipulation such as 
cytokine activation or cycloheximide treatment in order for any mycobactericidal activity to be 
detected. Reports which indicated that CD4+ CTl were not mycobactericidal used clones 
which were derived from peripheral blood of healthy donors, M. bovis BCG was used as 
antigen, and HlA-matched donor macrophages were used as antigen presenting cells 
(Fazal et al., 1995; Pithie et al., 1995). Although the mechanism of killing of the cells in these 
studies was not addressed, it is likely that Fas-Fasl interactions predominated. The current 
study has also found that peripheral blood-derived CD4+ CTl, which utilised a predominant 
Fas-Fasl pathway, were not mycobactericidal. This contrasts with effusion-derived cells 
which possessed predominant granule-mediated killing pathways and which were 
mycobactericidal. The requirement for granule constituents indicates some similarities with 
mycobactericidal CD8+ CTL. Whether the mycobactericidal activity of the CD4+ CTl was 
dependent on the occurrence of a predominant granule-mediated pathway, or ~n the 
presence of a particular cytolytic granule constituents at an elevated concentration will need 
to be addressed in subsequent studies. 
The findings of the present study have important implications in the understanding of 












CD4+ T lymphocytes, which can kill infecting mycobacteria, could aid in the rapid clearance 
of pathogenic organisms. This activity would account for the contact-dependent activity of 












A .non-cytolytic CD8+ effusion-derived T lymphocyte clone mediates 
suppression of autologous T lymphocyte proliferation 
5.1. Introduction 
Several features of immune suppression or hyporesponsiveness have been observed in 
patients with active tuberculosis. These features include depressed tuberculin skin test 
reactivity, decreased proliferative responses to Mycobacterium tuberculosis antigens, and 
suppression of the production of the cytokines IL-2 and interferon-y (Toossi and Ellner, 
1996). The cause of immune suppression in active TB is not known, however several 
possible mediating factors have been proposed. By far the best characterised has been the 
production of immunosuppressive cytokines by both macrophages and T lymphocytes. 
Exposure of mononuclear cells to mycobacterial components results in enhanced production 
of IL-4 and IL-6, both of which suppress the production of Th1 cytokines (Wadee et al., 
1993). Similarly, infection of macrophages with M tuberculosis results in production of IL-6 
which suppresses T cell proliferation and IL-2 production (van Heyningen et al., 1997). TGF­
Pproduction by macro phages has also been implicated in immunosuppression (Hirsch at al., 
1996). TGF-f3 inhibits lymphocyte proliferation, down-regulates macrophage effector 
functions and promotes fibrosis (Wahl, 1992). The T lymphocyte-derived cytokine IL-4 and 
the macrophage-derived cytokine IL-10 have both also been directly implicated in inhibition 
of T cell responses to mycobacterial antigens (Sieling et al., 1993). 
The frequency of the two major components of immunosuppression (decreased tuberculin 
reactivity and depressed lymphocyte responses) correlates with the spectrum of clinical 
disease. In pulmonary TB 17-25% of patients are PPD skin test unresponsive (Daniel at al., 
1981). Low blastogenic responses are present in 40-60% of patients, which includes almost 
all skin test negative and some skin test positive patients (Kleinhanz and Ellner, 1987). In 
disseminated (miliary) TB, 50-75% of patients are skin test non-responsive, and low 
blastogenic responses are common (Bhatnagar at al., 1977). Both skin test anergy and 
lymphocyte responses to PPD vary according to mycobacterial load and/or the extent of 
pathology at the site of disease (Toossi at al., 1986). In pulmonary TB advanced disease is 
accompanied by higher frequency of skin test negativity as well as very low blastogenic 
response to PPD. 
The fact that depression of M tuberculosis-induced T cell responses is not only immediate 
(at time of infection), but also protracted (for several months after infection), suggests that 












1997; Hirsch at al., 1999). Alternative explanations of suppression of immune 
responsiveness have included enhanced levels of apoptosis in responder T cells (Hirsch at 
al., 1999), and compartmentalisation of antigen-specific T cells to disease sites (Dieli at aI., 
1999). In addition, both anergic :r cells and antigen-specific suppressor T lymphocytes are 
able to mediate inhibition of T lymphocyte responses. Although the activity of these cells has 
been noted in experimental systems and certain other diseases, no detailed characterisation 
of the activity of either of these cells in TB has been reported. Although the activity of 
suppressor T lymphocytes in this disease has previously been noted (Kleinhanz and Ellner, 
1987), no detailed assessment of functional activity has been possible due to the inability to 
generate clones of M. tuberculosis-specific suppressor T cells. The existence of suppressor 
cells could provide an alternative explanation for immune suppression in TB. T cell-mediated 
suppression may involve the production of immunosuppressive cytokines, or direct 
interference in responder T cell functioning via disturbances to normal signal transduction 
pathways, resulting in induction of anergy or non-responsiveness. 
Studies of effusion mononuclear cell activity in tuberculous pleuritis have shown that 
protective immunity in TB correlates with CD4+ Th1 memory T cell activity. (Lukey et al., 
1998). Severe pulmonary disease resulting in miliary TB, on the other hand, has been found 
to correlate with depressed responsiveness and possible type-2 cytokine predominance 
(Dlugovitzky et aI., 1999). This dichotomy is more pronounced in leprosy where distinct 
polarisation of disease outcome is observed. Protective immunity, which is associated with a 
strong Th1-type cellular immune response, results in the manifestation of the tuberculoid 
form of leprosy. The lepromatous form of the disease, on the other hand, has been linked to 
predominance of a type-2 response. Thus, a switch from a type-1 to a type-2 predominance 
has a profound effect on disease outcome (Bloom et al., 1992). Both CD4+ and CD8+ M. 
leprae antigen-specific suppressor T cell lines and clones have been isolated from the 
lesions of lepromatous leprosy patients. These cells produce type-2 cytokines, and the 
CD8+ suppressor T cells are uniquely MHC class II-restricted. These cells are able to inhibit 
or suppress autologous PBMNC or PBMNC-derived clone prOliferation. These findings have 
implicated the activity of such suppressor cells in the inhibition of protective Th1 responder 
cell activity (Salgame et al., 1991 b). This would allow for the enhancement of a type-2 
response as observed in the lepromatous form of the disease. 
Extrapulmonary TB resulting in an effusion offers a unique opportunity to obtain a window to 
the site of active pathology. Compartmentalisation of PPD CD4+ proliferative and cytotoxic 
responses in the mononuclear population of the effusion has been described (Barnes et al., 
1989; Lorgat et al., 1992). Although CD4+ cell numbers, and their functional activity, are 
increased at sites of disease, evidence exists that other cell types such as CD8+ T cells also 
playa role (Orme, 1993). The activity of T lymphocytes in tuberculous effusions is in itself 











of T cells to mycobacterial antigen is a feature of the majority of effusion-derived 
populations. However, both non-accelerated and "flat" in vitro responses have also been 
observed (Lukey et a/., 1996; 1998; Lorgat et aI., 1992b). This is suggestive of suppression 
that may be mediated by the other cell populations within the effusion which are not 
components of protective immunity. 
In this chapter a C08+ T cell clone derived from a pleural effusion was shown to mediate 
supprBssion of T cell responses in vitro. The clone produced IL-4, was poorly responsive to 
mycobacterial antigens and did not display any antigen-specific cytolytic activity. The clone 
was MHC class 11- (DR) -restricted and did not express the C028 co-receptor. This clone 
was able to suppress the proliferation of type-1 C04+ clones, as well as PBMNC cells. This 
active suppression was mycobacterial antigen-specific, dependent on contact between 
suppressor and responder celis, and partially mediated by the type-2 cytokines IL-4 and IL­
10. The activity of suppressor T cells may help to explain the unusual response kinetics and 
LOA data of the ex vivo-derived patient cells used in the study. In addition the activity of 
suppressor T cells may help to explain certain of the immunosuppressive features observed 












5.2. Materials and methods 
5.2.1. Generation and maintenance of a CD8+ T cell clones 
CD8+ T lymphocyte clones were generated by limiting dilution as described in Chapter 2. 
EMNC (1 Oml of 1 06/ml ) were cultured together with M. bovis BCG (105 CFU/ml) at 37°C for 7 
days, and then for an additional 3 days with 100 IU/ml recombinant human IL-2 (Cetus, 
Emeryville, USA). The CD8+ cells were purified by magnetic bead separation (Minimax, 
Miltenyi Biotec, Bergisch Gladbach, Germany) as described. Population purity was assessed 
by flow cytometry prior to clor.ing. The CD8+ fraction of antigen-primed EMNC cells was 
then cloned by limiting dilution at ratios of 1 and 0.3 cells per well. Cloning was carried out in 
RPMI 1640 medium (Flow Laboratories) to which the following were added: 2mM L­
glutamine (Highveld Biologicals, Johannesburg, SA), 10mM non-essential amino acids 
(Highveld Biologicals, Johannesburg, SA), 5x10,sM 2-mercaptoethanol (BDH Chemicals, 
England), 1 mM Sodium Pyruvate (Highveld Biologicals, Johannesburg, SA). This cloning 
medium was supplemented with 10% autologous human serum. Autologous feeder cells 
(PBMNC) were prepared, diluted to a concentration of 106/ml and irradiated at 40 Gray. M. 
bovis BCG was added to the feeder cells at a ratio of 10 bacteria per cell (107CFU/ml) 
together with 100 IU/ml recombinant human IL-2 (Cetus). Aliquots (20/-11) of feeder celis were 
plated into Terasaki well plates (Becton-Dickinson, Mountain View, CA) using a multi­
channel microdispenser (Titertek). The T-cells (EMNC) were then plated (20IlI) into the wells 
containing feeder cells at ratios of 1 and 0.3 cells per Terasaki well. Each well contained a 
final volume of 40 /-II. Plates were wrapped in foil and sterile distilled water added to each 
package to ensure minimal evaporation of well contents. Plates were incubated at 37°C in a 
5% CO2 incubator. After 10 days the plates were assessed for growth by examining well 
contents using an inverted microscope, The contents of the wells showing positive growth 
were expanded into 96-well round-bottomed plates (Greiner) containing freshly prepared 
feeder cells (irradiated PBMC), BCG and rIL-2. Following further expansion into 24-well 
plates (Becton-Dickinson) clones were phenotypically assessed by flow cytometry and they 
were screened for proliferative responses (3H-thymidine incorporation) and cytotoxic function 
(
51 Cr-release). Aliquots (1-5 x 106) were cryopreserved in human AB serum containing 10% 
DMSO (Merck, Darmstadt, Germany) and stored in liquid nitrogen. 
The CD8+ clones grew slowly and it was difficult to obtain sufficient cell numbers for detailed 
characterisation and cryopreservation. Several clones died before characterisation was 
possible. Due to the slow growth rate of the CD8+ clones and their poor proliferative 
responses to mycobacterial antigens, cells were passaged by alternate stimulation with the 
mitogen PHA and M. tuberculosis H37Rv. Clones were maintained in culture by weekly 
restimulation with fresh autologous irradiated APC's (PBMNC), antigen or mitogen (M. 
tuberculosis H37Rv (2 x 105 CFU/ml) or PHA (5,75 x 10.3 mitogenic units/ml)) and IL-2. After 












Five CD8+ clones were generated, however only 2 could be maintained and expanded for 
further characterisation. These were clones 11.SA and 2.9D. Both these clones were 
phenotypically characterised by flow cytometry, and they were analysed for their cytokine 
production profile. 
5.2.2. Phenotypic characterisation and cytokine production profile of the CD8+ clones 
The 2 CD8+ clones were phenotyped by flow cytometric analysis of monoclonal antibody­
labelled cells. Markers used for phenotyping included~ CD3, CD4, CD8, and CDS6 (see 
section 4.*) Clone cells (100fll of 106/ml) were incubated for 10 minutes with Sfll of FITC­
labelled monoclonal antibody (Coulter), or with isotypic controls (FITC-Iabelled mouse anti­
human IgG1}(Coulter, Hileah, CA). Cells were fixed prior to flow cytometry by the addition of 
100fli of freshly prepared 1% paraformaldehyde (Merck, Darmstadt. Germany). Flow 
cytometry was carried out using a Coulter Epics Profile II flow cytometer. 
The cytokine production of the clones was assessed by analysis of clone-derived 
supernatant fluid. Initial characterisation of clone cells into type-1, type-2 or type-O was 
based on levels of IFN-y and IL-4 production. Clones were later also assessed for the 
production of IL-S, IL-10. and TGF-~. Supernatants were generated following antigen 
stimulation in the absence of IL-2. Feeder cells (irradiated PBMNC) were prepared and 
diluted to 106/ml. Clone cells (1ml of 106/ml) were then added to SOOfll of feeder cells and 
105SOOfll of antigen (H37Rv at 2 x CFU/ml) in 24 well plates (Becton-Dickinson). 
Supematants were removed after 48 hours of incubation at 37°C. Supernatants from wells 
containing feeder cells and antigen but no clone cells were also collected. Supernatants 
were filtered through 0.2~ syringe filters to remove any mycobacteria. Aliquots (1 ml) were 
frozen at -20°C. 
Commercial ELISA kits were used for cytokine detection. These included kits for IFN-y, IL-4, 
IL-S, IL-10 (all Pharmingen), and TGF-~ (Promega). All ELISA tests were performed 
according to manufacturer's instruction (see section 2.2.8). For TGF-P. supernatants were 
acid activated by treatment with 0.1 N HCI. TGF-p levels in un-activated and activated 
samples were compared. 
5.2.3. Proliferative and cytotoxic activity of CD8+ clones 
CD8+ clones were assessed for their proliferative responses to various mycobacterial 
antigens (PPD, M. bovis BCG, M. tuberculosis H37Rv), irrelevant antigen (streptokinase­
streptodornase) and mitogen (PHA). Proliferation assays were carried out as described in 
Chapter 2. Briefly, CD8+ clones (100fll Of 106 cells/ml) wei'e cultured in round-bottomed 96 
well microtitre plates (Greiner) in the presence of irradiated feeder cells (SOJ..LI of 106 












days. 3H-thymidine was added to the wells the the last 8 hours of culture (44-52 hours). Well 
contents were harvested onto filter paper using a cell harvester (Titertek). Filter paper discs 
were placed into scintillation vials and 1ml of scintillation fluid was added. The amount of 
incorporated label was determined by measuring p-emission. 
The cytotoxic activity of the C08+ clones was evaluated using standard clone cytotoxicity 
assay techniques (see section 2.2.9). Briefly, day 4 adherent macrophage cultures derived 
from fresh PBMNC were infected with H37Rv and labelled with 5iCr for 24 hours ~lrior to the 
assay. On day 5, clone cells were prepared by washing free the growth medium and 
resuspending in fresh RPMI 1640 supplemented with 10% human AB serum. Clone cells 
were used 6 days (120 hours) after exposure to feeder cells, antigen and IL-2, 48 hours after 
re-stimulation with IL-2. Cells were counted using trypan blue exclusion staining, and cell 
concentration was adjusted to 106 cells/ml. Three effector to target ratios were used (Le. 
10:1, 3:1, and 0.3:1). Clone cells were then added to infected 51Cr-labelled macrophages 
after extensive washing with warm PBS supplemented with 5% FCS to remove 
unincorporated 51Cr label, non-adherent cells and antigen. Spontaneous release was 
assessed in wells to which no clone cells were added. The cytotoxicity assay was carried out 
over 16 hours. The percentage lysis was determined as discussed in Chapter 2. 
5.2.4. Assessment of suppressor activity of the CD8+ clones by determining their 
ability to inhibit proliferation of autologous CD4+ clones and PBMNC 
The suppressor activity of the C08+ clones (11.5A and 2.90) was assessed by determining 
the level of inhibition of proliferation mediated by the clones. Suppressor activity against both 
autologous PBMNC and C.P4+ clones was examined. The protocol was an adaption of 
several published methodologies (Sasazuki at a/., 1989; Salgame at al., 1991). Standard 
proliferation assays of both PBMNC and C04+ clones were carried out in the presence or 
absence of C08+ clone cells. 100~.tI of 106/ml responder cells (PBMNC or C04+ clone cells) 
were incubated with 50111 of 2 x 105/ml C08+ clone cells. The final concentration of cells was 
therefore 104 C08+ clone cells plus 105 responder cells. 50111 of antigen was also added to 
the wells. Various mycobacterial antigens were used including PPO, M. bovis BCG, M. 
tuberculosis H37Rv and a sonicated preparation of M. tuberculosis H37Rv. The irrelevant 
antigen streptokinase-streptodornase, and the mitogen PHA, were also included in certain 
experiments. Optimal concentrations of antigen for inhibition of proliferation were determined 
by dose response. Optimal suppression was observed at concentrations slighly lower than 
used to generate peak proliferative responses. Concentrations of antigens used in 
suppressor assays were as follows: PPO 2llg/ml; M. bovis BCG, 2.5 x 105 CFU/ml; M. 
tuberculosis H37Rv, 7.5 x 104 CFU/ml; sonicated preparation of M. tuberculosis H37Rv, 
241l1/ml; streptokinase-streptodornase, 200U/ml and 50U/ml respectively; PHA, 4.5 x 10-3 
mitogenic units/ml. Proliferative responses of PBMNC were assessed after 3 days (PHA) 












for both mitogenic and antigenic responses (see section 2.2.9). In PBMNC assays, 3H_ 
thymidine was added for the last 18 hours of culture for both PHA and antigen assays. In 
CD4+ clone proliferations, 3H-thymidine was added for the final 8 hours of culture. The level 
of 3H-thymidine incorporation was determined as described in Chapter 2. Briefly, microtitre 
well· contents were harvested onto filter paper, filter paper discs were placed into scintillation 
vials containing scintillation fluid, and the level of p-emission was determined using a p­
counter. Percentage suppression was calculated using the formula: % suppression = [1­
(cpm in presence of suppressor clone/cpm in absence of suppressor clone)] x 100%. 
To determine whether suppression mediated by clone 11.SA was dependent on cell function, 
the effect of inhibition of cellular metabolism on suppressor activity of the CD8+ clones was 
assessed. The ability of clone 11.SA to suppress PBMNC proliferation was determined after 
irradiation. Clone 11.SA cells were irradiated (SO Gy) and then used in standard assays for 
inhibition of proliferation (section S.2.4.). Control, untreated clone celis were also used to 
compare the effects of irradiation on suppressor activity. 
Depletion or inactivation of IL-2 by T lymphocytes mediating suppression has been 
implicated in affecting normal proliferative responses of responder cells (U et al., 1990). To 
assess the importance of IL-2 depletion on activity of responder cells, proliferation inhibition 
assays were set up in which endogenous IL-2 was added to the microtitre wells. IL-2 (100 
IU/ml) was added to wells containing PBMC, clone 11.SA cells, and mycobacterial antigen. 
In addition the effect of IL-2 addition on normal PBMC proliferation in the absence of clone 
11.SA was assessed. 
5.2.5. Assessment of the suppressor activity of CD8+ clone-derived supernatant fluid 
To determine whether the suppressor activity of the CD8+ clone was mediated by soluble 
factors, clone-derived supernatants were examined for their ability to suppress proliferation 
of autologous PBMNC. Supernatants were generated as for cytokine analysis (section 
S.2.2.) by incubating resting clone cells (1 week post exposure to antigen presenting cells 
and antigen) with freshly isolated PBMNC and antigen. Feeder cells (irradiated PBMNC) 
were prepared and diluted to 106/m l. Clone cells (1ml of 106/ml) were then added to SOOIlI of 
feeder cells and SOOIJ.I of antigen (H37Rv at 1 x 105 CFU/ml) in 24 well plates (Becton­
Dickinson). Each well (total volume 1 ml) therefore contained 106 clone cells, S x 105 feeder 
cells and antigen. In addition to H37Rv, the mitogen PHA was also used for generation of 
supernatants. Control wells containing feeder cells and antigen or mitogen, but no clone 
cells, were also set up. No IL-2 was added to any of the wells. Supernatants (SOOIJ.I) were 
removed after 48 hours of incubation at 3rc. The supernatants were filtered using a 











To assess the ability of the clone supernatants to mediate suppression of freshly isolated 
PBMNC, 100,..11 of 106/ml responder cells (PBMNC) were incubated with 50~1 of clone cell­
derived supernatant and 50~1 of antigen. The level of proliferative activity was determined 
after 6 days by adding 3H-thymidine to the cultures for the last 18 hours of culture. Cells 
were harvested, bottled, and the level of radio label incorporation was determined as 
described above. Parallel wells were set up for standard clone inhibition of proliferation 
assays (section 5.2.3.). Comparison of the levels of proliferation of the PBMNC to various 
antigens in the presence of either cloned suppressor T cells, or clone-derived supernatants 
allowed for an evaluation of the suppressor activity of soluble mediators. 
5.2.6. Assessment of the importance of cell-to-cell contact in suppression 
The importance of contact between the CD8+ clone cells and the responder cells (PBMNC) 
in the induction of suppression was determined using transwell plates (Costar). These plates 
are flat-bottomed 24-well plates which hold between 1 and 2ml of culture fluid. Experiments 
were initially carried out to determine whether the suppressor activity observed using 
microtitre plates (total volume 200~l/well) was mirrored when assays were scaled up to 2ml. 
The ratios of suppressor cells to responder cells (1: 10) were maintained, but 10 times the 
number of cells were added to each well (1 x 105 suppressor cells in upper chamber, 1 x 106 
PBMNC in lower chamber). Increasing the volume and numbers of cells was found not to 
affect levels of suppression observed .. 
In experiments utilising transwell plates, clone cells were placed in the upper chamber and 
104responder cells in the lower chamber. Irradiated feeder cells (5 x PBMNC) were co­
cultured with the suppressor cells to ensure antigen presentation and clone stimulation in the 
absence of responder PBMNC. In certain wells, feeder cells were excluded. Replicate wells 
were set up in which suppressor cells were incubated together with PBMNC in normal 24­
well plates. The level of proliferation of the PBMNC was determined in both normal wells, 
and the PBMNC cultured in the lower well of transwell plates. The effect of physical 
separtion of suppressor cells from reponder cells was then compared in the presence of 
various mycobacterial antigens, as well as the irrelevant antigen SK-SD. 
5.2.7. The role of IL-4, IL-10 and TGF-~ in the mediation of suppressor activity 
Cytokine analysis of clone 11.5A-generated supernatants indicated that this clone produced 
the cytokines IL-4, IL-5, IL-10, and TGF-~. The role of two of these cytokines (IL-4 and IL-10) 
in the suppressor activity of clone 11.5A was determined by adding neutral ising antibodies to 
the cytokines in certain experiments. Anti-human IL-4 (Boehringer Mannheim, Germany), 
and anti-human IL-10 (Serotec, Oxford, UK) were used at various concentrations (10ng/ml ­
10~g/ml) in assays which assessed levels of inhibition of proliferation mediated by clone 
11.5A. Additional experiments using neutralising antibody to TGF-~ (1 ~g/ml) (Promega) 











respective commercial companies) were used in control experiments. Antibodies were used 
singly or in combination with each other. 
In addition to blocking cytokine activity, the effect of addition of endogenous recombinant 
human IL-4 (Boehringer Mannheim) and IL-10 (Genzyme) on suppression of PBMNC 
proliferation was assessed. A range of concentrations (0.1 pg/ml - 10ng/ml) were used for 
both cytokines. The combined effect of addition of both cytokines was also monitored. For 
comparative purposes end09 :nous IFN-y (Genzyme) was used in certain experiments. 
5.2.8. Analysis of the MHC~restriction of the Ts clone 
The importance of MHC-restriction in mediation of clone suppressor activity was determined 
by examining the ability of the clone to suppress PBMNC proliferation of MHC-DR or -DO 
matched or mismatched donors. Tissue typing (HLA A, B, C, DR, DO) of the patient was 
carried out by the Tissue Immunology Department, University of Cape Town. Donors for 
experiments were selected from a database of tissue typed individuals who were readily 
available for blood donation. The ability of the clone to mediated suppression of proliferation 
of PBMNC from patients who were matched at DR or DO loci was determined by standard 
assays as described above. 
The role of DR in mediation of suppression was also investigated by examining the ability of 
L243 ascites to block suppression. Ascites containing anti-human HLA-DR antibodies (lgG1) 
was collected from mice immunised with the antibody (anti-DR) secreting cell line L243 
(Department of Immunology, University of Cape Town). Various dilutions of antibody 
preparations were used, with optimal inh bition being observed at a dilution of 10-6. Control 
experiments were carried out using isotypic mouse anti-human IgG1. L243 blocking was 
also carried out in standard CD4+ clone proliferation assays to determine the efficacy of the 
chosen concentrations to block proliferation. L243 was added to standard inhibition of 
proliferation assays in varying concentrations, and the proliferative response of PBMNC was 













5.3.1. Proliferative and cytolytic activity of CD8+ T lymphocyte clones 
The EMNC-derived C08+ clones 2.90 and 11 .5A both displayed poor proliferative 
responses to mycobacterial antigens. The proliferative responses of clone 11 .5A are 
illustrated in Figure 5.1. Clone 2.90 had a similar proliferation profile, with no single antigen 
response resulting in a mean delta cpm value > 5000. The poor proliferative responses to 
mycobacterial antigens may have been due to sub-optimal stimulation by the mycobacterial 
antigens used. These antigens may have been ineffective in stimulating a proliferative 
response in the C08+ clones due to the absence of the specific response-inducing 
mycobacterial epitope. The epitope specificity of HLA-OR-restricted C04+ suppressor T cell 
clones has been shown to reside between amino acid residues 439 and 448 of the 
mycobacterial heat shock protein , hsp65 (Mutis et al., 1994). Additional epitopes may induce 
proliferative responses in C08+ T cell clones which mediate suppression, however the use 
of whole organisms, PPO or sonicated cell material did not appear to provide the correct 
epitope for succesful proliferation. The nature of the mycobacterial antigen (whole cell 
versus soluble cell extract) did not appear to play a role in T cell clone response as 
evidenced by both PPO and H37Rv responses being similar. The absence of the co-receptor 
C028 in clone 11 .5A may have contributed to the apparent non-responsiveness. However, 
clone 2.90, which was equally non-responsive to mycobacterial antigens, did possess 
C028. This suggests that absence of this co-receptor was unlikely to account for the non­
responsiveness of both the clones. Both clones were, however, able to proliferate more 
strongly in response to the mitogen PHA. The proliferative responses to this polyclonal 
activator were similar to mycobacterial antigen-specific responses of C04+ clones (delta 
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Figure 5.1. Proliferative responses of clone 11.5A to PHA, PPD, BCG, H37Rv and SK-SO. 
Poor proliferative responses (mean ~cpm < 5000) were observed for all the antigens. 
Mitogenic (PHA) response is also illustrated. Data are representative of 4 experiments 











Although proliferative responses were consistently low for all mycobacterial antigens, 
stimulation indexes of > 3 were observed using PPD. This indicates that the PPD responses 
were significantly greater than those observed in non-stimulated cells. In the absence of any 
defined epitope specificity, PPD appeared to be the most successful activator of the CD8+ T 
cell clones. The broad range of secreted mycobacterial antigens present within PPD may 
have accounted for this responsiveness. 
The cytolytic activity of the CD8+ clones was also examined using a range of mycobacterial 
antigens. No cytolytic activity was apparent with either of the clones using standard 16 hour 
51Cr-release assays, as illustrated for clone 11 .5A in Figure 5.2. Standard 16 hour adherent 
macrophage target cytolytic assays involve labelling of the cells with Sl Cr and infection with 
antigen for 24 hours prior to the addition of the CTL clones. The kinetics of MHC class I 
antigen presentation differ from MHC class II (Rock and Goldberg , 1999), and the extended 
incubation prior to assessment of CTL activity may have resulted in sub-optimal antigen 
presentation . To address this, certain assays were carried out with short 4 hour pulsing with 
antigen directly before addition of the clones. This variation in antigen challenge did not 
affect the levels of cytolysis observed for either of the CD8+ clones. 
In both the overnight and 4 hour antigen challenge assays, the CD8+ clones were able to 
lyse target cells in the presence of PHA This finding confirms that the CD8+ clone cells 
possessed lytic machinery, but were not successfully stimulated to kill infected target 
macrophages by the antigens examined . This again may have been linked to the absence of 
the clone-specific mycobacterial epitope. The absence of any mycobacterial antigen-specific 














Figure 5.2. Cytolytic activity of clone 11.5A to PHA ( . ), H37Rv (.&), PPD (- ), BCG ( ) and 
SK-SD (e). Percentage specific cytolysis of antigen pulsed macrophages by the clone 
following 16 hours of incubation is illustrated. Poor cytolytic activity (specific cytolysis < 10% 












The inability of the CD8+ clones to respond to various mycobacterial antigens in both 
proliferation and cytotoxicity assays may have been indicative of induction of anergy. Anergy 
has been shown to be induced by inappropriate or unusual antigen presentation (Allen , 
1994, Broeren et ai , 1995). The possibility of the CD8+ clones being anergic was 
investigated further by assessing the ability of exogenous IL-2 to abrogate the anergic status 
of the clones . Addition of 100 IU/ml of recombinant IL-2 to proliferation assays had no effect 
on their apparent non-responsiveness. Th is contrasts with other reports of anerg ic T cells , 
where addition of exogenous IL-2 could restore antigen-specific responsiveness (Taams et 
a/. , 1998). Additional assessment of the role of I L-2 in CD8+ clone function is addressed in 
section 5.3.4. Anergy was also excluded due to the ability of the CD8+ clones to produce a 
range of cytokines (discussed below) 
5.3.2. Phenotypic characterisation and cytokine production by CD8+ clones 
Phenotyping of both of the CD8+ clones showed that they were CD3+ , CD4- , CD8+ , CD56-. 
As mentioned above, clone 11 .5A was CD28- , whereas clone 29D was CD28+ The status 
of CD28 expression was examined due to the report that suppressor T lymphocytes lack this 
co-receptor molecule (Li et ai, 1990) These authors also reported that although suppressor 
clones lacked CD28 , they were still able to respond to antigen, a finding not reproduced in 
the present study. 
Initial assessment of cytokine production by the clones has been discussed in Chapter 2. 
Following the initial characterisation of the clones, production of additional cytokines was 
examined . These included IL-5, IL-10, and TGF-~ A detailed comparison of cytokine 
production by the two CD8+ clones as well as several CD4+ clones and PBMNC is 
illustrated in Table 5.1. Clone 11 .5A was novel in that it not only produced the lowest level of 
IFN-y (8000 pg/ml) but uniquely produced IL-4 (150 pg/ml) as well, a pattern reminiscent of 
type-2 clones isolated from lepromatous leprosy as previously described (Modlin et a/. , 
1986; Mutis et ai , 1993b) Clone 11 .5A also produced high levels of IL-5 (4027 pg/ml), 
another type-2 cytokine By contrast, clone 2.9D produced high levels of IFN-y (22500 
pg/ml) , no detectable IL-4 , and the lowest levels of IL-5 (923 pg/ml), TGF-~ (2992 pg/ml) and 
IL-10 (505 pg/ml) . Comparable levels of type-2 cytokines IL-10 and TGF-~ were produced by 
clone 11.5A and all the CD4+ clones. The high levels of production of IL-4 and IL-5 by clone 
11 .5A were not observed in any of the CD4+ clones or PBMNC . 
Could the individual profile of cytokines account for the function of the specific clones? It is 
important to consider that these cytokines have cross-regulatory, counter balancing 
activities. Therefore, the possibility of suppressive function for any clone will be more related 
to the ratio of type-1 to type-2 cytokines than the absolute level of any single cytokine 
produced . The type-1 :type-2 ratio therefore more accurately reflects type-2 suppressive 











As shown in the table, clone 11 .5A had the lowest IFN-y:type-2 cytokine ratio of all the 
clones, confirming its greater suppressive potential. Most significant is the striking difference 
in IFN-y:IL-4 ratio between clone 2.9D and clone 11 .5A (>3750 vs 53). Furthermore, clone 
11.5A had the lowest IFN-y:type-2 ratio for IL-5, IL-10, and TGF-~ of all the clones and 
PBMNC, which probably accounts for the fundional difference between the two CD8+ 
clones and the unique suppressive activity of clone 11.5A. 
Table 5.1. Cytokine production by CD8+ and CD4+ clones as determined by clone-derived 
supernatant ELISA. All values expressed in pg/ml. TGF-B values are for acid hydrolysed 
supernatant fluids 
IFN=y IL-4 IL--5 IL-10 TGF-f3 
C08+ 11.5A 8000 150 4027 2121 4288 
C08+ 2.90 22500 <6 923 505 2992 
C04+ 3.20 56300 <6 <12 2122 8032 
C04+ 11.2E 50105 <6 <12 2579 6700 
C04+ 14.10C 52340 <6 <12 1767 4792 
C04+ 15.3A 42610 <6 <12 2345 6484 
PBMNC 24936 <6 <12 509 4192 
Table 5.2. Ratios of cytokine production by CD8+ and CD4+ effusion-derived clones and 
PBMNC. The ratios of IFN-y to type-2 cytokines (IL-4 and IL-5) as well as IL-10 and TGF-~ 
are indicated. 
IFN-y:IL-4 IFN=y:IL--5 IFN=y:IL-10 IFN=y:TGF-f3 
C08+ 11.5A 53 1.9 3.7 1.8 
C08+ 2.90 >3750 24 44 7.5 
C04+ 3.20 >9383 >4691 26 7 
C04+ 11.2E >8350 >4175 19.4 7.4 
C04+ 14.10C >8723 >4361 29.1 11 
C04+ 15.3A >7101 >3550 18 6.5 
PBMNC >4156 >2078 49 6 




Several unique features of the EMNC population including generation of a v-shaped from the 

LDA data , and the unique proliferation kinetics of the effusion mononuclear cells, suggested 

possible suppressor activity. In addition, the non-responsiveness of the CD8+ clones, 

coupled with the unique type-2 cytokine predominance and lack of CD28 (in clone 11 .5A) 

was suggestive of suppressor T cells. The ability of clone 11 .5A to mediate suppression was 





The levels of suppression of proliferation of CD4+ clones and PBMNC mediated by clone 
11.5A varied considerably. Figure 5.3 illustrates the level of suppression detected in 











used as responder cells, with mean levels of suppression > 78% for both mycobacterial 
antigens. The stronger suppression of PBMNC may have been due to less potent production 
of pro-inflammatory cytokines as compared with the clones. Production of IFN-y by PBMNC 
was 24936 pg/ml , whereas all C04+ clones produced >40000pg/ml. If cytokines were 
involved in suppression of proliferation, the very high levels of IFN-y produced by the C04+ 
clones may have masked the suppressor effects mediated by the type-2 cytokines. In 
addition fresh PBMNC are not antigen primed like C04+ clones, so the kinetics of induction 
of pro-inflammatory cytokines may differ from those of the clones. The delay in cytokine 
production by PBMNC may have allowed for early suppression mediated by clone-derived 
type-2 cytokines. The variability of suppression of C04+ clone proliferation may also have 
been related to differing cytokine production patterns. Clone 11 .2E produced lower levels of 
IFN-y than either clones 3.20 or 1OAC. Clone 3.20, which was most resistant to 
suppression, produced the highest level of IFN-y of all the C04+ clones. The balance 
between of clone 11 .5A-derived type-2 and C04+ clone type-1 cytokines may therefore have 
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Figure 5.3. Percentage suppression of proliferation of C04+ clones and PBMC mediated by 
clone 11 .5A. Blue bars represent suppression in the presence of H37Rv, red bars in the 
presence of PPO. Data are representative of 3 experiments showing standard deviation 
Figure 54. illustrates the inhibition of proliferation of PBMNC by clone 11 .5A in response to 
various antigens. Clone 11 .5A was able to induce high levels of suppression in response to 
all four mycobacterial antigens, with no suppressor activity being detected in response to 
SK-SO. Interestingly, suppression of proliferation in the presence of PHA was also detected . 
This contrasts with earlier reports on leprosy-derived clones in which suppressor activity was 
restricted to mycobactrial antigens (Modl in et a/. , 1986; Ottenhoff et a/. , 1986). A possible 
explanation for this finding is that the suppression observed was artefactual. PHA (Figure 
5.1) optimally stimulated clone 11 .5A. Resultant cell replication and activation may have led 
to exhaustion of IL-2 in the system. The absence of IL-2 may then have prevented any 
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Figure 5.4. Suppression of PBMNC proliferation by Ts clone 11 .5A. Blue bars represent 
proliferation in the absence of Ts, Red bars with Ts added. 4 mycobacterial antigens were 
used , as well as the mitogen PHA and the irrelevant antigen SK-SD. Data are representative 
of 4 experiments showing standard deviation 
By contrast, the C08+ clone 2.90 was unable to suppress proliferative responses. The 
presence of this clone led to an increase in delta cpm values irrespective of antigen used . 
Suppressor activity was thus unique to the type-O clone 11 .5A. The effect of clones 11.5A 
and 2.9D on PBMNC proliferation are summarised in Table 5.3. Negative levels of 
suppression in the presence of clone 2.90 are indicative of enhanced proliferative activity. 
Table 5.3. Levels of suppression (%) of PBMNC proliferation by clone 2.90 and 11.5A 
Antigen 2.90 11.5A 
H37Rv -25±9 78±8 
PPO -13±8 92±8 
BCG -21±11 83±11 
Rv-sonicate -9±9 84±10 
PHA -19±10 69±16 
SK-SO -27±13 -26±9 
5.3.4. IL-2 depletion could not account for antigen-specific suppression 
IL-2 is important for T cell growth and proliferation . Earlier studies have suggested that 
"suppression" mediated by T cells may simply be a consequence of IL-2 depletion by the 
suppressor cells (Li et aI., 1990). This possibility is unlikely due to the very low number of 
suppressor cells being added to responder cells in the inhibition assays. Final ratios of 1 
suppressor cell to 10 responder cells were used throughout the study. Such low numbers of 
suppressor T cells are unlikely to have exhausted IL-2 in the system, especially since clone 
11.5A proliferated poorly in response to mycobacterial antigens. To ensure that IL-2 
depletion was not taking place, certain assays were performed in the presence of 











significant effect on either the level of PBMNC proliferation , or on the ability of clone 11.5A to 
inhibit proliferation . These data indicate that IL-2 depletion was not a contributory factor in 
the activity of clone 11 .5A. However, as discussed above, IL-2 depletion may indeed have 
accounted for "suppression" in response to PHA 
5.3.5. CD8+ clone-derived supernatants could not mediate suppression 
Due to the fact that only clone 11 .5A, and not clone 2.90, was able to mediate suppression, 
the role of the predominant type-2 cytokines produced by clone 11.5A in this process was 
investigated further. Initially, the ability of clone 11.5A-derived supernatants to mimic the 
activity of the cells themselves was assessed. The addition of clone cell-derived supernatant 
fractions to PBMNC did not result in the high levels of suppression observed in the presence 
of the clone cells. These findings are illustrated in Figure 5.5. Although the clone 11.5A­
derived supernatant fractions could not replicate the suppressive effect of the cells 
themselves, some inhibition of PBMNC proliferation was still apparent. This suggests that 
optimal suppression may have been dependent on localised production of type-2 cytokines. 
In addition , these findings indicate that cytokine activity was not solely responsible for all 
suppressor activity observed. The role of type-2 cytokines in the mediation of suppression is 
discussed further in section 5.3.8. 
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Figure 5.5. Clone 11.5A-derived supernatant and irradiated clone cells could not mediate 
suppression . Black bar (1) represents proliferation of PBMNC to H37Rv. Red bar (2) 
illustrates the effect of the presence of clone 11.5A on PBMNC proliferation. Blue bar (3) 
illustrates the effect of addition of clone 11.5A-derived supernatant on PBMNC proliferation . 
Green bar (4) illustrates the effect of irradiation of clone 11 .5A on its ability to inhibit PBMNC 
proliferation. Data are representative of 3 experiments ± standard deviation. 
5.3.6. Suppression was dependent on functional integrity of the CD8+ clone 
Since cytokines or other soluble lymphocyte-derived factors could not solely account for the 
strong suppressor activity of clone 11 .5A, the importance of cellular events was examined by 
irradiating the clone cells. Irradiation serves to damage the DNA and also to initiate 











but it would inhibit cellular activation and associated processes such as expression of novel 
receptors and/or the production of novel cytokines. 
The effect of irradiating clone cells on their ability to inhibit PBMNC proliferation is presented 
in. Figure 5.5. The addition of irradiated clone cells resulted in potent inhibition of 
suppression . However, irradiated cells did not completely abrogate inhibition of PBMNC 
proliferation . The absence of possible activation-dependent processes may have accounted 
for this finding . AIH, lugh irradiated cells show diminished levels of cytokine production, it 
seems unlikely that inhibition of cytokine release could account for the strong inhibition of 
suppression observed . Interaction of clone cells with antigen-presenting cells may have 
resulted in the altered expression of cell surface receptors, or the down-regulation of APC­
specific receptors such as CD80 or CD86, a phenomenon which has been characterised in 
xeno-specific suppression (Jiang et al., 1998; Liu, Z. et al., 1999). Alteration in receptor 
expression may therefore represent an important alternative mechanism of suppression of 
PBMNC proliferation. The importance of an intimate interaction between the suppressor 
cells and the resoponder cells for optimal suppression was addressed by physically 
separating the two populations during the suppressor assays. 
5.3.7. Contact between suppressor cells and effector cells · was essential for 
suppression 
Dual chamber tissue culture dishes are useful for examining whether biological phemonena 
are dependent on cell-to-cell contact, or whether soluble mediators are sufficient to elicit a 
response. This is possible since cell populations remain separated by a semi-permeable 
membrane between the two chambers but diffusion of soluble mediators is unaffected . In the 
current study, transwell plates (Costar) were used to determine whether contact between 
suppressor cells (clone 11.5A) and responder cells (PBMNC) was necessary for inhibition of 
proliferation. 
Standard assays, which assess inhibition of proliferation, were adapted to 24-well plate 
format. Preliminary experiments illustrated that increasing cell volumes and numbers for the 
larger wells, but retaining cell ratios , did not affect PBMNC proliferation or the inhibition 
thereof. Transwell plates were subsequently used to physically separate the two populations 
of cells The upper wells contained clone 11.5A cells and irradiated PBMNC as antigen 
presenting cells. The lower well contained PBMNC alone. Control experiments were carried 
out in standard 24 well plates (Becton-Dickinson) without separation of the cell populations. 
The effect of separating suppressor cells from effector PBMNC is illustrated in Figure 5.6. 
Although inhibition of proliferation occurred in standard 24-well plates, in the Transwell 
plates inhibition of proliferation of PBMNC was reduced. The abrogation of suppression was 











the two cell populations greatly inhibited the suppressor activity of clone 11 .5A, some 
residual suppression still occurred, possibly mediated by cytokines . No suppression of 
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Figure 5.S. The effect of separation of clone 11 .5A cells and responder PBMNC. Column 1 
illustrates PBMNC proliferation to PPD (A) , BCG (B) , H37Rv (C) , and SK-SD (D) . Column 2 
illustrates the effect of addition of clone 11 .5A to PBMNC. Column 3 indicates the effect of 
incubating clone 11 .5A and responder PBMNC in transwell plates which inhibits cell-to-cell 
contact. Data are representative of 3 experiments showing standard deviation. 
Contact between suppressor and responder cells was necessary for optimal suppression of 
PBIIJII\JC proliferation. These experiments could not conclusively indicate whether direct 
contact between the suppressor cells and the responder PBMNC, or indirect contact via the 
antigen presenting cells was the pivotal interaction. Direct interactions between suppressor 
and responder cells may include MHC-TCR interactions without co-receptor engagement. T 
lymphocytes which express MHC class " molecules, and which present antigen to helper T 
cells in the absence of co-stimulation can induce anergy in the responder T cells (Pichler 
and Wyss-Coray, 1994; Broeren et aI., 1995). Alternatively, the suppressor cells may affect 
expression of certain molecules on the surface of the APC , which in turn could inhibit 
responder T cell activity. Xenospecific suppressor T cells are able to down-regulate 
expression of CD80 and CD86 on APC (Jiang et aI., 1998). Presentation of antigen to 
responder to cells in the absence of co-stimulation, or in the presence of altered co­











addition , interaction between suppressor cells and APC may result in induction of 
immunosuppressive cytokine production and release . Macrophage-derived cytokines such 
as IL-6 and TGF-p have been implicated in suppressor activity in TB (Wadee et ai , 1993 ; 
van Heyningen et al., 1997; Rojas et al., 1999). Additional undefined macrophage-derived 
suppressor factors have been implicated in induction of non-responsiveness or oral 
tolerance (Channon et ai , 1999; Channon and Kasper, 1996). Interaction of all three cell 
populations (i.e . suppressor T cells , responder T cells, and macrophages) may thus be 
important for induction of optimal suppression . The interaction of th, se cells at the APC 
surface may also amplify the suppressive effect of type-2 cytokines produced by the 
suppressor cells. Release of cytokines such as IL-4 and IL-10 by suppressor cells situated 
adjacent to responder cells could result in inhibition of responder cell activation . Although the 
exact nature of the contact-dependent interactions remains unknown, the fact that both 
suppressor and responder populations were provided with APC in these experiments, 
suggests that competition for receptor sites on APC was not an important contributory factor 
in suppression . 
5.3.8. IL-4 and IL-10 partially mediated suppression 
The role of type-2 cytokines produced by clone 11 .5A in the mediation of suppressor activity 
was investigated further by neutralisation of IL-4, IL-10 and TGF-p The contribution of each 
cytokine to the net suppressive effect was assessed by determining the level of abrogation of 
PBMNC proliferation inhibition (i.e . suppression) in the presence of cytokine-specific 
neutralising antibodies. The effect of addition of neutralising antibodies to both IL-4 and IL-10 
is illustrated in Figure 5.9. 
The addition of both anti-IL-4 and anti-IL-10 abrogated the inhibition of prol iferation mediated 
by clone 11.5A Neither of these antibodies affected antigen-specific PBMNC proliferation in 
the absence of suppressor T cells . Isotypic control antibodies had no effect on clone 11 .5A­
mediated suppression . The levels of inhibition of suppression were optimal at 0.5 ~g/ml and 1 
~g/ml for anti-IL-4 and anti-IL-10, respectively. The addition of anti-IL-4 reduced suppression 
in the presence of both PPD (65% to 50%), and H37Rv (59% to 44%). Anti-IL-10 reduced 
suppression from 65% to 46% and from 59% to 34% in the presence of the same antigens. 
Maximal reduction of suppression was observed when these two antibodies were added 
simultaneously . Levels of reduction of suppression from 65% to 40% in the presence of PPD, 
and 59% to 31 % in the presence of H37Rv were observed. The enhanced inhibition of 
suppression in the presence of both anti-IL-4 and anti-IL-10 was not, however, truly 
synergistic. Partial inh ibition of M leprae-specific suppressor cell activity by neutralisation of 
IL-4 and IL-10 has previously been reported (Mutis et ai , 1993b). In that study, variable 
levels of abrogation of T cell unresponsiveness were observed following inhibition of type-2 
cytokine activity. However, Salgame et al. (1991b) have reported that the activity of IL-4 











added. This contrasts with the findings of both the present study and that of Mutis et al. 
(1993b) , and suggests that the suppressor activity in the latter two studies was not solely 
cytokine-mediated. 
Anti-TGF-p antibody did not affect clone mediated suppression, nor did the antibody to the 
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Figure 5.7. Effect of anti-IL-4 (0.5 ~g/ml) and anti-IL-10 (1 ~g/ml) on suppression of 
proliferation mediated by clone 11.5A. Experiments were carried out using three antigens: 
PPD, H37Rv and SK-SD. Standard PBMNC proliferation is indicated by the blue bars. The 
red bars indicate proliferation in the presence of clone 11 .5A. The effect of anti-IL-4, anti-IL­
10 and a combination of both are indicated by the yellow, green, and purple bars, 
respectively. Isoypic control antibodies had no effect on suppressor activity . Data are 
representative of 3 experiments showing standard deviation 
Clone-mediated suppression was therefore at least partly mediated by the cytokines IL-4 and 
IL-10. To confirm this, the effect of addition of exogenous IL-4 and IL-10 on clone-mediated 
suppression was examined. These data are illustrated in Figure 5.8. The addition of both 
these cytokines augmented the inhibition of PBMNC proliferation by clone 11 .5A. Maximal 
inhibition of proliferation (82%) was observed in the presence of a combination of 100 pg/ml 
of IL-4 and 2000 pg/ml of IL-10. This was equivalent to a 13% increase in suppression over 
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Figure 5.8. Effect of addition of IL-4 and IL-10 at various concentrations on level of 
suppression mediated by clone 11.5A. Maximal enhancement of suppression was observed 
at 100pg/ml IL-4 (77% suppression) and 2000pg/ml IL-10 (80% suppression). The increase 
in suppression was not statistically significant. Data represent mean values of 3 experiments 
These results appear to conflict with the finding that clone generated supernatants could not 
mediate suppression (section 5.3.5) . However, addition of IL-4 or IL-10 to PBMNC in the 
absence of clone 11 .5A had no effect on proliferative ability of the PBMNC. Only when IL-4 
and IL-10 were added to the suppressor clone cells was suppression enhanced . This 
suggests that both clonal receptor and cytokine involvement was necessary for suppression 
to occur. The fact that blocking cytokine activity did not completely abrogate suppressor 
activity confirmed that cytokines alone were not capable of inducing suppression. 
5.3.9. Suppression was MHC class" DR-restricted 
Detailed analysis of suppressor T cell activity in lepromatous leprosy has indicated that 
these cells are MHC class II-restricted. Both HLA-DR-restriction (Ottenhoff et al., 1986; Li et 
aI., 1990), and HLA-DO-restriction (Modlin et al., 1986) have been reported . The MHC­
restriction of suppressor activity mediated by clone 11.5A was investigated on several levels. 
Initially, the suppressor activity of clone 11.5A in HLA-DR-matched and -mismatched donors 
was inliestigated . The patient was tissue typed at the Tissue Typing Laboratory , Groote 
Schuur Hospital , Cape Town . The tissue typing profile of the patient, as well as other donors 
used in the study, are illustrated in Table 5.4. 
Table 5.4. MHC class I and II (HLA-A, -B, -C, -DR, -DO) typing of patient AJ and 3 other 
donors 
MHC class I MHC class II 
AJ A2,24 B15,47 Cw-,­ DR12 ,1 3 001 ,7 
RG A2 ,31 B51 ,62 Cw3,­ DR4,11 003,­
BR A2 ,24 B7,51 Cw3,6 DR2,13 001 ,­
EC A3,30 B7,65 Cw7,8 DR2,11 001 ,7 
Using donors matched at DR or DO, the activity of clone 11 .5A in inhibiting proliferation was 











(EC), or neither DR nor DO (RG) were used in standard suppressor assays. The ability of 
clone 11.5A to suppress proliferation of the PBMNC is illustrated in Figure 5.9 
Apart from suppression of autologous PBMNC, clone 11.5A was only able to inhibit PBMNC 
proliferation in donor BR. This donor was matched at both DR and DO loci. PBMNC from 
donor EC (matched at DO alone) were unaffected by clone 11.5A. These findings indicate 
that matching of the DR13 loci between AJ and BR was sufficient to induce suppression at 
comparable levels. This finding confirms earlier reports that suppressor clones are DR 
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Figure 5.9. The ability of clone 11.5A to mediate suppression of PBMNC in HLA-DR­
matched and -mismatched donors. Blue bars represent PBMNC proliferative responses to 
H37Rv in the 4 donors. AJ is the response of autologous PBMNC. EC and RG are two DR­
mismatched donors, and BR is DR-matched to AJ. Green bars represent proliferation in the 
presence of clone 11.5A. Red bars illustrate the effect of addition of the type-1 CD8+ clone, 
2.90. 
The co-culturing of CD8+ clone 11 .5A with allogeneic donors resulted in enhanced 
proliferation of PBMNC cells from donors EC and RG. This enhanced proliferation was 
probably due to allogeneic stimulation of T cell activity. Co-culturing of clone 11 .5A with 
PBMNC from donor BR did not result in this enhanced proliferative activity. This may have 
been due to early induction of suppressor activity in the DR-matched cultures . Early 
suppressor activity may have prevented subsequent expansion of T cells due to any 
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Figure 5.10. Inhibition of suppressor activity mediated by clone 11 .5A. Addition of L243 
(anti-DR) ascites (10'6) to PBMNC and clone 11.5A completely abrogated inhibition of 
H37Rv-specific proliferation of PBMNC (column marked L243). Addition of an isotypic 
control antibody to PBMNC and clone 11.5A had no effect on clone 11.5A-mediated 
suppression (column marked IgG control) 
Mouse anti-human HLA-DR antibody from ascites fluid of animals inoculated with L243­
derived HLA-DR molecules was used in neutralisation assays. Anti-HLA-DR antibody was 
able to completely abrogate suppressor activity of clone 11 .5A at a dilution of 10.6 (Figure 
5.10) . This finding appeared to confirm H LA-DR locus involvement in mediation of 
suppressor activity . Why did neutralisation of HLA-DR not affect PBMNC proliferation? A 
possible explanation may be that low concentrations of anti-DR antibodies were used. 
Antigen presenting cells are likely to express higher levels of DR than suppressor T cells. 
Complete inactivation of the T cell-associated DR molecules may not necessarily have been 
accompanied by complete APC-associated DR blocking. Residual DR molecules on the 
APC could then have enabled CD4+ T cell proliferation to occur in the presence of low 
concentrations of neuralising antibody. The detection of PBMNC proliferation in the 
presence of anti-DR indicates that complete blocking of DR molecules did not occur. 
However, abrogation of suppressor cell activity in the presence of neutralising antibody, 
suggests that suppressor cell-associated DR was important in the mediation of suppressor 












In tuberculosis the paradox of simultaneous immune activation and suppression has been 
well documented (Ellner, 1997; Vanham et al., 1997). Features indicative of 
immunosuppression include suppressed proliferative responses to mycobacterial antigens 
and impaired cytokine secretion by T lymphocytes. The relative strength of either activation 
or suppression may be important in determining the outcome of the disease. The patient in 
the current study encapsulated both of these phenomena, with the mononuclear cell 
population derived from the pleural effusion displaying elements of ooth activation and 
suppression. Immune activation is advantageous for the host in that a strong pro­
inflammatory response generally results in infection clearance and recovery. Immune 
suppression, on the other hand, is more often associated with systemic spread of infectious 
organisms and ultimately death. Enhanced antigen-specific immunosuppression therefore 
bestows a distinct advantage upon the infecting organism (Marrack and Kappler, 1994). 
Antigen-specific immune suppression is particularly well characterised for viral diseases 
J 
(Smith, 1994; Ploegh, 1998), however it is also a feature of certain intracellular bacterial 
diseases, particularly the mycobacterial diseases leprosy and tuberculosis (Bloom at al., 
1992). 
Induction of suppressor activity in T lymphocytes represents one of several possible 
responses following exposure to antigen. Generally, antigenic stimulation of T lymphocytes 
results in one of the following responses: (i) activation, (ii) ignorance, (iii) apoptosis, (iv) 
anergy, or (v) suppression. Activation encompasses both clonal expansion and enhanced 
functional activity (e.g. cytokine secretion and cytotoxicity). Activation represents the up­
regulatory arm of cellular immunity. Ignorance, also termed non-responsiveness, refers to 
the decision of a T lymphocytes not to respond to a particular antigen. Apoptosis (or 
programmed cell death) is the process which results in clonal deletion of T lymphocytes. 
Apoptosis is an important homeostatic control mechanism which regulates T lymphocyte 
expansion at disease sites. Anergy (or induced non-responsiveness), unlike ignorance, 
refers to antigen-specific unresponsiveness in situations which would normally result in 
activation. Suppression is an antigen-specific T lymphocyte response which results in active 
inhibition of normal responder T lymphocyte activation. Not all immune suppression can' be 
accounted for by the activity of T lymphocytes, indeed a range of possible mediating factors 
has been proposed. 
The processes of clonal deletion, anergy and suppression all represent the down-regulatory 
arm of normal cellular immune responses. Anergy and suppression are closely related 
phenomena, and as such these terms are sometimes used interchangeably. Both 
suppressor cells and anergic cells are often non-responsive to antigenic 3timulation in vitro. 
In addition, both cell types are able to induce suppression (Lombardi et al., 1994; Frasca et 












is alive but fails to display certain functional responses (e.g. proliferation, IL-2 or other 
cytokine secretion, cytotoxicity) upon exposure to antigen under otherwise stimulatory 
conditions (Schwarz, 1996). T cell anergy can be induced by exposure to an antigen 
stimulus in the absence of co-stimulation (Mueller at al., 1989). In the presence of co­
stimulation, the addition of altered peptide ligands can also cause anergy (Allen, 1994). In 
addition, antigen presenting T cells which express MHC class II molecules can induce 
anergy in preactivated T cells even when co-stimulation is provided (Pichler and Wyss­
Coray, 1994; Broeren at aI., 1995). In models of autoimmunity' e.g. experimental arthritis and 
allergic encephalomyelitis, states of immunological unresponsiveness have been induced by 
T cell clones that following in vitro culture have lost their effector capabilities (van Eden at 
aI., 1985; Sun at al., 1988). These findings seem to support the notion of anergic T cells 
themselves inducing anergy or unresponsiveness in other responder T cells (Frasca et al., 
1997; Taams et al., 1998). The suppressor activity of anergic cells is linked to interference in 
normal T cell activation processes, and excludes a role for cytokines (Lombardi et aI., 1994). 
Anergic cells can often be induced to respond to antigen in the presence of exogenous IL-2, 
which suggests that inability to produce lL-2 is an important defining feature of these cells 
(Taams et al., 1998). This represents an important distinction between anergic and 
suppressor cells, since suppressor cells retain the ability to produce IL-2, and several other 
cytokines, following antigen stimulation. 
Although the two CD8+ clones generated in the current study were non-responsive to 
antigenic stimulation in vitro, their mechanism of action was not linked to their apparent 
anergic status. Since only one of the non-responsive CD8+ clones could suppress 
proliferation of lymphocytes, non-responsiveness or anergy did not explain the suppressor 
~ctivity of clone 11.5A The inability to induce antigen responsiveness in the presence of 
exogenous IL-2 coupled with the ability to produce a range of cytokines in response to 
antigenic stimulation, confirmed that these clones were not anergic (Taams et al., 1998; 
Schwartz, 1996). The non-responsiveness to mycobacterial antigens in vitro was probably 
due to the absence of specific mycobacteria-derived epitopes to which the clones were able 
to respond. 
Immune suppression in intracellular infections such as M. tuberculosis and M. leprae. 
generally refers to the inhibition of antigen-responsive helper T cell activity. Suppression in 
TB may be associated with one or more overlapping phenomena. These include (i) 
compartmentalisation of antigen-responsive cells to disease sites, (ii) cytokine-mediated 
induction of T lymphocyte non-responsiveness, or interference in antigen presenting cell 
function, (iii) enhanced levels of apoptosis of responder lymphocytes, (iv) anergic cell­













Compartmentalisation of antigen-responsive cells to the disease site is accompanied by a 
reduction in the number of responder cells in the peripheral blood (Barnes et al., 1989; Dieli 
et al., 1999). The reduction in responder lymphocytes in the peripheral blood is reflected by 
an in vitro reduction in proliferation and/or cytokine production. Compartmentalisation occurs 
during active disease and peripheral blood anergy can be reversed following chemotherapy 
(Dieli et al., 1999). The suppression detected in the present patient was not related to 
compartmentalisation since peripheral blood responses to mycobacterial antigen were 
normal. 
The predominance of immunosuppressive cytokines in TB has been linked with skin test 
non-responsiveness. The ratio of IL-4/IL-10 to IL-12 seems to be important in determining 
skin reactivity, and suggests that cytokine ratios may determine disease outcome (Baliko et 
al., 1998). In addition. a recent study has correlated enhanced patient IL-4 mRNA 
expression with more extensive disease manifestations (Seah et al.. 2000). These patient­
based studies seem to indicate that predominance of cytokines such as IL-4 and IL-10, at 
time of infection, may dictate outcome of disease. T cell unresponsiveness in TB has also 
been linked to direct inactivation of T lymphocytes by the macrophage-derived cytokines 
TGF-~ and IL-10 (Vanham et aI., 1997; Hirsch et al., 1996). Th  synergistic effects of these 
cytokines have recently been shown to inhibit T cell production of interferon-y (Othieno et al., 
1999), suggesting that cytokines may actively inhibit important T cell functions. In addition, 
inhibition of APC function (i.e. antigen presentation and co-stimulatory molecule expression) 
by cytokines such as TGF-~ and IL-10 may result in immune suppression (Wahl, 1992). M. 
tuberculosis infection of macrophage APC itself can results in enhanced production of 
inhibitory cytokines such as IL-6 (Van Heyningen et al., 1997), and decreased production of 
important pro-inflammatory cytokines such as IL-12 (Ellner, 1997). In the present study, the 
CD8+ clone, which was able to inhibit T cell prOliferation, produced type-2 cytokines, and 
had the lowest ratio of type-1 to type-2 cytokines of all the clones and PBMNC. The activity 
of type-2 cytokines in the mediation of suppression was also demonstrated by the partial 
abrogation of suppression in the presence of neutralising antibodies to IL-4 and IL-10. 
However, cytokines alone could not account for all suppressor activity, suggesting that 
additional components were involved. 
Enhanced apoptosis, possibly related to T cell overstimulation, may account for much of the 
immune suppression observed in TB (Hirsch et al.. 1999). Increased numbers of apoptotic 
cells in responder Th1 populations have been reported in TB. Although levels of apoptosis 
were not examined in the present study. viability of Doth effusion- and peripheral blood­
derived mononuclear populations was high. This does not, however, exclude a possible role 
for clonal deletion in effecting certain immunosuppressive features of the patient. The activity 
of CD8+ clone 11.5A could not be explained by induction of enhanced T cell apoptosis. The 












death of other responder cells. If the suppressor clone cells induced apoptosis of 
lymphocytes, neutralising cytokine antibodies would have been unable to affect levels of 
suppression. However, these findings do not exclude the possibility of more than one 
mechanism of suppression induction. 
Suppressor T cell activity has been defined in two circumstances. Firstly, in situations where 
there is a failure to respond to a particular antigen in the presence of certain T cells and 
where responsivel;~ss is restored by removing the T cells (Gershon and Kondo, 1971). 
Secondly, in situations where unresponsiveness can be induced in individuals otherwise 
capable of responding. This normally occurs when low dose soluble antigen is introduced, or 
where antigen is chemically modified or coupled to self antigens (Mitchison, 1964; Mueller at 
a/., 1989; Claman at a/., 1980). Of particular importance in the present study has been the 
description of antigen-specific suppressor T cells in leprosy. 
Mediation of suppression in T8 by anergic and/or suppressor T lymphocytes has not been 
documented. Suppressor T cells have, however, been isolated from the lesions of 
lepromatous leprosy patients. In lepromatous disease there is an increase in the number of 
CD8+ T cells in lesions (Modlin et aI., 1983). In addition lepromatous lesions have been 
found to contain an abundance of the type-2 cytokines IL-4; IL-5 and IL-10 (Yamamura et 
aI., 1991). T lymphocytes isolated from such lesions display antigen unresponsiveness and 
removal of the CD8+ cells resulted in restoration of antigen responsiveness in certain cases 
(Modlin et a/., 1986). Lines and clones of lepromatous lesion-derived T cells (both CD4+ and 
CD8+) have been generated and characterised (Modlin et aI., 1986; Ottenhoff et a/., 1986). 
At the clonal level these cells produce high levels of IL-4 and IL-5, but little IFN-y (Salgame 
et al., 1991a). In several studies, suppressor T lymphocytes have been shown to lack CD28 
(Li et al., 1990). The activity of these cells has been found to be MHC class II-restricted, 
either at the HLA-DQ locus (Modlin et a/., 1986), or the HLA-DR locus (Otten hoff et al., 
1986). However, exceptions to this pattern have been noted (Mutis et a/., 1994). Although 
the exact mechanism whereby such cells induce immune suppression remains unknown, the 
outcome of their activity is the induction of clonal anergy or apoptosis (Salgame et al., 
1991b; Sambhara and Miller, 1991). 
The mechanisms by which antigen-specific suppressor and/or anergic T lymphocytes effect 
inhibition of proliferation of responder cells are not clearly understood. Several possible 
scenarios have been suggested focusing on either the APC or the responder T lymphocyte 
as the prime target. At the level of the APC, suppressor cells may directly lyse the APC, 
induce suppressor factor/cytokine production by the APC, compete for MHC molecules 
and/or co-receptors on the APC, mediate alteration in expression of receptors (MHC, co­
receptors) on the APC, or directly inhibit APC function via cytokine activity. At the level of the 












activity (Le. exhaust IL-2 supplies, inhibit IL-2 production by T cells, or down-regulation IL-2 
receptor expression), directly inhibit T cell responses via inhibitory cytokine activity, or 
provide inappropriate signalling to responder cells (e.g. direct antigen presentation without 
co-receptor involvement), resulting in non-responsiveness. 
CD8+ suppressor clones in leprosy appear to induce unresponsiveness by interference with 
normal antigen recognition by the responder T cell (Salgame et al., 1989). This may involve 
direct antigen presentation by the suppressor T cell to responder cells, or blocking of antigen 
recognition by the responder T cell. The activity of suppressor T cells is dependent on CD8 
and TCR expression, as well as MHC class II expression (Salgame et al.. 1991b). 
Monoclonal antibodies to all these molecules abrogated suppression. Other potential 
mechanisms proposed include release of suppressor factors which inhibit responder cell 
activity, release of cytokines such as IL-4 and IL-5 which directly inhibit responder celis, 
competition for antigen or MHC receptors, and deactivation or blocking of IL-2 resulting in 
responder cell anergy (Bloom et al., 1992). 
Competition for MHC molecules or co-receptors on the surface of antigen presenting cells by 
the suppressor T cells (Webb et al., 1994), was unlikely to hav  played a role in the present 
study since there were far fewer CD8+ clone cells than PBMNC present in suppressor 
assays. Direct lysis of APC by suppressor cells (Bloom et ai, 1992; Taams et al., 1998), was 
excluded on the basis that the clone showed minimal cytolytic ability when exposed to 
macrophages pulsed with mycobacterial antigen. Dysregulation of IL-2 activity by 
suppressor cells (Li et al., 1990), was excluded due to the finding that addition of exogenous 
IL-2 did not affect suppressor activity. Although IL-2 depletion was unlikely to have 
accounted for antigen-specific supp eSSion, it may have been a contributory factor in PHA­
mediated suppression due to optimal activation of suppressor cells. 
Direct inhibitory cytokine effects are linked to a predominance of type-2 cytokines in 
generalised immunosuppression. Suppressor T cell-derived cytokines such as IL-4, IL-5, IL­
10, and TGF-f3 have been associated with immune suppression. The activity of 
immunosuppressive cytokines was confirmed in the present study. Both IL-4 and IL-10 were 
directly implicated in T lymphocyte-mediated suppressor activity. Macrophages can also 
produce immunosuppressive cytokines such as IL-6, IL-10 and TGF-f3. as well as other 
mediators such as arachodonic acid metabolites (prostaglandins and leukotrienes). The 
induction of cytokine release from macrophages by the suppressor cells may involve a 
suppressor cell cytokine mediator. In addition, alteration of macrophage receptor expression 
may also be linked to the activity of a suppressor cell-derived cytokine. This latter 
phenomenon is important since xenospecific suppressor T cells are able to affect expression 
of B7.1 and B7.2 molecules (Lederman and Sucia-Foca, 1999). These molecules are 












induction of anergy in responder cells. Enhancement of 87.2 expression, and engagement 
with the CTLA-4 receptor would result in non-responsiveness. Similarly, reduced expression 
of 87.1 would reduce CD28 engagement, also resulting in non-responsiveness. Direct 
activity between suppressor and responder cells may be linked to cytokine effects, but also 
to direct signalling . Suppressor cells may express MHC class II, and as such may be 
capable of presenting antigen to T cells (Schwarz, 1996). If this occurs in the absence of 
appropriate co-stimulation, anergy may be induced . 
How are suppressor T cells generated? There is no clear indication of how cells develop a 
suppressor phenotype, however several studies have suggested that antigen-primed CD4+ 
Th cells when exposed to CD8+ cells in the absence of specific antigen, induce a 
suppressor phenotype. When the suppressor T cells are subsequently incubated with 
responder cells in the presence of antigen , suppression occurs (Koide and Engleman, 1990; 
Damle and Engleman, 1989; Damle et aI., 1984). These findings suggested that suppressor 
cells respond to antigen recognition molecules on Th cells. In studies using xenospecific 
suppressor cells, it has been demonstrated that suppressor cells inhibit CD4+ Th1 
responder cell activity via modulation of macrophage receptor expression, most importantly 
87.1 and 87.2. These studies implicate cross-talk between three cell types as pivotal in 
determining response (Lederman and Suciu-Foca, 1999; Jiang et aI. , 1998). A similar 
scenario has been proposed in anergic cell induced suppression (Taams et aI. , 1998). At 
least two functional scenarios have thus been demonstrated in vitro. This, in combination 
with suppressor cells in leprosy that have been shown to mediate effects at least partially via 
cytokine inactivation , suggests complex interactive pathways in the mediation of active 
suppression . 
















Possible mechanisms of CD8+ T lymphocyte-mediated suppression are illustrated in Figure 
5.11 :-The CD8+ T cell clone 11.5A, whichproduced both type-2 and type-1 cytokines, was 
able to inhibit responder PBMNC and done proliferation. The clone lacked CD28, was HLA­
DR-restricted, was non-resp~msive to mycobacterial antigen, was non-cytolytic and was not 
.... . • ~ I 
anergic. Suppression was partially mediated by T cell-derived cytokines IL-4 and IL-10 (A 
and E., Figure 5.11), but cytokine a~tivity was apparent only in the presence of the Cloned 
suppressor T cell. Cell-to-cell contact was required for suppression to occur (B., C., and F., 
Figure 5.11). 'This contact dependency has been observed in bothlepramiri-specific and 
. . . . i ' . ., . 
anergic suppressor clones as well (Li et aI, 1990; Taams et aI, 1998). It seems possible that 
the suppressor cell on recognisihg antigen, was' activated and produc~d a range of 
cytokines. These cytokines may h~ve induced macrophages to 'alter receptor expression, 
preventing optimal signalling to responder celis (C., Figure 5.11).- Macrophages may also 
have been stimulated to produce 'immunosuppressive' cytokines (D., Figure' 5.11). 
Alternatively, interaction between rksponder celis and suppressor cens (F., Figure 5.11)­
possibly via inappropriate MHC-TCR signalling - may have induced non-responsiveness. 
The activity' of suppressor T cells, similar to that descfibed in 'the present study, may help to 
explain immunosuppressive phenomena at disease sites. The'occurrence of cells that .can 
... ,,'; • ,f -,.,,_ 
mediate immune suppression would help to explain the divergent manifestations of infection 
with M. tuberculosis. An increase if, the number of suppressor celis cihd/orin their aCtivity 
could account for rapid organism, spread observed in certain patients.' An increase in 
'" . I. .;.... . " . 
mycobacterial numbers is disadvan'tageous to the host, therefore inappropriate stimulation of 
suppressor cells activity needs to b~ counteracted: It is possible that infeCtiOUS mycobacteria 
have· exploited the 'activity of t~ese' cells. Manipulation of antigen' pre:;entation, 'co­
stimulation, 6ytokinesecretion or o\her mechanisms wcfuld' enable enhanced . replication and 
spread. A more deta'iled assessniJnt of the universality 'of such suppressor cells and their 
! 
rore in the pathogenesis of IB isr~quired, h.owever it appears tnat the:activity of such cells 
may enhance certain features off immune suppression~ and therefore they represent a 












Peripheral blood-derived CD4+ CTL possessed a predominant Fas-mediated killing 
component, whereas CTL derived from the effusion had a predominant granule exocytosis 
killing mechanism. What causes this discrepancy? It seems that the unique localised 
environment of the effusion is able to initiate an enhanced granule-dependent mode of killing 
in TB antigen-responsive cells. This may be due to the cytokine milieu, or to the recognition 
of unique pathogenic epitopes derived from M. tuberculosis. The predominant granule­
mediated component of killing may also be accompanied by an increased concentration of 
particular cytolytic granule components. These components may themselves be pivotal in 
the clearance of infection following lysis of infected macrophages by CD4+ CTL. 
CD8+ CTL have been reported to be mycobactericidal if they kill macrophages by granule 
exocytosis (Stenger et al., 1997). Although CD8+ lymphocytes are now accepted as playing 
some role in immunity to TB, the fact that they are not expanded at disease sites, and that 
elimination of CD8+ cells does not cause death of mice, or exacerbation of disease in 
humans, suggests their role is not pivotal (Schluger and Rom, 1998). This is probably due to 
the nature of the infection, with mycobacteria remaining within the phagosome in host cells. 
Access to the MHC class I pathway is in this way prevented, and subsequent stimulation of 
antigen-specific CD8+ cells is sub-optimal. For this reason MHC class II-responsive CD4+ 
cells may have assumed the role traditionally played by CD8+ cells in intracellular viral 
infections. 
Generation of cytolytic activity in vitro in the absence of CD8+ cells has been shown to result 
in CD4+ CTL which possess a granule exocytosis mechanism of killing (Sevilir-Williams and 
Engelhard, 1997). In TB, CD4+ cells would be expanded (possibly in the lymph nodes) and 
then recruited to the disease site, in the absence of extensive CD8+ expansion. This may 
result in generation of granule mediated killing, which in itself is mycobactericidal. 
Mycobactericidal killing is important and suggests that the cytolytic activity of CD4+ T cells, 
together with cytokine activation of macrophages, may be essential in clearance of infected 
organisms from the disease site. This has major implications in the development of possible 
immunotherapeutic control measures. Determination of the factors unique to the disease 
site, which may play a role in the generation of mycobactericidal CD4+ cells, could be 
incorporated into possible vaccine strategies. Promoting CD4+ CTL activity could enhance 
the efficacy of novel antibiotic treatments, or other anti-microbial measures. A clearer 
understanding of the mycobacterial peptides that stimulate cytolytic CD4+ T cells, and of the 
cytokine milieu of the disease-associated site, would aid in development of possible future 
therapeutic procedures. In addition, an investigation of the cytolytic granule components of 
the CD4+ CTL, arid how particular granule constituents are able to kill mycobacteria, is 












The other important finding in this study has been that a CD8+ clone derived from the 
effusion could suppress proliferation of autologous lymphocytes. This suggests that CD8+ T 
cells may playa regulatory role in TB. Switching off the expansion of Th 1 cells at disease 
sites may be important to prevent tissue damage caused by certain cytokines. Without 
regulation of the localised inflammatory response, necrosis and disseminated spread of 
organisms may occur. The activity of any population of cells, which can down-regulate the 
inflammatory response, would thus normally be beneficial to the host. The activity of 
suppressor T lymphocytes becomes proble.:natic if they are over-active or stimulated before 
adequate clearance of infecting organisms has occurred. In the present study suppressor 
cells may have accounted for an inhibition of the pattern of accelerated in vitro 
responsiveness to mycobacterial antigens observed in over two thirds of patients with TB 
pleuritis (Lukey et al., 1996, Lorgat et al., 1992b), The generalised non-responsive immune 
reactions to TB of a sub-population of patients may be due to expansion and stimulation of 
suppressor T cells. A more detailed understanding of the mechanisms by which these cells 
operate would aid in treating such patients. Switching off active suppression may result in 
the development of a normal Th1 dominant response. 
Although this study has highlighted important new functional roles for CD4+ and CD8+ 
lymphocytes, certain limitations are apparent. Due to continuous use of T cell clones, this 
study concentrated on a single patient. A cross-sectional study would aid in determining the 
universality of these findings. If mycobactericidal cytolytic CD4+ cells and/or suppressor 
CD8+ cells can be demonstrated in a broad cross-section of TB patients, the findings of the 
present study would have served as the basis for novel immunotherapeutic approaches in 
tuberculosis research. 
Mycobactericidal activity may be the result of late events associated with apoptosis, or novel 
components of the cytolytic granules, Future experiments need to address involvement of 
apoptosis-associated caspases and compare PBMNC and effusion lines, in order to identify 
any mediators selectively involved in effusion induced apoptosis. An understanding of the 
components of the cytolytic T cell granules - what initiates their production, and of how they 
kill bacteria when the cell is undergoing apoptosis - would aid in the development of future 
treatment strategies. If novel mycobacterial epitopes can be shown to be involved in 
development of predominant granule-dependent CTL, then a vaccine incorporating these 
mycobacterial determinants that stimulate mycobactericidal CD4+ T cell activity would 
ensure a rapid and efficient clearance of organisms. Similarly, an understanding of the 
antigenic determinants which stimulate suppressor cells, definition of unique markers 
expressed by these cells, and an understanding of the environment which favours their 
expansion, could help in the design of anti-tuberculosis therapies. Exclusion of any 
mycobacterial components that could trigger suppressor activity, would ensure greater 












responses. Enhancing the protective host response will result in more rapid organism 
clearance, allowing for shorter treatment time, and thus aid in the future combating of this 
disease. 
In conclusion, the current study describes novel functional activities of both CD4+ and CD8+ 
T lymphocytes in the host immune response to M. tuberculosis infection. This study 
represents the first report of both TB patient-derived mycobactericidal cytolytic CD4+ T cells, 
and a CD8+ suppressor T cell clone. The description of the novel actvities of these two cell 
populations may be important for a better understanding of protective immune responses at 
the localised disease site, and may ultimately aid in the development of a TB vaccine and/or 
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